Control of S-phase genes in fission yeast by McInerny, Christopher
Control of S-phase genes in fission yeast 
Christopher Mclnerny 
Thesis presented for the Degree of 
Doctor of Philosophy 
at the University of Edinburgh 
1992 
8% 
This thesis is dedicated to my parents, with love and gratitude 
'what can be said at all can be said clearly, and what we cannot talk about 
we must pass over in silence' 
'Back off - I'm a scientist!' 
Declaration'  
111 
I declare that this thesis was composed by myself and that the research 
presented is my own. Due acknowledgement is made within the text for 




Working for this thesis over the last two and half years have been a 
very happy period of my life. Not only do I feel that I have learnt a great 
deal, but I've been lucky enough to see how exciting science can be, and 
how much I enjoy doing it. This happiness is due to a number of people. 
Primarily, I would like to thank Peter Fantes for his supervision of 
this work, and for all the care that has taken to encourage me to try to 
become a better scientist. 
I would like to thank all the people in the Fantes lab for creating an 
such a good working atmosphere. Particularly I would like to thank 
Emma Warbrick for initiating me into molecular biology, Stuart MacNeill 
and Pamela Harris for so carefully reading and commenting on the 
manuscript and for advice on experiments, Jim Creanor for the fun of 
running an eluiator rotor, and Joan Davidson and Aileen Greig for 
superb technical support. 
I would like to thank Lee Johnston for the hospitality that he 
showed to me while I worked in his laboratory, and Noel Lowndes for the 
pleasure I had working with him. 
Thanks also to the photographers, Frank and Dave, for doing the 
figures, and to the Oswell DNA service for their excellent oligonucleotide 
service. 
Also I would like thank the following: Richard Meehan for ideas in 
-the shower (which unfortunately went down the plughole), and for telling 
me to 'just do it' when I seemed to hesitate with a new experiment; Sally 
Cross for ice-packs and a prompt and reliable taxi service; Jillian Charlton 
for matchmaking and the reverse sequence primer; Joe Lewis for the 
terminal transferase idea; Shaun Mackie for allowing me to 'get angry' on 
the squash court; Eugen Ulrich for being a pain in the neck; Cohn Gordon 
for intense talks about science between pints of 801..; SERC for financial 
support; and my commiserations to the Macintosh Mouse that died while 











Chapter 1: Introduction 
1 a Introduction i 
lb Cell cycle concepts 
i 	Phases 2 
ii Control points 2 
iii 	Coordination of growth and division 3 
1 c How is the cell cycle studied? 
i 	Yeasts 3 
ii Xenopus oocytes and sea urchin eggs 5 
1 d Fission yeast 
i 	Classification, cell biology and cell cycle 6 
1 e Molecular mechanisms of cell cycle control 
i 	Mitotic control 9 
ii Dependency of mitosis on S-phase 10 
iii 	Dependency of S-phase on mitosis 11 
iv S-phase control 11 
1 f Eukaryotic transcriptional regulation 
i 	Promoter structure and function 18 
ii Yeast cell cycle transcriptional control 20 
1 g Universal cell cycle controls? 22 
1 h Aims of the work 23 
Chapter 2: Materials & Methods 
2 a Commonly used reagents and buffers 	 24 
2 b Nucleic acid manipulations 
i 	Dissolving and storage 	 26 
ii Extraction with phenol/chloroform 	 26 
iii 	Precipitation of nucleic acids 	 26 
iv Quantification and quality control 	 27 
v 	Plasmid vectors 	 27 
V 
2 c Molecular analysis of DNA 
i 	Restriction enzyme digestions 30 
ii Ligations 30 
iii 	Agarose gel electrophoresis 30 
iv Acrylamide gel electrophoresis 31 
v 	Purification of large DNA fragments 31 
vi Purification of small DNA fragments 31 
vii 	Gel electrophoresis of RNA 32 
viii Filter hybridization of RNA 34 
ix 	Autoradiography 37 
2 d Radio-labelling of DNA molecules 
i 	Random-primed labelling 38 
ii End-labelling 39 
iii 	Purification of labelled DNA 40 
2 e Fission yeast manipulations 
Strains 42 
ii 	Media and growth conditions 42 
iii Genetical analysis 44 
iv 	Cell physiology 45 
v Transformation 46 
vi 	Preparation of nucleic acids from fission yeast 48 
vii Preparation of protein from fission yeast 51 
2 f Escherichia coli manipulations 
i 	Strains 53 
ii Media and growth conditions 53 
iii 	Plasmid preparation 55 
iv Transformation 58 
2 g DNA sequencing methods 
i 	Deletions 60 
ii Production of single-stranded DNA 63 
iii 	Sequencing 65 
iv Gel electrophoresis 66 
2 h Polymerase chain reaction 68 
2 i Primer extension 70 
2 j Bandshift assay 73 
Results Chapters 
Chapter 3: Sequence analysis of cdc22 
3 a Introduction 75 
3b Experimental strategy 76 
3c Sequence 
Open reading frame 78 
ii 	Intron 82 
iii 5'sequence 85 
iv 	3 sequence 85 
3d Sequence comparisons 86 
3e Conclusions 89 
vi 
Chapter 4: cis- and trans-acting components 
controlling cdc22+ expression 
4 a Introduction 90 
4b Mapping transcriptional start 91 
4c MCBs 94 
4 d MCBs confer cell cycle gene expression in fission yeast 98 
4 e Identification of a DSC1-like complex in fission yeast: DSP1 100 
4 f Cell cycle behaviour of DSP1 107 
4 g Conclusions 110 
Chapter 5: cdclO+ 
5 a Introduction 111 
5b in vivo temperature shift of cdclO mutants 112 
5 c in vitro temperature shift of cdclO mutants 114 
5 d Supershift of DSP1 116 
5 e Effect of cdclO mutants on cdc22+ and reporter gene expression 118 
5 f Effect of cdclO-C4 on cdc22 transcript levels 121 
5 g Cell cycle behaviour of cdc22 transcript in cdclO-C4 cells 124 
i Dominance relation of cdclO alleles 126 
5 j Conclusions 128 
Chapter 6: Discussion 
6 a Conclusions 129 
6b Model 130 
6 c Problems with the model 
i 	Introduction 131 
ii What is the constitution of DSP1? 131 
iii 	What does DSP1 bind in the cdc22 	promoter? 134 
iv cdclO-C4 136 
v 	Are there other genes under DSCl/MCB control? 137 
vi How does DSPI induce transcription of cdc22 7 138 
vii 	Are there alternate modes of induction of cdc22 7 139 
viii What other roles might cdc1O 	have in C1? 140 
6 d General considerations 
i 	Why is cdc22 	cell cycle regulated? 141 
ii Is the DSPI /MCB system likely to be present in higher eukaryotes? 143 
References 	 144 
Appendix A: Oligonucleotides 	 155 
Appendix B: Publications 	 158 
vii 
Abbreviations 
Ax Absorbance (turbidity) at x nm wavelength 
AMV avian myoblastosis virus 
AT!' adenosine triphosphate 
BSA bovine serumalbumin 
CCB cell cycle box 
cdc, CDC cell division cycle 
cDNA complementary DNA 
CPS counts per second 
dATP deoxyadenosine triphosphate 
dcl'!' deoxycytidine triphosphate 
DEPC diethyl pyrocarbonate 
dGTP deoxyguanosine triphosphate 
DMSO dimethyl suiphoxide 
dNTPs all four deoxy triphosphates 
DTT dithiothreitol 
dTI'P deoxythymidine triphosphate 
DNA deoxyribonucleic acid 
EDTA ethylenediaminetetraacetic acid 
EEO electroendosmosis 
EMM Edinburgh minimal medium 
Exo III exonuclease III 
Fig. Figure 
GABP guanosine adenine binding protein 
Hepes N-(Hydroxyethyllpiperazine-N-[2-ethanosulphonic acid] 
IPTG isopropylthio--D-galacto side 
kb kilobase 
kDa kilodalton 
MCB MIuI cell cycle box 
min minutes 
MOPS 3-(N-morpholino)propane-sulphonic acid 
MPF maturation promoting factor 
mRNA messenger RNA 
MW molecular weight 
NETO new end take off 
ORF open reading frame 
PCR polymerase chain reaction 
PEG polyethylene glycol 
PMSF phenylmethylsuiphonyifluoride 
PNK polynucleotide kinase 
RNA ribonucleic acid 
rpm revolutions per minute 
RNR ribonucleotide reductase 
SDS sodium dodecyl sulphate 
ssDNA single stranded DNA 
ts temperature sensitive 
UAS upstream activating sequence 
UV ultraviolet light 




YE yeast extract medium 
viii 
Abstract 
The work described in this thesis uses the fission yeast 
Schizosaccharomyces pombe as model system to analyse the molecular 
processes that control passage through the G1 and S-phases of the cell cycle. 
In particular, the work analyses the control of expression of cdc22, a gene 
whose transcript varies in abundance during the cell cycle with a 
maximum at the G1-S phase boundary. 
Chapter 3 describes the sequencing of cdc22 and shows it encodes 
the large subunit of ribonucleotide reductase, an enzyme required for 
DNA precursor metabolism. 
In the next Chapter, cis-acting elements, resembling MCBs 
previously identified in budding yeast, are shown to be present 5' to the 
cdc22+ open reading frame. MCBs can confer cell cycle expression on a 
heterologous gene in fission yeast, implicating them in controlling 
periodic expression of cdc22. A trans-acting complex that specifically 
binds MCBs is identified, and called DSPI- for DNA synthesis control in S. 
ombe. DSP1 is related to DSC1, an MCB binding activity identified in 
budding yeast. 
Experiments in Chapter S demonstrate that the gene product of the 
cdc10 START gene, p87CdCO3 is a component of DSP1. Furthermore, 
cdc22+ is shown to be constitutively over-expressed in a cdclO mutant, 
cdclO-C4. Over-expression of cdc22 in cdc10-C4 is recessive to wild-type. 
It is proposed that DSP1 containing p87CdC10 C4 is hyperactive and 
deregulated as a transcription complex. 
In summary, p87CdClO is part of a transcription complex that controls 
expression of cdc22, a gene required for DNA synthesis. Thus this work 
demonstrates a molecular link between START and S-phase. 
Chapter 1: Introduction 
1 a Introduction 
The cell cycle can be broadly defined as the ordered biological 
processes that occur when a cell duplicates its cell contents and divides, 
forming two daughter cells. 
Over the past few years there have been considerable advances in 
our understanding of the molecular mechanisms that control progression 
through the eukaryotic cell cycle. This rapid progress is due to the 
summation of two areas of scientific analysis: genetics in yeasts 
(particularly the fission yeast Schizosaccharomyces pombe and the 
budding yeast Saccharomyces cerevisiae); and biochemistry in metazoan 
cells such as Xenopus oocytes and sea urchin eggs. Using these systems, 
proteins have been identified that are required for cell cycle progress. 
Functions for the proteins have been found, and molecular mechanisms 
suggested which control various cell cycle stages. These cell cycle 
mechamisms are of wide interest because homologues of the proteins are 
present all eukaryotic cells. 
This introduction will discuss current understanding of the 
mechanisms that control the cell cycle. A vast number of genes and 
proteins from a wide range of organisms are now implicated in 
controlling all stages of the cell cycle: to discuss them all would be beyond 
the scope of this introduction. I will concentrate on the principal 
organisms used as cell cycle models systems, and discuss only those genes 
and proteins for whom cell cycle functions have been found. The 
molecular processes that control mitosis and cytokinesis will not be 
mentioned. 
First, general cell cycle concepts are outlined, followed by a 
discussion of the main model organisms used to study cell cycle 
mechanisms. Next there is a detailed description of the molecular 
mechanisms that control the two most important cell cycle control stages, 
START and the G2-M transition. Finally, the role of transcriptional 
regulation in cell cycle control is discussed. 
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Figure 1 A 	The four successive phases of a typical eukaryotic cell cycle. 
The cell cycle is split into four phases: Gi, 5, G2, and M. S-phase 
is the period during which DNA synthesis occurs when the chromosomes are 
duplicated. During M-phase mitosis occurs resulting in the separation of 
duplicated chromosomes. C1 and C2 are 'gaps 'between S and M phase and 
contain the important cell cycle control stages of START and the G2-M 
transition. 
lb Cell cycle concepts 
i 	Phases 
The eukaryotic cell cycle has been traditionally divided into four 
distinct phases: G1, S. G2, and M (see Fig. IA). S-phase represents DNA 
synthesis, the period during which the DNA of the cell is replicated. M-
phase represents mitosis, where the mitotic spindle is formed and the the 
sister chromatids are separated. G1 and G2 were originally designated as 
'gaps' between these two phases, but are now known to contain the two 
important control points of the cell cycle, the restriction point or START, 
and the G2-M transition. 
ii 	Control points 
In higher eukaryotic cells and in budding yeast, the principal control 
point of the cell cycle occurs during G1. Cells which have been propagated 
in tissue culture, if starved of serum, cease to proliferate and enter a 
quiescent state from G1, called Go (Baserga, 1985). G1 has been split into 
two parts, depending on the serum sensitivity of the cell (Zetterberg & 
Larsson, 1985). Cells in early G1 are serum-sensitive and so if starved of 
serum enter G0; in later G1, cells becomes serum-insensitive and continue 
to enter S-phase, even in absence of serum. The transition point between 
these two parts of C1 has been called the 'restriction point' (Pardee, 1974). 
A stage analogous to the restriction point in G1 has been identified 
in budding yeast, and is called 'START' (Hartwell, 1974). START is the 
stage at which cells become committed to either the vegetative or sexual 
life cycles. Cells arrest at START if deprived of essential nutrients, or 
when exposed to mating pheromone from cells of the opposite mating 
type. Additionally, START is the arrest point of CDC28. 
Fission yeast is different from higher eukaryotes and budding yeast 
in that START is not rate-limiting for cell cycle progress during 
exponential growth, this role being taken over by the control over entry 
into mitosis (Nurse, 1975). START is less understood in fission yeast: the 
only evidence for its existence coming from the ability of cells at different 
stages during G1 to conjugate: START is the arrest point of the cdc2 and 
cdclO mutants (Nurse & Bissett, 1981). 
2 
Budding yeast cells enter an analogous stage to G0 - stationary phase 
- when nutritionally arrested, before the completion of START. 
Fission yeast cells can enter stationary phase from either G1 or G2 (Costello 
et al., 1986). 
iii 	Coordination of growth and division 
When cells grow faster than they divide, they become larger; and 
when they grow slower than they divide, they get smaller. In a normal 
population of growing cells cell size at division remains constant, so 
coordination between growth and division must be occurring. The model 
most attractive to explain this coordination is that cell are able to gauge 
their size by means of some internal sizer', and are are only able to pass 
certain cell cycle stages having obtained a critical size (Nurse & Fantes, 
1981). Examples of such cell cycle stages are START in budding yeast 
(Johnston et al., 1977), and the G2-M transition in fission yeast (Nurse, 
1975). 
1 c How is the cell cycle studied? 
i 	Yeasts 
The seminal breakthrough in yeast cell cycle studies was the 
identification, by mutation, of genes required for cell cycle progress 
(Hartwell et al., 1974; Nurse et al., 1976). Such cell division cycle genes (cdc 
or CDC for fission or budding yeast, respectively) encode mutants in 
proteins essential for cell cycle progress; thus, the cells block at the 
particular cell cycle stage at which the gene product is required. Obviously, 
cells with mutations in such essential genes would be inviable: this 
problem is overcome by using conditional mutants which only display 
their mutant phenotype under certain conditions. 
Temperature-sensitive (ts) cdc mutants, at the permissive 
temperature, progress through the cell cycle apparently normally: on 
shifting to the restrictive temperature cells accumulate which cannot 
traverse the specific cell cycle stage that the gene product is required at. 
This is because the change in the gene product only disrupts its function at 
a certain temperature. In fission yeast the cdc phenotype is manifested 
usually as abnormally long cells which cannot divide, but continue to 
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grow. In budding yeast CDC arrested cells have a range of phenotypes 
from an unbudded cell, to a mother cell with a single daughter bud. 
Temperature-sensitive cdc mutants have been selected at both high or low 
temperatures: this reflects the respective mutant protein's inability to 
function at the restrictive temperature. 
Techniques have been developed which permit the cloning of cdc 
genes by mutant rescue (Nasmyth & Reed, 1980). Shuttle vectors which 
can be maintained in both bacteria and yeast have been constructed 
(Wright et al., 1986). Gene libraries, made from yeast chromosomal DNA, 
are ligated into the shuttle vectors, and the recombinant DNA 
transformed into yeast cdc strains at the permissive temperature (Beach & 
Nurse, 1981). On incubating the cells at the restrictive temperature, those 
cells transformed with a vector containing the equivalent cdc gene, or 
other genes that can complement the cdc lesion, survive. Once the gene 
has been cloned, this allows sequencing and subsequent genetic 
characterization. Knowing the sequence of a gene permits further 
manipulations, such as over-expression of the gene and its deletion from 
the chromosome. 
Other genes that interact with cdc genes can be isolated by two 
methods. The first method exploits the fact that mutants can be 
complemented by other genes when present in multiple copies. Such 
multicopy suppressors may be cloned when attempting to screen for the 
cdc+ gene using a wild-type genomic library, as the shuttle vector carrying 
the complementing gene is maintained in fission yeast at high copy 
number. Examples of multicopy suppressors include the CLNs and 
suc22+, which complement cdc28ts and cdc22ts mutants, respectively 
(Hadwiger et al., 1988; Gordon & Fantes, 1986). The second method uses 
the fact that mutants can sometimes be complemented by compensatory 
mutations in other genes. Such extragenic suppressors can be cloned by 
making a genomic DNA library from cells carrying the extragenic 
suppressor, and using this to complement the original cdc mutation. An 
example of an extra genic suppressor is sdcl + which, when mutated, 
suppresses cdclO mutants (Caligiuri & Beach, 1992). 
Cloning of a cdc gene allows its gene product to be analysed 
biochemically. The gene product can be expressed in bacterial systems for 
the production of specific antisera, which permits the identification of 
native protein from yeast cell extracts. A number of proteins required for 
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cell cycle progress have been found to be putative protein kinases or 
phosphoproteins from sequence data: specific antisera permits formal 
characterization of such functions. Additionally, antisera allow sub-
cellular localization of the gene product by indirect immunofluorescence, 
which may be informative about potential functions. 
A wide range of genes required for a variety of cell cycle processes 
have been isolated by such genetic approaches (Review: Fantes, 1989), 
including START (cdc2, cdc1O and CDC28), S-phase (cdc22, cdc17, 
CDC9), mitotic onset (cdc2, cdc13, cdc25, CDC28), mitosis (cut7, nuc1), 
and cytokinesis (cdcl 1 + and cdcl 6+).  The functions of the products some of 
these genes are discussed in Section le. 
ii 	Xenopus oocytes and sea urchin eggs 
In contrast to yeasts, cell cycle studies in higher eukaryotic cells 
began with biochemical analysis. Identification of proteins involved in 
cell cycle progress was permitted by the exploitation of several 
experimental systems which provide populations of synchronously 
dividing cells. Two examples of such systems are Xenopus oocytes and sea 
urchin eggs. 
Fully mature Xeno pus oocytes are physiologically arrested in 
prophase I of meiosis, but can be artificially stimulated to resume cell 
division by the addition of progesterone (Review: Masui & Clark, 1979). 
The same response can be observed if the cytoplasm of mature oocytes is 
transferred to immature oocytes, as the recipients enter metaphase and 
undergo oocyte maturation (Masui & Markert, 1971). The component 
transferred between the two oocytes which is responsible for inducing 
metaphase, was named maturation promoting factor (MPF; Masui & 
Markert, 1971). MPF has been purified (Lohka et al., 1988), and shown to 
consist of a homologue of p34cdc2  (Gautier, et al., 1988; Dunphy et al., 1988) 
and a mitotic cyclin (Gautier et al., 1990). 
Sea urchin eggs can be stimulated to divide synchronously en masse 
after addition of sperm. Such large numbers of dividing cells allowed the 
discovery of a group of polypeptides that oscillate in level during the cell 
cycle, with steady-state synthesis and accumulation until metaphase when 
they are rapidly and specifically degraded as cells enter anaphase (Evans et 
al., 1983). These polypeptides were christened 'cyclins', and are required 
for mitotic entry (Swenson et al., 1986; Murray et al., 1988). Cyclins have 
homologues in both fission and budding yeast. Fission yeast cyclin 
homologues so far isolated are cdc13(Hagan et al., 1989), puc1 (Forsburg 
& Nurse, 1991) and cig1 (Bueno et al., 1991). Budding yeast cyclins 
include CLNs (Hadwiger et al., 1988), CLBs (Surana et al., 1991) and SCB1 
(Ghiara, et al., 1991). 
1 d Fission yeast 
i 	Classification, cell biology and cell cycle 
The fission yeast Schizosaccharornyces porn be Lindner is a 
unicellular ascomycete yeast, whose basic growth properties have been 
well defined (Mitchison & Nurse, 1985; Tanaka & Kanbe, 1986). 
Fission yeast is a rod with hemispherical ends, and grows by length 
extension alone (Figs. lB and 1C). During interphase cells grow only at the 
tips, and increase in length for approximately three quarters of the cell 
cycle. Cell size can therefore be used as a marker of a cell's position in the 
cell cycle. Cells begin the cell cycle -7 .Lm in length, and first grow at one 
end, until they reach a length of -9.5 p.m, when then initiate growing at 
both ends. This transition has been termed new end take off (NETO; 
Mitchison & Nurse, 1985). Cells grow -1.7 times faster during bipolar 
growth than monopolar growth, until they reach -14 p.m, when they enter 
the "constant volume" stage. The cells then stop growing, undergo 
mitosis and cytokinesis, and lay down a medial septum, which is cleaved 
to form two daughter cells. 
The cytoskeleton of fission yeast has studied by indirect 
immunofluoresence, and provides additional markers for cell cycle stages 
(Review: Robinow & Hyams, 1989). In interphase cells an array of 
cytoplasmic microtubules is present which run longitudinally from one 
pole to another (Hagan & Hyams, 1988). At the beginning of mitosis these 
disappear and are replaced by an intranuclear mitotic spindle. During 
anaphase A this spindle separates the sister chromosomes, and in 
anaphase B it elongates, and moves the duplicated nuclei to the ends of 
the cells. As the nuclei reach the ends of the cells, two microtubule 




NETO 	 Itosis 	 Septation 
I 	 I 
0 	 0.34 	 0.75 	 0.86 	 1.00 
Figure 1 	B 	Phase contrast image of living fission yeast cells. 
Arrows indicate a mitotic cell and a cell undergoing septation. 
Bar - 51.Lm. 
C 	Schematic diagram summarizing the principal events of 
the fission yeast cell cycle. 
The numbers indicate that stages at which events occur in a wild 
type cell cycle of abitrary total length 1. In the first 0.34 of the cell 
cycle cells grow at one end, until new end take off (NETO), when bipolar 
growth commences. At a stage 0.75 through the cell cycle cells enter the 
constant volume stage, and proceed into mitosis. From 0.86 to the end of the 
cell cycle, cytokinesis and septation occur to form two daughter cells. 
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organising centres are formed at the equator, which, coincidentally with 
the breakdown of the mitotic spindle and start of the next interphase, seed 
new cytoplasmic microtubules in the two daughter cells. 
Actin microfilaments occur as two forms in fission yeast: dots and 
filaments (Marks & Hyams 1985). Dots are only found in growing regions 
of the cell. Before NETO, when cells are only growing at one end, dots are 
only found at one end; after NETO, dots are found at both ends. Filaments 
have been observed during the two major transitions of cell growth: the 
initiation of single end growth following septation, and the switch to 
bipolar growth at NETO. A microfilament ring is formed at the equator 
during anaphase A, predicting the site of septation. 
Fission yeast has a typical higher eukaryotic cell cycle at a cytological 
level, as each of the described phases are discrete and consecutive, the only 
major difference being that the nuclear membrane remains intact during 
mitosis (Review: Nurse, 1985). In particular, DNA is fully duplicated 
before a mitotic spindle is formed and mitosis occurs. This is in contrast to 
budding yeast, the organism traditionally used as a cell cycle model system, 
where the mitotic spindle is formed before DNA synthesis occurs, though 
mitosis does not occur until the DNA is replicated. Furthermore, in a 
recent reappraisal of the phylogeny of fission yeast has argued that it is 
more closely related to metazoans than budding yeast (Sipiczki, 1989). 
Fission yeast should, therefore, be a good model for studying eukaryotic 
cell cycle processes. 
G2 	 Mitosis 
Figure 1 D 
	
Outline model for the control of mitotic onset in fission yeast. 
Entry into mitosis, due to activation of p34cdc2,  occurs by a 
combination of dephosphorylation of tyrosine (Y) at residue 15, and 
complexing to p56' 13. Dephosphorylation is promoted by a combination of 
p56' 13 and p8Ocdc25,  which together form a phosphatase. Inhibition of 
p34cdc2 activation is mediated by the action of the p107V2l  and miki 
protein kinases. 
1 e Molecular mechanisms of cell cycle control 
i 	Mitotic control 
The fission yeast cdc2 gene product is extremely important in the 
control of mitotic onset (Review: Nurse, 1990). At the restrictive 
temperature cdc2 mutants arrest at two cell cycle stages: one arrest point 
being at the G2-M boundary, and the other in C1 at START (Nurse & 
Bissett, 1981). 
The cdc2+ gene encodes a 34 kDa protein, p34CdC2,  which is a 
serine/threonine protein kinase (Simanis & Nurse, 1986). cdc2 has a 
pivotal role at the G2-M boundary, as the regulation of p34cdc2  activity 
determines the precise timing of entry into mitosis (Fig. ID). 
p34CdC2 activation is determined by its phosphorylation state. A 
tyrosine residue at position 15 must be dephosphorylated for p34CdC2 
activation, and consequent entry into mitosis (Gould & Nurse, 1989). 
Additionally, at this stage, p34CdC2  is complexed with a mitotic cydin, 
encoded by the cdc13 gene (Hagan et al., 1988; Booher & Beach, 1988). 
Two classes of gene products act antagonistically to regulate the 
phosphorylation state of p34CdC2  at tyrosine 15: p80cdc25 dephosphorylatés 
and so activates p34cdc2 ; p107Weel and mikl phosphorylate, and so 
inactivate p34CdC2  (Fig. 1D). 
If cdc25 is over-produced cells enter mitosis prematurely, which is 
reflected in a smaller size at division (Russell & Nurse, 1986). Thus, 
cdc25 is a dose dependent inducer of mitosis. A number of observations 
suggest that cdc25 induces mitosis by dephosphorylation of the tyrosine 
residue 15 of p34CdC2.  cdc25 is dispensable if p34CdC2  is permanently 
dephosphorylated, by mutating the tyrosine to phenylalanine (Gould & 
Nurse, 1989). A mammalian T-cell phosphatase will compensate for loss 
of cdc25 (Gould et al., 1990); and p80CdC25 produced in bacteria will activate 
p34CdC2 by dephosphorylating tyrosine 15 in vitro (Kumagai & Dunphy, 
1991). Although the predicted cdc25 gene product is not obviously 
similar to phosphatases, some homologies have been noticed (Moreno & 
Nurse, 1991). Recently, it has been shown that a mitotic cyclin promotes 
the phosphatase activity of p80cdc25 (Galaktionov & Beach, 1991). As 
cdc25 transcript varies in amount during the cell cycle with a maximum 
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at the G2-M boundary (Moreno et al., 1991), it is proposed that it is a 
combination of a mitotic cyclin and p8Ocic25 that forms the phosphatase 
that activates p34cdc2. 
Inactivation of p34cdc2  is under complex regulation. If the tyrosine 
residue at position 15 remains permanently phosphorylated, cells cannot 
enter mitosis (Gould & Nurse, 1989). Two genes encoding protein kinases 
are thought to be important in this regulation: wee1and mik1. wee1 is 
a dose dependent inhibitor of mitosis (Russell & Nurse, 1987), and itgene 
product, p107Weel, is a protein kinase that phosphorylates serine and 
tyrosine residues (Featherstone & Russell, 1991). If p34cdc2  and plO7Weel 
are expressed in insect cells, p34CdC2  is maximally phosphorylated in the 
presence of p107Weel (Parker et al., 1991). This observation argues that 
p107Weei directly phosphorylates p34Cdc2.  In contrast, in fission yeast in the 
absence of weel +, p34cdc2 is still phosphorylated. This contradiction is 
explained by the discovery of a wee1 homologue, encoded by mikl+ 
(Lundgren et al., 1991), whose function is redundant with weel+. In cells 
carrying mutants of both weel and miki p34CdC2  becomes rapidly tyrosine 
dephosphorylated, suggesting that either one or other of the genes is 
required for p34cdC2  phosphorylation (Lundgren et al., 1991). 
ii 	Dependency of mitosis on S-phase 
If cells are arrested in S-phase, by drugs such as hydroxyurea, mitosis 
does not occur: there is a dependency between the completion of S-phase 
and the initiation of the next mitosis. 
In fission yeast this dependency can be obviated if p80CdC25 is over-
produced, or a mutant form of cdc2, which does not require p80CdC25  for 
activation, is present (Enoch & Nurse, 1989). In the presence of 
hydroxyurea such cells attempt premature mitosis, with consequent rapid 
loss of viability. Thus, p80cdc25 is implicated in dependency of mitosis on 
the previous S-phase. 
A corollary observation to this experiment supports this 
interpretation: cell cycle arrest is observed in cells which lack either wee1 
or mik1 when exposed to hydroxyurea. If both of these genes are lost, in 
the presence of hydroxyurea, cells enter mitosis unregulated (Lundgren et 




iii 	Dependency of S-phase on mitosis 
Whereas cells have to finish S-phase before they can initiate the 
next mitosis, DNA synthesis can commence when only early stages of 
mitosis have been completed. Indeed, certain mutants which block in 
mid-mitosis can initiate the next round of S-phase (Uzawa et al., 1990). 
This dependency has been shown to involve p34CdC2  (Broek et al., 
1991). If certain mutants of cdc2 are shifted to the restrictive temperature 
for a brief period, they undergo a second round of DNA synthesis without 
an intervening mitosis, thus forming diploid cells. This abnormal DNA 
duplication correlates with the disappearance of p34CdC2.  It has been 
proposed that p34CdC2  carries the cell memory of cell cycle stages, and in 
these mutant cells such memory is lost, as p34cdc2  is destroyed. On re-
synthesis p34CdC2  is made as default in a G1 form, resulting in an S-phase 
prior to mitosis. 
iv 	S-phase control 
Budding yeast 
In budding yeast a considerable amount is known about the 
molecular processes that mediate passage through G1 and into S-phase. 
The two cell cycle control stages about which most is known are START 
and the DNA synthesis genes. 
START is the major rate-limiting cell cycle stage during normal 
vegetative growth in budding yeast. CDC28 (the budding yeast cdc2 
homologue) is required at START, as mutants of this gene arrest at this 
stage (Hartwell, 1974). CDC28 encodes a protein kinase, p34CDC28,  whose 
activity is crucial for cell cycle advancement (Review: Reed, 1991). 
Two C1 cyclins have been identified by multicopy suppressor 
analysis that interact with CDC28, CLN1 and CLN2, as they can rescue the 
conditional Gi arrest of CDC28 (Hadwiger et al., 1988). The CLN1 and 
CLN2 products are similar to each other, and are related to previously 
identified mitotic cyclins. Another gene isolated independently shows 
similarities to these two genes, and has been renamed CLN3. CLN3 was 
first isolated as WHI1, in a screen for small sized mutants (Sudbery et al., 
1980), and second as DAF1, in a screen for genes conferring resistance to 
mating factor-induced cell cycle arrest (Cross, 1988). The three CLNs are 
functionally redundant, as one will complement deletions of the other 
two; deletion all three genes, however, results in G1 arrest (Richardson et 
al., 1989; Cross, 1990). 
CLNI and CLN2 transcripts levels vary during the cell cycle with a 
maximum during early G1, decreasing before S-phase (Wittenberg et al., 
1990). The CLN2 product, CLN2, has been shown, at least in vitro, to 
stimulate the protein kinase activity of p34CDC28,  suggesting that it may 
interact in cells with p34CDC28  to activate it (Wittenberg et al., 1990). 
Consistent with this hypothesis are the observed low levels of both CLN1 
and CLN2 transcript, and protein kinase activity of p34CDC28,  in Gi 
arrested cells (Mendenhall et al., 1987). In contrast, CLN3 transcript levels 
are invariant during the cell cycle (Wittenberg et al., 1990). To 
accommodate this observation with the known redundancy of the three 
genes, it has been suggested CLN3 activity is modified post-translationally 
(Reed, 1991). 
START transition only occurs when conditions, such as cell size 
and nutrients, and mating . pheromone are permitting (Section lb.ii). The 
CLNs are thought to mediate the integration of these conditions on 
START transition. A dominant mutant of CLN2 in which the gene 
product is stabilized, is unable to arrest at START in response to nutrient 
limitation (Hadwiger et al., 1988). Similarly, the CLN3-2 allele (DAFt) 
confers a-factor resistance, allowing cells to traverse START in the 
presence of mating pheromone; furthermore, over-expression of CLN 
genes results in cells prematurely dividing at reduced size (Cross, 1988). 
Two independent lines of research have indicated that a positive 
feedback loop operates in G1, involving p34CDC28,  CLNs, Swi4, and Swi6 
(Fig. IE). CLNs bind to p34CDC28  to activate it, and so stimulate 
transcription of CLN1 and CLN2: thus, they can induce their own 
production (Dirick & Nasmyth, 1991; Cross & Tinkelenberg, 1991). SWI4 
and SWI6 have also been shown to positively regulate CLN1, CLN2, and 
CLN3 (Nasmyth & Dirick, 1991), and another putative Gi cyclin HCS26 by 
binding CCB (cell cycle box) elements in their promoters (Ogas et al., 1991). 
Thus, it has been proposed that G1 cyclin expression is stimulated by Swi4 
and Swi6, which in turn are activated by p34CDC28  complexed with CLNs. 
Although both Swi4 and Swi6 are excellent candidates for direct 
phosphorylation by p34CDC28,  this has not yet been proven. 
Such a positive feedback model could account for the START 
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Figure 1 E 	 Proposed regulatory network controlling START 
transition and entry into S-phase in budding yeast. 
To pass START cells must have active p34CDC28,  in which form it is 
complexed with G1 cyclins, CLNs. CLN1, 2 and HCS26 (CLN4) transcript are 
positively regulated by Swi4 and Swi6, which bind to cell cycle box (CCB) motifs in 
their promoter regions. Additionally, Swi4, 6 post-translationally activate CLN3. 
These cyclins bind to p34CDC28, activate it, and stimulate the production of 
more CLNs, possibly by direct phosphorylation of Swi4, 6. Such a positive 
feedback loop would only have two stable states: one in which p34CDC28  is 
inactive, and the other where it is maximally active. Such a transition from low 
to high kinase state could be stimulated by factors such as nutrients, or inhibited 
by pheromones, affecting any part of the network, and might account for the 
biochemical basis of START. 
Swi6 is also a component of a transcription complex, DSC1, which binds 
MluI cell cycle boxes (MCBs) in the promoter regions of DNA synthesis genes, to 
stimulate their expression at the G1-S boundary. 
Swi4 and Swi6 activate expression of the HO endonuclease which mediates 
mating type switching by binding CCBs in the HO promoter (Section lf.ii). 
transition. With such regulation, p34CDC28  is either inactive, or fully 
active. Stimulation by nutrients or cell size, or inhibition by pheromones, 
could affect any of the proteins in the network, and so trigger a cascade 
which would result in the activation of p34CDC28,  completion of START, 
and entry into S-phase. 
In budding yeast a group of genes required for DNA synthesis have 
been identified whose transcripts are periodically expressed during the cell 
cycle, with a maximum at the G1-S phase boundary (Table IA, Johnston 
1990). 
Gene Gene product Reference 
CDC2I Thymidylate synthase Storms et al., 1984 
CDC9 DNA ligase White et at., 1986 
CDC8 Thymidylate kinase White et al., 1987 
POLl DNA polymerase I Johnston et at., 1987 
POL2 DNA polymerase II Araki et at., 1992 
DPB2 DNA polymerase II subunit B Araki et at., 1991a 
DPC2 DNA polymerase II subunit C Araki et at., 1991b 
POL3 (CDC2) DNA polymerase III Bauer & Burgess, 1990 
POL30 PCNA Bauer & Burgess, 1990 
PRII DNA primase I Johnston et al., 1990 
PRI2 DNA primase II Foiani et at., 1989 
RNRI Large subunit of RNR Elledge & Davis, 1990 
Table 1 A Budding yeast DNA synthesis genes that are periodically 
expressed at the Gi-S  phase boundary. 
The DNA synthesis genes appear to be coordinately expressed, in 
that the pattern of abundance of their transcripts during the cell cycle is 
very similar (White et al., 1987). Furthermore, differences in relative 
transcript levels cannot be distinguished in a variety of cell cycle arrest 
conditions (Johnston et al., 1987). 
A common cis-acting sequence in the promoter region of these 
genes has been discovered, and been called the MCB (for M IO cell cycle 
box, Verma et al., 1992), since they are either identical or closely related to 
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the site recognized by the restriction endonuclease MluI. MCBs consist of 
the nucleotides; ACGCGT, or a /6  match, with the core CGCG intact; a few 
MCBs have an adenine at position 8 (McIntosh et al., 1991; Gordon & 
Campbell, 1991). MCBs are strongly implicated in the periodic control of 
gene expression as they can confer cell cycle expression on a reporter gene 
at the G1-S phase boundary (Lowndes et al., 1991). 
A trans-acting activity has been identified in budding yeast protein 
extracts by bandshift analysis which specifically binds MCBs, and called 
DSC1 (for DNA synthesis control; Lowndes et al., 1991). Originally, DSC1 
was reported to bind MCBs coincidentally with DNA synthesis gene 
expression at the Gi-S phase boundary (Lowndes et al., 1991), suggesting a 
mechanism by which it stimulates expression of the DNA synthesis genes. 
Subsequently, however, DSC1 has been shown to bind MCBs invariantly 
in cell extracts after a-factor block and release (Dirick et al., 1992). Swi6 has 
recently been shown to be a component of DSC1 (Lowndes et al., 1992b; 
Dirick et al., 1992). 
As Swi6, in combination with Swi4, is also part of the transcription 
complex that controls expression of CLNs and the HO endonuclease by 
binding CCB elements (Ogas et al., 1991; Nasmyth & Shore, 1987), binding 
specificity must be conferred by other parts of the complexes. 
Fission yeast 
The molecular processes controlling S-phase onset in fission yeast 
are not as well understood as those in budding yeast. Two cdc genes are 
required for START transition: cdc2 and cdc1O (Nurse & Bissett, 1981). 
The potential roles of p34CdC2  in Ci are at present unknown 
(Review: Bartlett & Nurse, 1990). This is largely due to the fact that no Ci 
specific cdc2 mutants have been isolated. 
The cdc1O gene has been cloned and sequenced (Ayes et al., 1985), 
but the sequence was uninformative about its function, although 
similarities with cell cycle transcriptional activators, such as SWI4 and 
SWII6 were subsequently noticed (Breeden & Nasmyth, 1987b; Andrews & 
Herskowitz, 1990b). The cdc1O gene product, p87CdC10, has been identified 
and shown to be a phosphoprotein (Simanis & Nurse, 1989). The work 
described in this thesis demonstrates that p87CdClO is part of a transcription 
complex, DSP1, controlling the periodic expression of cdc22 transcript at 
the onset of S-phase (Lowndes et al., 1992a). Two genes, which when 
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mutated, suppress cdclO mutants have been identified, sctl and sdcl 
(Marks et al., 1992; Caligiuri & Beach, 1992). Both can suppress a deletion 
of cdc1O. sdcl+ has been cloned and sequenced, and is essential (Caligiuri 
& Beach, 1992). sdc1 encodes a predicted polypeptide with strong 
similarities to the cdclO polypeptide. 
Several cdc mutants defined two genes, cdc22 and cdc20, that were 
required late in Ci after START, or in early S-phase (Nasmyth & Nurse, 
1981). cdc22+ has been cloned, and an extragenic multicopy suppressor, 
suc22, also isolated (Gordon & Fantes, 1986). 
cdc22 is unusual in that its transcript varies in abundance during 
the cell cycle with a strong maximum at the Cl-S phase boundary (Gordon 
& Fantes, 1986). Both cdc22 and suc22 have been sequenced and shown 
to encode the large and small subunits of ribonucleotide reductase, 
respectively (This thesis, Chapter 3; M-J. Fernandez-Sarabia, P. Harris & P. 
Fantes, pers. comm.). cdc22 has a number of motifs resembling budding 
yeast MCBs in its promoter which are strongly implicated as cis-acting 
control elements, as an MCB trimer can confer periodic expression on a 
reporter gene in fission yeast (This thesis, Chapter 4). Two transcripts 
hybridize to suc22 probes: a smaller mRNA which is present 
constitutively; and a larger mENA which is only observed after conditions 
of cell cycle arrest, or after treatment with hydroxyurea (C. Gordon, P. 
Harris & P. Fantes, pers. comm.). A transcript that hybridizes to cdc22 
probes is also over-expressed after hydroxyurea treatment (P. Harris & P. 
Fantes, pers. comm.). 
Two other fission yeast genes have been isolated that are required 
for DNA synthesis: DNA ligase (cdc17; Johnston et al., 1986) and DNA 
polymerase I (POLl; Damagnez et al., 1991). Both genes are constitutively 
expressed during the cell cycle (White et al., 1987; Bouvier et al., 1992), and 
so are unlikely to be under DSP1/MCB controls. 
A putative fission yeast G1 specific cyclin has been cloned and 
sequenced, and named pucl (Forsburg & Nurse, 1991). pucl+ shows 
similarities to previously characterised mitotic cyclins, and when over-
expressed causes a delay in mitosis. However, pucl+ has not yet 
conclusively been shown to have a role in Gi. 
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Higher eukaryotes 
A limited amount is known about C1 controls and the onset of 5-
phase in higher eukaryotes. A number of genes required for DNA 
synthesis are periodically expressed during the cell cycle cycle, with peak 
levels of transcript during early S-phase. These include such examples as 
thymidylate synthase (Pelka-Fleischer et al., 1989), proliferating-cell 
nuclear antigen (PCNA; Morris & Matthews, 1989) and both subunits of 
ribonucleotide reductase (Engstrom et al., 1985; Bjorklund et al., 1990). For 
each of the three genes studied it has been suggested that their expression 
may control the onset of S-phase. Indeed, in the case of PCNA, injection 
of antisense oligodeoxynucleotide does inhibit DNA synthesis (Liu et al., 
1989), which is consistent with such a proposal. However, there is a large 
pool of PCNA protein present throughout the cell cycle, only a small 
proportion of which associates with the nucleus during S-phase (Morris & 
Matthews, 1989), suggesting that PCNA is likely to exert only a coarse 
control on DNA synthesis. 
Dihydrofolate reductase (DHFR) is also periodically expressed 
during the cell cycle, with a transcript peak in late G1 (Farham & Schimke, 
1985). DHFR has a sequence in its promoter, TTFCGCGC, which is 
functionally important (Blake & Azizkan, 1989), and shows some 
similarity to the MCB sequence (5 out of 6 nucleotides). This sequence is 
bound by the transcription factor E2F which is active during G1 (Muridj et 
al., 1990). E2F may, therefore, be nearest metazoan relative to DSCl/DSPI. 
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Figure 1 F Schematic diagram of eukaryotic promoter structure. 
Eukaryotic transcriptional activators can be split into two classes: 
general and specific. The former class contains TFJID which binds the TATA box, and 
directs assembly of the general transcription complex (including RNA polymerase II) 
onto the DNA. The latter class contains proximal factors such as Spi, and Jun and Fos 
which bind the CC box and API site, respectively; and distal enhancer-like 
upstream activating sequences (UASs) which bind trans-acting complexes. It is a 
combination of the general and specific transcription activators that control 
expression of yeast genes. 
1 f Eukaryotic transcriptional regulation 
i 	Promoter structure and function 
Studies of transcriptional promoters in metazoan cells and yeasts 
have revealed that genes transcribed by DNA polymerase II are controlled 
by a variety of cis-acting sequence elements 5' the transcriptional initiation 
site which bind trans-acting factors (Fig. iF). The molecules and 
underlying mechanisms controlling transcription are remarkably 
conserved in all eukaryotes (Review: Guarente & Bermingham-
McDonogh, 1992). 
The cis-acting elements and trans-factors can be split into two types: 
cis-elements that interact with the general transcription apparatus, and so 
are common to all genes; and cis-elements that bind specific 5' regulatory 
factors to stimulate transcription of particular genes at appropriate times. 
The TATA box element binds the general transcription factor TFIID 
and directs assembly of the general transcription complex, containing 
RNA polymerase II and associated factors, onto the promoter DNA 
(Sawadogo & Roeder, 1985). Alone, the general transcription complex is 
capable of inducing low level transcription. TFIID is highly conserved: 
budding yeast TFIID can functionally substitute in vitro for TFIID from 
HeLa cells (Buratowski et al., 1989); and a functional homologue of 
budding yeast TFIID has been cloned from fission yeast (Fikes et al., 1991). 
The core region of budding yeast TFIID carries out all the essential 
functions, such as binding to the TATA box, and interaction with other 
general factors (Reddy & Hahn, 1991). It is thought that the peripheral 
regions of TFIID interact with regulatory factors. 
The efficiency and specificity of transcription is controlled by further 
sequence specific elements 5' to the TATA box, which bind regulatory 
factors. Such sequences can be near to the TATA box, and include 
examples such as the mammalian CC box which binds Spi (Pugh & Tjian, 
1990) and the AP-1 site, present in mammalian cells (Bohmann et al., 1987) 
and fission yeast (Jones et al., 1988), which binds Fos and Jun transcription 
factors. Additionally, transcription can be affected by cis-acting elements 
that are far away from the transcriptional START site which bind 
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transcription complexes. In yeast, such cis-acting elements are called 
upstream activating sequences (UAS) and are related to metazoan 
enhancer elements (Struhi, 1982). 
Upstream regulatory factors generally have two two domains: one 
that binds sequence specific DNA, and another which influences 
transcriptional activity by binding with the general transcriptional 
apparatus (Brent & Ptashne, 1985). In some instances it has been suggested 
that coactivators, in addition to the regulatory and general factors, are 
required to potentiate transcription. 
For Spi, the need for coactivators has been inferred from in vitro 
transcription studies. Replacement of the TFIID fraction by pure cloned 
TFIID restores basal transcription, but not the ability to respond to Spi 
(Pugh & Tjian, 1990). Thus, a coactivator is thought to be present in the 
TFIID fraction. Heat treatment of the MID fraction selectively inactivates 
TFIID, but leaves the coactivator intact, as cloned TFIID can be added back 
to restore both basal transcription and the ability to respond to Spi 
(Peterson et al., 1990). It is thought that the amino terminus of TFIID 
interacts with the coactivator: if truncated TFIID is added back, only basal 
transcription is restored. 
There is evidence for the presence of coactivators in yeast. Herpes 
virus regulatory factor VPI6 which has lost its DNA binding domain, 
when added to an in vitro transcription system made from budding yeast 
extracts, inhibited activated but not basal transcription (Kelleher et al., 
1990). This result was interpreted as meaning that VP16 binds a 
coactivator and not the general transcription complex, to selectively 
reduce activated transcription. Recently, the potential coactivator that 
mediates VP16 activation has been cloned and called ADA2 (Berger et al., 
1992). 
Two models have been proposed to account for the role of the 
coactivators (Guarente & Bermingham-McDonogh, 1992). The coactivator 
may bind the regulatory factor to provide additional activation surface to 
the general transcription complex. Alternatively, the coactivator could be 
an adaptor that bridges the gap between the regulatory and general 
transcription complexes (Fig. IF). 
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ii 	Yeast cell cycle transcriptional control 
A number of yeast genes are expressed in a cell cycle manner, and 
are controlled at the level of transcription. The mechanisms that control 
periodic expression of DNA synthesis genes and CLNs in budding yeast 
have already been discussed (Section le.ii). Three other examples of cell 
cycle control of gene expression will be discussed in this section: histone 
genes, HO endonuclesase, and the chitinase gene. 
Histones are present in both budding and fission yeast. The four 
core histones, H2A, H2B, H3, and H4 have all been identified; HI has not 
been yet been found in either organism (Hereford et al., 1979; Matsumoto 
& Yanagida, 1985). 
In fission yeast nine histone genes have been identified: two genes 
for histone H2A, one for H2B, and three each for H3 and H4 (Matsumoto 
& Yanagida, 1985). Both histone H2A1 and H2B are periodically expressed 
during the cell cycle with a maxima during S-phase, later than the peak of 
cdc22+ transcript (Matsumoto et al., 1987). A common upstream sequence 
has been noted in the promoters of all the histone genes (the AACCCT 
box) that has internal nucleotide repeats. It is thought that this repeat is a 
cis-acting element that controls their coordinate regulation. 
In budding yeast there are eight histone genes, with two genes for 
each of the four core histones, arranged as two pairs of H2A-H2B and H3-
H4 (Hereford et al., 1979). All eight of the genes are expressed during S-
phase. Using fusions of one of the H2A genes to !acZ, a fragment of DNA 
required for periodic expression was identified, consisting of three copies 
of GCGAAAANTNNGAAC (Osley et al., 1986). In addition there is a 
negative control element situated between two of the repeats, deletion of 
which results in dramatic over-production of the transcript and an 
impairment but not abolition of cell cycle regulation (Osley et al., 1986; 
Lycan et al., 1987). Three genes (HIR1-3) involved in the negative 
regulation of H2A/H2B have been isolated by mutation studies, by means 
of the negative control element in the promoter (Osley & Lycan, 1987). 
Mating type switching in budding yeast is determined by the HO 
gene which encodes an endonuclease. HO transcription is confined to a 
shoit period during late G (Nasmyth, 1983), and is dependent on cells 
passing START. In addition to cell cycle control, HO is also regulated by 
the mating type locus (Jensen et al., 1983) and is only expressed in mother 
cells (Review: Nasmyth & Shore, 1987). The HO promoter contains at 
least three different types of control element, one of which, the CACGA4 
repeat, is sufficient to give. START dependent transcription when joined 
to the cytochrome c TATA box (Breeden & Nasmyth, 1987 b). The repeat 
(recently renamed as the cell cycle box CCB; Andrews, 1992) is present 10 
times in the HO promoter: removal of them causes the promoter to 
become START independent during G1 (Nasmyth, 1985). 
At least six different genes, S WIl -6, are required for efficient HO 
expression (Haber & Garvik, 1977). Of these only SWI4 and SWI6 are 
required for expression specifically mediated by CCBs (Andrews & 
Herskowitz, 1989a). Both Swi4 and Swi6 have been shown to be part of a 
transcription complex that specifically binds to CCBs (Andrews & 
Herskowitz, 1989a). Two forms of Swi4/Swi6-DNA complexes have been 
identified by bandshift assays, called L and U, which are distinguished by 
their electrophoretic mobility (Taba et al., 1991). L complexes are detectable 
at all cell cycle stages, whereas U complexes are only detected in cells that 
have just undergone START. It has been suggested that formation of the 
U form of the complex may trigger HO activation. 
HO activation is inessential for cell division. As S W14 and 
SWI6 are required for HO activation, it is surprising that deletion of both 
genes is fatal to the cell. This is explained by the discovery that S W14 and 
S W16 have other essential functions in cell cycle regulation, including the 
transcriptional control of CLNs and DNA synthesis genes (Section le.iv). 
The gene encoding chitinase in budding yeast (CTS1) is expressed in 
late C1 at the same time as HO (Kuranda & Robbins, 1991), and is thought to 
be required for separating the daughter cell from the mother cell, by 
dissolving the 'neck'. SWI4 and SWI6 have been shown recently to be 
required for this periodic expression (Dorhmann et al., 1992). Surprisingly, 
CCBs have not been found in the promoter region of CTS1, suggesting that 
the Swi4/Swi6 complex must bind other cis-acting elements to stimulate 
expression of CTS1. Why two genes that are coordinately expressed by the 
same trans-factor should have different cis-acting elements is as yet unclear. 
There are similarities between the transcriptional mechanisms that 
control periodic expression of yeast cell cycle genes. In each case, cis-acting 
elements 5' to the transcriptional start of the gene influence expression 
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levels by binding trans-acting factors. The cis-acting elements are often 
present as repeats, and are common to groups of genes that are coordinately 
expressed. In none of the genes studied is it understood how the trans-acting 
factor stimulates transcription at the appropriate time during the cell cycle. 
1 g Universal cell cycle controls? 
The exciting prospect of all cell cycle research is that many of the 
molecular mechanisms so far elucidated will be found to be universally 
conserved. The most well known example of this is p34CdC2.  Human and 
yeast cdc2 are functionally interchangeable (Lee & Nurse, 1987). A 
number of the other cell cycle genes initially isolated in yeasts are also 
being found to have homologues in higher eukaryotes, such as cdc25+ 
(Sadhu et al., 1990) and wee1 ( Igarashi et al., 1991). Indeed, the more we 
know about the cell cycle, the more universal it seems the controlling 
mechanisms are. 
One of the great beauties of cell cycle research is the simplicity of 
both the core observations and models proposed to explain cell cycle 
events - for examples see Figures ID and IE. In yeasts the molecular 
mechanisms are simple, but in higher eukaryotes, although the 
underlying mechanisms may be the same, the systems have become 
complicated and confusing. For example, in fission yeast there is one 
cdc2 gene and one mitotic cyclin (cdc13), whereas in humans there are at 
least three genes of each (Lew et al., 1991; Yue et al., 1991; Meyerson et al.;  
1992). What do these extra genes do? Are they merely redundant genetic 
copies? Because of the difficulty of genetics in higher eukaryotes, the most 
productive organisms in cell cycle research will continue to be yeasts. 
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1 g Aims of the work 
The work described in this thesis uses fission yeast as a model 
system to understand the molecular mechanisms that control the onset of 
S-phase. This is done by studying cdc22, a gene which is periodically 
expressed during the cell cycle at the G1-S phase boundary. cdc22 is 
sequenced and shown to encode the large subunit of ribonucleotide 
reductase. The mechanisms controlling cdc22 expression during the cell 
cycle are then examined: both cis- and trans- acting components required 
for cdc22+ expression are identified. The cis-acting elements are MCBs, 
and the trans-factor a protein complex we have called DSPI. Both MCBs 
and DSP1 are related to components previously isolated in budding yeast. 
A part of DSPI is shown to the gene product of the cdc1O 'START' gene. 
Finally, a mutant form of cdclO, cdclO-C4, is shown to cause constitutive 
over-expression of cdc22. 
In essence, this work has demonstrated that the product of a gene 
required for START is part of a transcription complex which controls the 
expression - of a gene during S-phase. 
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Chapter 2: Materials & Methods 
2 a Commonly used reagents and buffers 
Most of the methods used in this work were based on those 
described in Sambrook et al. (1989). 
All chemicals used were of analytical grade, and were bought from 
Sigma, British Drug Houses (BDH), Gibco-BRL, Fisons, or Pharmacia. 
H20 refers to distilled autoclaved water. 
Eppendorf tube refers to 1.5 ml centrifuge tube. High speed 
centrifugation in Eppendorf tubes refers to a Microcentaur centrifuge at 
13, 000 rpm. 
Tris. Cl 
Tris base (tris[hydroxymethyl]aminomethane, Sigma T-1503) was 
dissolved in H20, and the pH adjusted to the required value by addition of 
HC1. H20 was added to give a I M stock solution. 
EDTA 
A stock solution of 0.5 M EDTA (ethylenediaminetetramino acid, 
di-sodium salt, Fisons D-0452) was made by dissolving solid EDTA in H20, 
adjusting the pH to 8.0 with NaOH, and adding water to the required 
volume. 
TE 
A buffer solution, suitable as a routine DNA solvent, consisting of 
10 mM Tris. Cl (pH 7.5) and 1 mM EDTA. 
Phenol 
Phenol (Fisons P-2360) was pre-equilibriated with 1 M Tris. Cl 
(pH 7.5), followed by TE buffer. To retard oxidation of the phenol solution 
0.1% (v/v) hydroxyquinoline (Sigma H-5876) and 0.2% (v/v) 
—mercaptoethanol were added, and it was stored at 4°C in the dark. For 




Chloroform (BDH 10077) refers to a 24:1 (v/v) mixture of 
chloroform and isoamyl alcohol (Sigma 1-1381). 
Sodium acetate 
Sodium acetate was dissolved in H20, the pH adjusted to 5.2 with 
HOAc, and H20 added to a final concentration of 3 M. 
Ethidium bromide 
Ethidium bromide (Sigma E-875) was dissolved as a stock solution 
of 10 mg ml-1 in H20, and stored at 4°C in the dark. 
Loading buffer 
x loading buffer for gel electrophoresis of nucleic acids was 
prepared and stored at room temperature: 
0.25% (w/v) bromophenol Blue (BDH 20015) 
15% (w/v) ficoll (Sigma F-2637) in H20. 
TBE 
TBE was routinely made up as a 10 x stock solution, and stored at 
room temperature: 
stock 	11 
0.89MTris base 	 108g 
0.89 M boric acid 55 g 
20 mM EDTA 	0.5 M 	40 ml. 
TAE 
TAE was made as a stock solution of 50 x, and stored at room 
temperature: 
stock 	U 
2 M Tris base 	 242 g 
HOAc 	 57.1 ml 
50 mM EDTA 	0.5 M 	100 ml 
DEPC H20 
RNAase free water, suitable for dissolving RNA, was made by 
adding 0.1% (vlv) diethyl pyrocarbonate (Sigma D-5758) to H20,  mixing 
for 5 minutes at room temperature, and autoclaving. 
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2b Nucleic acid manipulations 
i 	Dissolving and storage 
All DNA and RNA was dissolved in a solution of either TE or H20, 
depending on the subsequent use of the nucleic acid. Nucleic acids were 
routinely stored as solutions at 20 0C. 
ii 	Extraction with phenol/chloroform 
Proteins were removed from solutions containing DNA and RNA, 
by extraction with an equal volume of a 1:1 mixture of phenol and 
chloroform. Traces of phenol were removed by a further extraction with 
chloroform. 
Extractions were carried out by adding a volume of 
phenol/ chloroform equal to that of the nucleic acid solution. The two 
solutions were mixed thoroughly by vortexing to form an emulsion, and 
separated by centrifugation, routinely 5 minutes high speed, at room 
temperature. The aqueous phase was then transferred to a fresh tube 
carefully avoiding protein at the interface of the two phases, and the 
nucleic acids recovered by precipitation. 
iii 	Precipitation of nucleic acids 
DNA was precipitated by the addition of a 1  / 10 volume of 3 M 
sodium acetate (pH 5.2), followed by 2 volumes of -20°C absolute ethanol. 
RNA was precipitated by the addition of 1 /10 volume 3 M sodium acetate, 
followed by 2.5 volumes of 200C absolute ethanol. In each case the 
solution was mixed thoroughly by vortexing, frozen at -20°C for 30 
minutes, and the nucleic acids pelleted by centrifugation, at high speed at 
4°C. Very small fragments of DNA (<200 nucleotides) were precipitated as 
above, with the addition of 1 p.1 of carrieOW 	ml 1 , Boehringer 
Mannheim 12463420), before freezing at -20°C. 
To remove trace amounts of salt remaining from the precipitation, 
the nucleic acid pellet was washed in 100 p.1 of either 70% (v/v) -20°C 
ethanol (for RNA, or large fragments of DNA >500 nucleotides), or 90% 
(v/v) -20°C ethanol (for small fragments of DNA <500 nucleotides), and 
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pelleted by centrifugation. The nucleic acid pellet was air dried, and 
dissolved in an appropriate volume of H20 or TE buffer. 
iv 	Quantification and quality control 
DNA and RNA quality and amount was assayed by using two 
methods: spectrophotometry, and ethidium bromide staining after gel 
electrophoresis. 
The first method involves taking an absorbance reading at 
wavelengths 260 and 280 nm. The reading at 260 nm allows calculation of 
the concentration of nucleic acid in the sample. An A260 of 1 corresponds 
to approximately 50 p.g ml- 1 for double stranded DNA, 40 p.g ml -1 for single 
stranded DNA and RNA, and 20 pg ml -1 for single stranded 
oligonucleotides. The ratio between the readings at 260 nm and 280 nm 
provides an estimate of purity of the nucleic acid. Pure preparations of 
DNA and RNA have ratios of 1.8 and 2.0, respectively. Any ratios less 
than these values indicate protein and/or phenol contamination of the 
sample. 
The second method utilises ethidium bromide, which specifically 
and proportionately binds to DNA, and fluoresces under UV light. The 
nucleic acid sample is run in an appropriate gel containing ethidium 
bromide at a concentration of 0.5 j.tg ml -1 , in parallel with a nucleic acid 
sample of known amount (usually standard molecular weight markers), 
and visualised on a trans-illuminator. A rough estimate of DNA amount 
can be gauged from the relative staining intensities of the bands. 
v 	Plasmid vectors 
pUC-based plasmids 
The pUC based plasmids are used for the manipulation of foreign 
genes in E. coli (Vieira & Messing, 1982). They contain the pBR322 derived 
ampicillin resistance gene and origin of DNA replication, and a polylinker 
inserted into a portion of the lacZ gene of E. coli. Non-recombinant 
plasmids are able to synthesize this enzyme which breaks down X-Gal 
(Section 2f.ii), to release a blue pigmented derivative. In recombinant 
plasmids the lacZ gene is interrupted by foreign DNA, resulting in 
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Figure 2 B pSPA178 
pUC plasmids, but contain in addition the fl origin of replication. 
Consequently, if the host cell is super-infected with the helper phage 
M13K07, replication will be initiated at the fl origin, resulting in the 
excretion of phage coats containing single stranded DNA of the plasmid 
(Section 2g.ii). pBluescript SK/KS (Stratagene) plasmids have an 
alternative more extensive polylinker to the pTZ plasmids, and the 
ampicillin resistance gene has been replaced by the chioramphenicol 
resistance gene, for alternative selection. 
pDB262 
pDB262 (Fig. 2A) is capable of autonomous replication in both 
E. coli and S. pombe (Wright et al., 1986). Cloning fragments into either 
the Hind HI or Bc!! sites inactivates the ?cI suppressor gene product, which 
allows expression of the tetracycline resistance gene, under the control of 
the bacteriophage ?.Pr promoter. This plasmid is especially useful for gene 
library construction, since selection for tetracycline resistance ensures that 
all E. coli transformants contain recombinant plasmids. The presence of 
the leu2 gene permits selection for the plasmid in fission yeast. 
pSPi178 
pSPA178 (Fig. 2B) was developed to test cis-acting elements in 
fission yeast (Lowndes et al., 1992a). pSPA178 is a derivative of pLGAI78 
(Guarente & Mason, 1983), in which the 2j.t origin of replication is replaced 
by ARS6, a fission yeast chromosomal origin of replication (Maudrell et 
al., 1988). pSPAI78 contains a minimal promoter from a budding yeast 
cytochrome c gene, fused to the lacZ gene of E. coli. Selection is permitted 
in fission yeast ura4 mutants by the presence of the budding yeast LIRA3 
gene. A unique cloning site (XhoI) allows the insertion of putative cis-
acting elements directly 5' to the minimal promoter, and their activity can 
be assayed by monitoring !acZ gene expression. 
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2 c Molecular analysis of nucleic acids 
i 	Restriction enzyme digestions 
Restriction endonucleases were used, as recommended by the 
manufacturers, to cut DNA. For restriction enzyme buffers, the Gibco-BRL 
REact buffer system was used. Usually, 1-5 p.g of DNA was incubated with 
10 units of restriction enzyme and appropriate buffer, in a final volume of 
10 p.1, at 37°C for 1-15 hours. Digestions were stopped by the addition of 
1 /25 volume of 0.5 M EDTA, and freezing at 200C. 
ii 	Ligations 
Ligation of DNA was performed using T4 DNA ligase (Boehringer 
Mannheim, 862509) and ligation buffer for cohesive termini, and 
concentrated T4 ligase (New England Biloab 202CS) and ligation buffer for 
blunt termini. Routinely between 1-10 p.g of DNA was ligated with 0.5 p1 
of ligase (1 or 100 units, respectively), in a volume of 10 p1. Ligation 
reactions were incubated for 16 hours at 14°C for cohesive termini, and at 
25°C for blunt ended termini. 
Cohesive termini were converted to blunt ended termini by 
treatment with the Kienow fragment of DNA polymerase I. DNA was 
incubated at 37°C in the presence of 1 unit of Klenow fragment 
(Boehringer Mannheim, 100840), ligase buffer (New England Biolab), 1mM 
DTT, and 2 mM dNTPs for 30 minutes, before the addition of 0.5 p.1 of 
concentrated T4 ligase, and incubation at 25°C for 16 hours. 
iii 	Agarose gel electrophoresis 
For the analysis of both cut and ligated DNA preparations of DNA 
fragments larger than 300 nucleotides, 0.6% (w/v) agarose gels in the 
horizontal Bio-Rad gel system were used. 
Agarose (Type 2, medium EEO, Sigma A-6877) was dissolved in 1 x 
TBE or TAE buffer by brief boiling. DNA samples were mixed with a 1/5 
volume of loading buffer, and loaded into gel wells. Routinely 0.2 p.g of 
molecular weight markers (1 kb ladder, Gibco-BRL 5615SA) was loaded to 
assess the size and amount of DNA fragments. Gels were run with an 
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applied voltage of 4-8 V cm -1 for 1-3 hours. DNA was stained with 
ethidium bromide at a final concentration of 0.5 .tg ml -1 , visualized with 
a UV trans-illuminator, and photographs taken with a Mitsubishi Video 
Copy Processor Model P65B. 
iv 	Acrylamide gel electrophoresis 
For the analysis of both cut and ligated DNA preparations of DNA 
fragments less than 300 nucleotides in size, 6% acrylamide gels in the 
vertical Bio-Rad Gel system were used. 
Acrylamide: bisacrylamide (Gibco-BRL, Ultrapure) was dissolved at 
a ratio of 125 g: 3 g (33: 1) in 206 ml of 1-120, and stored as a stock 
solution. 
5 ml of acrylamide stock was added to 50 ml of 1 x TBE buffer and 
mixed. 
200 j.tl of 10% (w/v) ammonium persulphate (Sigma A-9164) and 
25 p.1 of TEMED (N,N,N',N'-Tetramethylethylenediamine, Bio-Rad 
61-0800) were added, and the solution poured immediately. 
DNA samples were mixed with a 1/5  volume of loading buffer 
and loaded onto the gel: gels were run at 10 V cm -1 for 2-3 
hours. 
DNA was visualised and photographed as for agarose gels 
(Section 2c.iii). 
v 	Purification of large DNA fragments 
To purify fragments of DNA over 500 nucleotides in length from 
agarose gels the GeneClean kit was used (Volgelstein & Gillespie, 1979), 
according to the manufacturer's instructions. 
vi Purification of small DNA fragments 
This method permits the purification of small DNA fragments, less 
than 500 nucleotides in length (Sambrook et al., 1989). 
1. 	DNA was separated on a 6% acrylamide gel (Section 2c.iv), stained 
with ethidium bromide, and visualised under short-wave UV (to 
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minimise damage to DNA). 
The desired fragment was excised with a scalpel. 
The tip of a 500 p.1 Gilson tip was sealed with a Bunsen flame and 
a siiconized glass wool 1 plug inserted. 
Acrylamide pieces were transferred to the Gilson tip, and mashed 
with a tooth pick. 
Acrylamide mash was suspended in 200 p.1 of elution buffer 2, and 
the top of the Gilson tip sealed with NescoFilm: this was incubated 
overnight at 37°C. 
The end of the Gilson tip was removed with a scalpel, and the 
solution allowed to elute into an Eppendorf tube: 200 p1 more of 
elution buffer was added and this allowed to elute. 
2 volumes of ethanol and 1 p.l of carrier glycogen was added to 
precipitate the DNA, the solution spun at high speed for 30 
minutes, and the pellet was washed with 90% ethanol 
(Section 2b.iii). 
1 	Siliconized Glass Wool: 
Glass wool (Sigma G-8389) was soaked in a 5% solution of 
trimethylchlorosilane (BDH 33164) and this allowed to 
evaporate (in a fume hood). The wool was then washed 
thoroughly in H20 and baked dry at 1800C for 2 hours. 
2 	Elution Buffer: 
stock 	100 ml 
0.2 M NaOAc 	 2.72 g 
1% SDS 	20% (w/v) 5 ml 
10 MM MgC12 	I M 	I ml. 
vii Gel electrophoresis of RNA 
RNA (Section 2e.vi) was separated using two methods: 
formaldehyde gels (Golberg, 1980) and glyoxal gels (Sambrook et al., 1989). 





1.0 g agarose (Type 2, medium EEO, Sigma A-6877) was dissolved in 
63 ml H20 and 16 ml 5 x MNE1 buffer by boiling: this was cooled to 
60°C, 17 ml of 38% (w/v) solution of formaldehyde (BDH-28121) 
added, and this poured immediately into a horizontal gel mold. 
Routinely, 10 p.g of fission yeast RNA (Section 2e.vi ) was run per 
lane: to each sample 15 .tl of RNA buffer2 and 1 .tl of 0.5 mg ml-1 
ethidium bromide was added, this incubated at 60°C for 5 minutes, 
and loaded onto the gel. 
Gels were run in 1 x MNE buffer with an applied voltage of 
10 V cm-1 for 3 hours. 
1 
	
5 x MNE buffer: 
500 ml 
0.12 M MOPS (Sigma M-1254) 13.08 g 
25 mM NaOAc 	 1.03 g 
5mMEDTA 0.19g. 




formaldehyde 	600 p1 
formamide (BDH 28241) 200 p.1 
MNE Buffer 	 240 p1 




A 1.0% (w/v) agarose gel (as above) was prepared in 10 mM 
Na2FfPO4/NaH2PO4 (pH 6.5)1. 
2. 	10 p.g of fission yeast RNA (Section 2e.iv) was routinely run per 
lane: each sample was incubated in 10 p.1 glyoxal buffer 2, at 50°C for 
15 minutes and loaded onto the gel. 
The gels were run in 10 mM Na2HPO4/NaH2PO4 
(pH 6.5), re-circularizing the buffer to maintain a pH less than 8.0. 
I 
	
10 mM Na2HPO4/NaH2PO4 (pH 6.5) was made by adding 3.9 ml of 
1 M NaH2PO4 and 6.1 ml of 1 M Na2HPO4, in 90 ml of H20. 
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2 	Glyoxal buffer: 
6.6 M glyoxal 	 2.5 ml 
50% (v/v) DMSO 	 8.0 ml 
15 mM Na2HPO4/NaH2PO4 (pH 6.5) 1. 6 ml. 
De-ionized glyoxal (Sigma G3140, ready prepared at 6.6 M) was made 
by mixing 50 ml of glyoxal with 5 g of AG 501-X8 (D) mixed bead 
resin (Bio-Rad 142-6425), stirred at room temperature for 30 minutes 
and filtered to remove resin. This was stored in aliquots at -70°C. 
viii Filter hybridization of RNA 
Northern blotting 
Northern blotting was performed using the capillary method onto 
GeneScreen membrane (New England Biolabs), following the 
manufacturer's instructions. 
GeneScreen membrane was cut to slightly larger than gel size, and 
soaked in 0.025 M Na2HPO4/NaH2PO4 (pH 6.5) (made as above) for 
20 minutes; the RNA gel was soaked in this buffer for the same 
time. 
10 pieces of filter paper (Whatman 3MM) were wetted with 0.025 M 
Na2HPO4/NaH2PO4 (pH 6.5), and placed on an elevated glass 








Figure 2 C Construction of a Northern blot. 
Details of construction are described in the text. 
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The gel was placed on filter paper, avoiding air bubbles, and gel 
spacers placed along each side of gel. 
GeneScreen membrane was placed on the gel ensuring there were 
no air bubbles. 
5 pieces of Whatman paper cut to the same size as the gel were 
placed on top of membrane. 
20 absorbent hand towels were placed on the filter paper, and a 
weight placed on top. 
RNA was transferred for at least 12 hours. 
Towels and Whatman paper were discarded. 
Membrane was washed in 0.025 M Na2HPO4/NaH2PO4 
(pH 6.5) buffer for 20 minutes with gentle agitation. 
The membrane was dried on filter paper at room temperature, and 
then baked at 100°C for 3 hours: membranes were stored at this 
stage. 
Hybridization 
Membranes were pre-hybridized in hybridization buffer 1 for 12 
hours at 42°C in a Techne hybridization oven. 
Radio-labelled probe (Section 2d) was boiled for 5 minutes, and 
chilled on ice for 10 minutes: this was added to hybridization buffer 
and hybridized for 16 hours at 42°C. 
Hybridization buffer was discarded, and the membrane washed in 
the Techne hybridization oven, as follows: 
twice with 100 ml of 2 x SSC2 at room temperature for 5 minutes; 
twice with 100 ml of 2 x SSC plus 1.0% SDS at 65°C for 30 minutes; 
twice with 100 ml of 0.1 x SSC at room temperature for 30 minutes. 
The membrane was never allowed to become dry at this stage, as 
the probe became covalently bound to the RNA, .preventing 
further hybridizations. 
The membrane was processed for autoradiography (Section 2c.ix). 
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1 	Hybridization buffer: 
10 ml de-ionized formamide, 4 ml P buffer, and 4 ml 50% 
(w/v) dextran sulphate were added together, mixed, and 
incubated at 42°C for 10 minutes. 1.16 g NaCl was added, 
mixed, and incubated at 42°C for a further 10 minutes until it 
had dissolved. 200 j.tl of denatured salmon sperm DNA was 
added, and thoroughly mixed. 
P Buffer: 
1.0% (w/v) bovine serum albumin (globulin free fraction, 
Sigma-A7638), 1.0% (w/ v) polyvinyl-pyrrolidone 
(Sigma P-5288), 1.0% (w/v) ficoll (Sigma F-2637), 
250 mM Tris. Cl (pH 7.5),0.5% (w/v) tetra-sodium 
pyrophosphate (BDH 10261), and 5% (w/v) SDS. 
50% (w/v) dextran sulphate (sodium salt, Pharmacia 17-0340-01) 
solution. 
De-ionized formamide prepared by mixing 100 ml of formamide 
(BDH 28241) with 5 g of AG 501-X8 (D) mixed bead resin, stirred at 
room temperature for 30 minutes, and filtered to remove resin. 
This was stored in aliquots, at -20°C. 
Salmon sperm DNA (Sigma D-1626): 
this was dissolved at a concentration of 10 mg m1 1 in 1-120, 
and sonicated until the solution was liquid. Prior to use, 
DNA was denatured by boiling for 10 minutes, and chilling 
on ice for a further 10 minutes. 
2 	SSC was made as a 20 x stock, as follows, and stored at room 
temperature: 
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3 M NaCl 	 876.6 g 
0.3 M sodium citrate 	441.15 g. 
Stripping 
Blots were stripped of radio-labelled probe, permitting further 
hybridizations with other probes. 
Membranes were washed in 250 ml of strip solution1 for 2 hours at 
70°C in Techne hybridization ovens. 
Membranes were air dried on Whatman paper (3MM) and stored. 
I 	Strip solution: 
stock 11 
5 mM Tris. Cl (pH 8) 	1 M 5 ml 
0.2 mM EDTA 	0.5 M 200 p.1 
0.05% (w/v) Na pyrophosphate 50 mg 
0.02% (w/v) polyvinyl-pyrrolidone 20 mg 
0.02% (w/v) bovine serum albumin 20 mg 
0.02% (w/v) ficoll 20 mg. 
ix 	Autoradiography 
GeneScreen membranes sealed in SaranWrap and vacuum dried 
gels, were placed in contact with Fuji Blue X-ray film in cassettes. For the 
detection of 32p,  cassettes were placed at 70 0C and intensifying screens 
used. For the detection of 35S,  cassettes were placed at room temperature 
without intensifying screens. Exposure times varied from 1 hour to 7 days. 
Films were developed using an X-ograph Compact X2. 
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2 d Radio-labelling of DNA fragments 
Radiolabelled fragments of DNA were used as probes for a variety of 
methods, such as Northern blotting (Section 2c.viii), primer extension 
(Section 2i), and bandshift assays (Section 2j). The choice of radiolabelling 
method depended on the size of DNA fragment which was used as probe 
in each method. For DNA fragments larger than 500 base pairs random 
primer labelling was used; for DNA fragments smaller than 500 base pairs 
end labelling was suitable. 
i 	Random-primed labelling 
This method is based on that described by Feinberg and Vogelstein 
(1983). The method uses random hexa-nucleotides which bind to the 
DNA fragment, and initiate DNA poerase reactions with the Kienow 
fragment of DNA polymerase I. One of the nucleotides incorporated is 
radiolabelled, and thus the newly synthesized DNA is radiolabelled. 
DNA was cut with appropriate restriction endonuclease. 
DNA fragments were separated in one lane of a 1.2% low melting 
point agarose gel (Gibco-BRL 5517UA) in 1 x TAE buffer. 
2. 	DNA was visualised by ethidium staining, and the desired band 
excised and transferred to a pre-weighed Eppendorf tube: 1 -120 was 
added at a ratio of 3 .tl mg-1 of gel. 
The tube was boiled in water for 7 minutes to dissolve gel and 
denature the DNA: DNA was stored at -20°C at this stage: 
preparatory to subsequent labelling reactions, gels were re-boiled for 
3 
	
	minutes and incubated for 10 minutes at 37°C, before use in the 
labelling reaction. 
4. 	The labelling reaction consisted of: 
H20 	(to a total of 50 p1) 
OLB1 10 p1 
BSA2 	2p1 
DNA 10-20 ng (up to 32.5 p1) 
[a-32P]dCTP 5 p1 (Amersham 10 pCi p14 ) 
Kienow 	191 (Boehringer Mannheim 100840, 2 U p14) 
incubated overnight at 25°C. 
WI 
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5. 	The reaction was stopped by addition of 200 p.1 stop buffer 3: labelled 
DNA was stored at 200C at this stage. 
1 	OLB: 
OLB was made from the following components: 
0: 	to 1 ml of 1.25 M Tris. Cl (pH 8.0) and 0.125 M M902, 
18 p.1 of [-mercaptoethanol added, and 5 p.1 each of 
100 mM dATP, d1TP, and dGTP 
(Pharmacia 27-2035-01). 
L: 	2 M hepes (Sigma H-3375), titrated to pH 6.6 with 
4 M NaOH. 
B: 	Hexa-deoxyribonucleotides at 90 OD units m1 1 
(Pharmacia 27-2166-01). 
Solution 0: L: B mixed at a ratio of 100: 250: 150, to make OLB. 
OLB stored as 20 p.1 aliquots at -20°C. 
2 	Bovine serum albumin (BSA): 
10 mg m1 1 (globulin free fraction, Sigma-A7638). 
3 	Stop buffer: 
stock I ml 
20 mM NaCl 5M 4 p.1 
20 mM Tris. Cl 1 M 20 p.1 
2mMEDTA 0.5M 4 g 
0.25% SDS 20% 12.5 p.!. 
ii 	End-labelling 
This method is based on that of Sambrook et al. (1989). End 
labelling uses bacteriophage T4 polynucleotide kinase (PNK), which 
catalyses the transfer of the y-phosphate of ATP to a 5' terminus of DNA 
or RNA. [y-32P]ATP is added in equimolar amounts to the number of ends 
of nucleic acid in the presence of PNK. This results in terminal 
y-phosphates being replaced by ['y- 32P]-phosphates, and so the DNA 
fragment is radiolabelled. 
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The following reagents were added together: 
DNA 	 10 pmoles 
PNK buffer 1 	I p.1 
H20 	 to 10 p.1 
[y32P]ATP 	3 p.1 	(Amersham, 10 p.Ci p1 -1 ) 
T4 PNK 1 p.! (Gibco-BRL, 10 U p.l-1 ). 
The reaction mixture was usually incubated at 37 0C for 30 minutes 
(although the time and temperature of incubation did vary with each 
DNA fragment), and stopped by incubating at 70°C for five minutes. 
PNK Buffer: 
stock 100 ml 
0.5MTris.Cl 1M 500p.1 
100 MM MgC12 1 M 100 p.1 
50mMDTT 1M 50 g 
1 mM spermidine 1 M 1 p.1 
1mMEDTA 1M 
H20 348 p.1. 
iii 	Purification of labelled DNA 
Radiolabelled DNA was separated from un-incorporated radio-
nucleotide by use of a G-50 matrix size exclusion column. G-50 matrix 
consists of small beads containing tiny holes. Small DNA fragments (<20 
nucleotides) enter the holes in the beads and are retained, whereas larger 
DNA fragments cannot enter the holes and pass through the column. 
Thus, fragments of labelled DNA can be separated from nucleotides, by 
passing a labelling reaction through such a column: labelled DNA will 
pass through and be found in the eluate. 
G-50 (Pharmacia 17-0042-01) beads were prepared by adding two 
volumes of TE and autoclaving. 
The plunger of a 1 ml disposable syringe (Plastipak) was removed, 
and a small wad of siliconized glass wool (Section 2c.vi ) pushed 
into the bottom. 
G-50 was added until the syringe was full: the column was spun for 
2 minutes at 2000 rpm, more G-50 was added and the column spun 
again until the G-50 had shrunk to about 800 jfl. 
Labelled DNA was added (in a volume of about 100 p.1, with 1 p.1 
of glycogen carrier (Section 2b.iii), and spun again for 2 minutes at 
2000 rpm. 
If separation of labelled DNA fragment from unincorporated 
radionucleotide had occurred, a certain radioactive profile in the 









Figure 2 D Radioactive profile observed in G-50 columns in 
which separation of radiolabelled DNA from 
nucleotide has occurred. 
High refers to high counts of radioactivity of 
unincorporated nucleotide, retained in the column. Low refers to 
low counts of radioactivity of labelled DNA excluded from the 
column. 
6. 	DNA was sodium acetate precipitated and Washed with 90% ethanol 
(Section 2b.iii). 
2 e Fission yeast manipulations 
Strains 
The wild type strain and mutant strains of the fission yeast 
Schizosaccharomyces pombe Linder, were all derived from the haploid 
heterothallic 972 (mating type h-) and 975 (mating type h) isolates 









cdclO-C4 ura4-D18 h 
cdclO-K28 ura4-D18 h 
cdc2-33 ura4-D18 h 
ura4-D18 h 
cdcl0-C4 mat2-102 ade6-M216 /cdcl0-C4 leul-32 
cdcl0-C4 mat2-102 ade6-M216 /cdclO-129 leul-32 
cdcl 0-129 leul -32 /cdcl 0-129 lysI -131 mat2-1 02 
cdclO-129 leul-32 /mat2-102 ade6-M216 
leu3-155 /mat2-102 ade6-M216 
cdcl 0-C4 leul -32 /mat2-1 02 ade6-M21 6 
ii 	Media and growth conditions 
Media 
Strains of fission yeast were routinely grown on solid YE complex 
medium supplemented with adenine and uracil. 
YE contains per litre: 
glucose 	30g 
yeast extract 	5 g 
adenine 75 mg 
uracil 	 75 mg 
Difco-Bacto agar 1.5 g 
For complex liquid medium YE was used minus Difco-Bacto agar. 
EMM (Moreno et al., 1991) was used as minimal medium, and is a 
modification of EMM2 (Mitchison, 1970 and Nurse, 1975), and contains the 
following per litre: 
glucose 20g 
KH phthalate 3 g 
Na2HPO4 1.8 g 
NH4C1 5g 
NaSO4 100 mg 
CaC12 15 mg 
MgC12 I g 
vitamins 1 ml 
minerals 	100 .tl. 
Where vitamins are: inositol, 5 g;  nicotinic acid, 5 g;  calcium 
pantathenate, 0.5 g;  and biotin, 5 mg all dissolved in 500 ml H20. 
Where minerals are: H3B03 1 g;  MnSO4. 4 HO, 1.04 g;  ZnSO4. 7 H0, 
800 mg; FeC13. 6 H20,400 mg; H2MoO4, 288 mg; CuSO4. 5 HO, 
80 mg; Citric acid, 2 g;  and KI, 20 mg, all dissolved in 200 ml H20. 
Both were stored at 4°C. 
Growth supplements such as adenine, uracil, lysine, and leucine 
were made as 50 x stock solutions of 375 mg ml -1, and were added as 
required after autoclaving. 
To generate fission yeast with thin cell wails to assist in 
spheroplasting for transformations, low glucose EMM was used. This is 
identical to EMM, except that glucose is at a concentration of 0.5% instead 
of 2%. 1.2 M sorbitol was included in solid media for the regeneration of 
osmotically sensitive spheroplasts. 
For the induction of conjugation and consequent sporulation, 
nitrogen limiting medium ME, consisting of 30 g 11 malt extract and 
20 g 11 agar, was used. 
To check ploidy of cells, phloxin B was added, from a stock solution 
of 10 mg rn!4 , to a final concentration of 20 p.g rnF 1 in solid media. 
Diploid cells die faster than haploid cells and accumulate the dye more 
quickly, so can be differentiated by relative colour staining. 
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Storage 
Short term storage of fission yeast (up to 4 weeks) was on solid 
medium at 4°C. Long term storage was in medium containing 20% (v/v) 
glycerol at -70°C. 
iii 	Genetical analysis 
Crossing strains 
The standard genetical procedures of Gutz et al. (1974) and Kohli et 
al. (1977) were followed. Strains were crossed by mixing together fresh 
isolates of two cell types (mating types h and h-) on the surface of an ME 
plate. The mating mix was incubated at 25°C for 2-3 days to allow zygotes 
to form. The progeny of the crosses were examined by random spore 
analysis. 
Random spore analysis 
A loopful of mating mix was suspended in 1 ml of sterile distilled 
water containing 20 p.1 of a stock solution of the snail gut enzyme (Suc 
d'Helix pomatia, Industrie Biologique, France) and incubated overnight at 
35°C. The stock solution is a 1 / 10 dilution of the preparation supplied, 
which is stored at 4°C. The spore concentration was estimated using a 
haemocytometer and an appropriate dilution, to give about 200 spores per 
plate, spread onto solid YE media. 
Analysis of phenotypes 
Phenotypes of cells were tested by replica plating, or by streaking, 
from a master plate onto EMM plus or minus growth supplements for 
auxotrophs; and onto YE with phioxin, at the restrictive and permissive 
temperatures, for temperature-sensitive strains. 
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iv 	Cell physiology 
Growth in liquid cultures 
For all experiments examining aspects of fission yeast cell 
physiology, actively growing cells were used. Such cells were undergoing 
exponential growth, and were at a concentration of 3 - 8 x 106  cells ml-1 . 
Exponentially growing cells were obtained by inoculating a single colony 
into a 10 ml YE pre-culture and incubating until the cells had entered the 
stationary phase of growth (usually 2 days). An aliquot of the pre-culture 
( 1 /100) was inoculated into 200 ml of EMM in a 500 ml conical flask, and 
incubated shaking for 14-18 hours at 25°C or 35 0C. Cell number was 
monitored until cells reached mid-exponential stage. 
Estimation of cell number 
Cell number was estimated using a Coulter counter (Industrial D). 
A 100 p.1 sample of cell culture was removed and mixed in 10 ml of 
ISOTON solution (a I / 1000 dilution), sonicated for 5 seconds at setting 2 on 
a Lucas Soniprobe Sonicator. Usually 2 counts of 500 p.1 volume were 
taken, and combined to give a cell count per ml. 
Synchronous cultures 
To obtain populations of fission yeast cells dividing synchronously, 
a Beckmann Elutriator rotor was used. These experiments were conducted 
with the kind and skilful help of Dr. Jim Creanor. 
Temperature shift experiments 
Cells were grown with shaking at the permissive temperature of 
24°C, until the mid-exponential phase of growth (3 x 10 6 cells m14) was 
reached, when the whole culture was transferred to the restrictive 
temperature of 36°C. 
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V 	Transformation 
The method used for fission yeast transformation was essentially 
that of Beach & Nurse (1981), and yields up to 20,000 transformant colonies 
per p.g of plasmid DNA. 
200 ml cultures, of mid-exponential stage of growth fission yeast 
cells (Section 2e.iv), were prepared in 0.5% glucose EMM. 
Cells were transferred to 250 ml Beckman bottles and pelleted by 
centrifugation at 5000 rpm for 10 minutes. 
The supernatants were discarded and cells resuspended in 10 ml of 
cPE1 . 
Cells were centrifuged out and the supernatants discarded. 
Pellets were resuspended in 5 ml of CPS 2 . 
Pellets were transferred to 50 ml screw cap tubes (Falcon 2070) and 
incubated at 37°C. 
After 20 minutes, 5 tl of cells were removed to check spheroplast 
formation under the microscope. When spheroplasts had formed 
(cells appeared round as opposed to 'sausage' shaped) the next stage 
was started. If the cells had not spheroplasted the incubation was 
continued and the cells checked every ten minutes. 
15 ml of TS3 was added, mixed, and 5 ml aliquoted into four 50 ml 
screw-cap tubes, and centrifuged at 2,000 rpm for 4 minutes. 
Step 8 was repeated four more times. 
Cells were finally resuspended at a density of 2.5 x 10 8 cells n* 1 in 
TCS4 . 
100 j.tl aliquots of cell suspension were transferred to 5 ml snap-cap 
polystyrene tubes (Falcon 2058) containing 1 and 5 p.g of plasmid 
DNA, and incubated at room temperature for 15 minutes. 
1 ml of TCP5 was added and cells incubated at room temperature for 
15 minutes. 
Cells were pelleted by centrifugation at 2,000 rpm for 5 minutes, and 
supernatants removed by aspiration. 
Cells were resuspended in 500 ml of TCS with 0.5 mg ml -1 yeast 
extract and 5 mg ml -1 supplements. 
Cells were incubated for 60 minutes at permissive temperature, and 
250 .tl plated onto each of two EMM plates with 1.2 M sorbitol. 
Transformant colonies appeared after 4-6 days. 
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17. 	Non-integration of plasmids was checked by a stability test. 
Transformant cells were streaked to single colonies, grown on YE 
('off selection') for 2 days, and then replica plated onto EMM ('on 
selection'). Cells containing non-integrated plasmids were 
evident having lost the ability to grow on EMM. 
1 	PE: 
20 mM citrate-phosphate buffer pH 5.6 
40 mM EDTA 
0.1% (v/v) 3-mercaptoethanol (added immediately before 
use). 
2 	CPS: 
50 mM citrate-phosphate buffer pH 5.6 
1.2 M sorbitol 
0.1% (vlv) 3-mercaptoethanol (added immediately before 
use) 
2 mg m1 1 Novozyme 234 (Novo Industries, Bagsvaerd, 
Denmark 69-289-01). 
3 	TS: 
10 mM Tris. Cl pH 7.6 
1.2 M sorbitol. 
4 	TCS: 
10 mM Tris. Cl pH 7.6 
10 mM CaC12 
1.2 M sorbitol. 
5 	TCP: 
10 mM Tris. C1pH 7.6 
10 mM CaC12 
20% PEG-4000. 
48 
vi 	Preparation of nucleic acids from fission yeast 
Genomic DNA 
This method produced fission yeast genomic DNA of sufficient 
quality for PCR amplification, and is as described elsewhere 
Durkacz et al., 1985). 
10 ml cultures of media were inoculated with a single yeast colony, 
and incubated until the the culture reached stationary phase 
(1-2 days). 
Cells were harvested (5 minutes at 2500 rpm) in 15 ml centrifuge 
tubes (Falcon 2095). 
Supernatants were discarded and cells resuspended in 1.5 ml CPS 1 
containing 2.5 mg ml-1 zymolyase 20 T (Seikaguku Kogyo 120491): 
suspensions were transferred to Eppendorf tubes. 
Cells were incubated at 37°C for 60 minutes. 
Cells were harvested by centrifugation at high speed for 2 minutes. 
Supernatants were discarded and cells resuspended in 300 j.tl of 
5 x TE; 35 p.1 of 10% SDS (w/v) was added and the mixture incubated 
at 65°C for 5 minutes. 
100 p.1 of 5 M potassium acetate (pH 5.6) was added and the mixture 
incubated on ice for 30 minutes. 
Cells were centrifuged at 4°C at high speed for 15 minutes: the 
supernatant was removed (400 p.1) and to this 1 ml ice-cold 95% 
(v/v) ethanol added and mixed. 
Centrifuged at high speed at 4°C for 10 minutes. 
Supernatant was discarded and pellet resuspended in 400 p.1 of 
5 x TE containing 100 p.g ml -1 RNAase 
(bovine pancreatic, Sigma R-5000): incubated for 2-4 hours at 37°C. 
Suspension was extracted once each with an equal volume of 
phenol, phenol/ chloroform, and chloroform (Section 2b.ii). 
The final aqueous phase was transferred to another Eppendorf tube, 
sodium acetate precipitated, and washed with 70% ethanol 
(Section 2b.iii). 
Pellets were dried, dissolved in 100 p1 of TE, and DNA quality 
and amount checked (Section 2b.iv). 
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1 	CPS: 
50 mM citrate-phosphate buffer pH 5.6 
1.2 M sorbitol 
0.1% (v/v) f3-mercaptoethanol (added immediately before 
use) 
2 mg ml-1 Novozyme 234 (Novo Industries, Bagsvaerd, 
Denmark 69-289-01). 
Total RNA 
This method, based on that of Kaufer et al. (1985), produced fission 
yeast total RNA which was used for Northern blotting (Sections 2c.vii and 
2c.viii) and primer extension (Section 20. 
Gloves were worn during all RNA procedures to prevent RNAase 
contamination. 
200 ml cultures of mid-exponential stage of growth fission yeast 
cells were prepared (Section 2e.iv), and harvested by centrifugation 
at 5000 rpm for 10 minutes in four 50 ml screw cap tubes 
(Falcon 7020). 
Each cell pellet was resuspended in 1 ml of sterile saline 1 and 
transferred to an Eppendorf tube; cells were pelleted by 
centrifugation at high speed, and the supernatant discarded (cells 
could be stored at -70°C at this stage). 
Cells were resuspended in 75 p.1 of STE 2 . 
Chronic acid washed beads (425-600 micron, Sigma G-9268) were 
added to just beneath meniscus, and the cells briefly vortexed. 
600 p.1 of NTES3 was added, and the mixture briefly vortexed again, 
500 p.1 of hot phenol (65°C) was added, and the mixture 
immediately vortexed. 
The mixture was incubated at 65°C for 5 minutes with frequent 
vortexing. 
The mixture was centrifuged for 1 minute at high speed, and the 
aqueous phase and protein interface were removed to a second 
500 p.1 aliquot of hot phenol. 
Incubated at 65°C for 2 minutes with frequent vortexing. 
Centrifuged for 1 minute at high speed, and again the aqueous 
phase and interface were removed to a third 400 p.1 aliquot of hot 
phenol. 
Incubated at 65°C for 2 minutes with frequent vortexing. 
Aqueous phase only was removed into 400 p.1 of 
phenol/ chloroform at room temperature, vortexed, and spun at 
high speed for 1 minute. 
Aqueous phase was re-extracted with 300 p.1 of chloroform, 
vortexed, and spun for one minute at high speed. 
Aqueous phase was sodium acetate precipitated (Section 2b.iii). 
Supernatant was discarded and the RNA pellet washed with 70% 
ethanol in DEPC H20; it was important that the pellet did not 
become completely dry, as this made re-dissolving difficult. 
RNA pellet was resuspended in 55 p.1 of ice cold DEPC H20. 
5 p.1 of each sample was used to estimate amount and quality by 
spectrophotometry (Section 2b.iv). 
RNA was stored at -20°C. 
1 	Sterile saline: 
0.9% (w/v) NaCl, autoclaved. 
2 	STE: 
0.32 M sucrose 
20 mM Tris. Cl (pH 7.5) 
10 mM EDTA (pH 8.0) 
0.5 mg m1 1 heparin (Sigma H-7005) added solid just prior to 
use. 
3 	NTES: 
100 mM NaCl 
5 mM EDTA 
50 mM Tris. Cl (pH 7.5) 
1%(w/v)SDS 
0.5 mg m1 1 heparin addedjsolid just prior to use. 
vii Preparation of protein from fission yeast 
This method was developed by Noel Lowndes and myself, and 
produced total non-denatured fission yeast protein extracts, which were 
used in bandshift assays (Section 2j). 
200 ml cultures of fission yeast cells in mid-exponential stage of 
growth were prepared (Section 2e.iv), and harvested by 
centrifugation at 5000 rpm for 10 minutes, in four 50 ml screw cap 
tubes (Falcon 7020). 
Supernatants were discarded and each cell pellet resuspended in 
100 j.tl of lysis buffer 1 in Eppendorf tubes: acid washed glass beads 
(425-600 micron, Sigma G-9268) were added to just beneath the 
meniscus. 
Cells were broken by vigorous vortexing: 15 minutes of 30 seconds, 
with 30 second intervals on ice: cell breakage was monitored 
microscopically. 
Cell walls were pelleted by centrifugation at high speed for 5 
minutes at 40C 
Supernatants were transferred to another Eppendorf tube, and the 
protein extract clarified by centrifugation at 17,000 rpm 
(Beckman JA-18) for 30 minutes at 4°C. 
Supernatants were transferred to another Eppendorf tube, and 5 p1 
removed for protein assay: the remainder was snap frozen on solid 








25% glycerol 	50% 
2mMDTT 1M 
0.1% Triton X-100 
chymostatin (Sigma C-7268) 
antipain (Sigma A-6271) 
leupeptin (Sigma L-2884) 
aprotonin (Sigma A-6279) 
pepstatin (Sigma P-4265) 
H20 













2 p1 (added at last moment). 
DTF: dithiothreitol (Sigma D-0632) 1 M solution in H20, 
stored at -20°C. 
PMSF: phenylmethanesulfonyifluoride (Sigma P-7626) 
100 mM solution in isopropanol, stored at 4°C. 
Protease inhibitors: each at 5 mg m1 1 : stored at -20°C. 
Protein concentration was estimated using the Pierce BCA Protein 
Assay kit (23225) according to the manufacturer's instructions. 
2 f Escherichia coli manipulations 
Strains 
Two Escherichia coli strains were used in this work: 
JM101 supE thi Mac-proAB) (F' traD36 proAB lacIqZDM15) 
JA226 recBC leuB6 trpE5 hsdR- hsdM+ lacY600. 
The former was specifically used for the propagation of pUC-based 
plasmids and the production of single stranded DNA, as it has the fl 
origin required for M13K07 helper phage infection (Section 2g.ii). The 
latter was used for routine plasmid propagation. 
ii 	Media and growth conditions 
Rich medium 
All E. coli strains were routinely grown in rich medium LB 
consisting of, per litre: 
Bacto-tryptone 	10 g 
NaCl 	 log 
Yeast extract 	5 g. 
Glucose was added from a sterile stock solution to 1 g 11 after - 
autoclaving. 




M9 minimal medium was used. 
750 ml of H20 containing 12 g of Bactoagar was autoclaved and 
cooled to 55°C in a water bath. Each of the following were autoclaved 
separately and then added together: 
200 ml of 5 x M 9 salts1 
2 ml of I M MgSO4 
100 .tl of 1 M CaC12 
20 ml of 20% glucose. 
5xM9salts: 
Na2HPO4. 7H20 64 g 
KH2PO4 	15 g 
NaCl 2.5 g 
NH4C1 	 5.0 g. 
The solution was dissolved to final volume of 1 litre in H 20, the pH 
adjusted to 7.4 with HC1, split into 200 ml aliquots, and autoclaved. 
Thiamine was added as supplement at a final concentration of 
1 mM thiamine-HC1 (Sigma T-4625). 
Selective antibiotics 
Ampicillin 
A 1000 x stock solution of 100 mg m1 1 of the sodium salt was 
dissolved in 50% ethanol. 
Chioramphenicol 
A 1000 x stock solution of 34 mg ml-1 chloramphenicol was 
dissolved in 100% ethanol. 
Kanamycin 
A 1000 x stock of 70 mg m1 1 kanamycin was dissolved in H20. 
Tetracycline 
A 500 x stock of 5 mg ml -1 of tetracycline was dissolved in 50% 
ethanol. 
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Antibiotic stock solutions were stored at 20 0C, and were added to 
autoclaved media. 
Colour selection 
Where blue/white colour selection was available in cloning vectors 
(Section 2b.v), X-Gal (5-Bromo-4-chloro-3-indo1yl--D-galactopyranoside, 
Sigma B-4252) to a final a concentration of 40 p..g m1 4, from a freshly made 
solution of 20 mg ml-1 in dimethyl formamide, and IPTG (isopropylthio-
[3-D-galactoside, Sigma 1-6758) to a final concentration of 
100 tiM, from a stock of 100 mM in H20, were added to media. 
Growth conditions 
All bacteria were grown at 37°C, in an orbital shaking incubator. 
Storage 
All bacteria were stored on LB agar plates for periods up to 4 weeks. 
Long term storage was in LB medium containing 20% (v/v) glycerol 
frozen at -70°C. Bacteria were revived from long term storage by 
removing a small stab from the frozen culture, and streaking out onto LB 
medium with appropriate antibiotic. 
iii 	Plasmid preparation 
'Quick-preps' 
This rapid method (Sambrook et al., 1989) produced about 5 jig of 
relatively 'dirty' plasmid DNA, which was useful for screening large 
numbers of transformant colonies. The resulting DNA degrades within 30 
minutes at 37°C, so restriction digests were incubated for 15 minutes at this 
temperature. This was not a problem as the DNA digested very quickly. 
Single colonies were inoculated into 5 ml of LB with selective 
antibiotic, and grown overnight shaking at 37°C. 
Cultures were transferred to disposable 20 ml test tubes 
(Sarstedt 55.466) and cells pelleted by centrifugation at 10,000 rpm for 
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10 minutes. 
Supernatants were removed by aspiration, and each pellet re-
suspended in 300 p.1 of STET 1; suspensions were transferred to 
Eppendorf tubes and incubated on ice for 5 minutes. 
A small hole was pierced in the lid of each Eppendorf tube to stop 
them 'popping' open at the next stage. 
Eppendorf tubes were plunged into bubbling boiling water for 45 
seconds, cooled on ice for 30 seconds, and immediately centrifuged 
at high speed for 10 minutes. 
5. 	Gelatinous pellets were removed with a tooth-pick from each tube. 
All remaining volumes were made up to 200 p.1 with STET, and 
200 p.1 of isopropanol added, mixed, and frozen at -20°C for 20 
minutes. 
Solutions were centrifuged at high speed for 10 minutes, and 
supernatants discarded. 
Precipitates were resuspended in 100 p.1 of STET, 100 p.1 of ethanol 
added, mixed carefully, and frozen at -20°C for 20 minutes. 
Solutions were centrifuged at high speed for 10 minutes, 
supernatants discarded, and pellets resuspended in 50 p.1 of TE: 
these were frozen at 20 0C immediately. 
I 	STET: 
stock 	11 
sucrose 	8% 	 80 g 
Triton X-100 	5% 50 ml 
EDTA 	 5 m 	0.5M 	10 ml 
Tris. Cl 50 mM 1 M 50 ml. 
'Midi-preps' 
This method, based on that of Birboim & Doly (1979), produced 
100 p.g amounts of 'clean' plasmid DNA, which was used for all common 
molecular biology techniques. 
Single colonies were inoculated into 100 ml of LB with appropriate 
antibiotic, and grown overnight shaking at 37°C. 
Cultures were aliquoted into two 50 ml screw cap tubes (Falcon 
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7050) and cells pelleted by centrifugation at 10,000 rpm for 10 
minutes. 
Pellets were carefully resuspended in a final volume of 3 ml of 
TESL1 by gentle pipetting, and incubated on ice water 20 minutes. 
6 ml of NS2 was added, mixed carefully by inversion, and incubated 
on ice for 10 minutes. 
Cells were pelleted by centrifugation at 15,000 rpms for 15 minutes, 
• in a swing-out rotor, and the supernatant carefully removed; this 
was transferred to another 50 ml screw cap tube, 50 .tl of RNAase3 
added and incubated for 20 minutes at 37°C. 
Supernatants were phenol/ chloroform extracted twice 
(Section 2b.ii). 
Two volumes of ice cold ethanol were added to precipitate DNA, 
and DNA pelleted by centrifugation at 10,000 rpm for 10 minutes. 
Supernatants were discarded, and pellets dissolved in 1.6 ml of H20; 
400 il of 4 M NaCl added and mixed; 2 ml of 13% (w/v) PEG 6000 
added, mixed, and the tubes incubated on ice water for 60 minutes. 
DNA was pelleted by centrifugation at 10,000 rpm for 10 minutes, 
supernatants were discarded, washed pellets with 70% ethanol 
(Section 2b.iii), and pellets dissolved in 100 jfl of TE. 
1 	TES: 
stock 	100 ml 
25 mM Tris. Cl (pH 8.0) 1 M 2.5 ml 
10 mM EDTA 	0.5M 	2m1 
15% sucrose 15 g 
2 mg ml-1 lysosyme (Sigma L-6876). 
2 	NS: 
stock 	100 ml 
0.2 M NaOH 	 800 mg 
1% SDS 	 20% (w/v) 5 ml. 
3 	RNAse (Bovine pancreatic, Sigma R-5503) 
Dissolved at a concentration of 10 mg ml -1 in Tris. Cl (pH 7.5) and 
15 niM NaCl. Incubated at 100°C for 15 minutes on a heating block, 
and then allowed to cool slowly to room temperature. 




This method is based on that of Hanahan (1983), and produced 
transformation frequencies of up to 10 8 colonies per p.g of plasmid DNA. 
Competent cells 
Pre-cultures were grown in LB overnight shaking at 37°C. 
200 ml of pre-culture was inoculated into 20 ml 9 broth 1 and grown 
at 37°C shaking to an A550 of 0.25: this usually took about 2 
hours. 
1 	5 ml of cells were inoculated into 20 ml (p broth, and grown to an 
A550 of 0.48. 
Cultures were cooled briefly on ice, and cells pelleted by 
centrifugation for 5 minutes at 9000 rpm at 4°C. 
Pellets were resuspended in 33 ml of ice cold TfBI 2, and incubated 
on ice for 15 minutes. 
Cells were pelleted again by centrifugation for 5 minutes at 9000 
rpm at 4°C. 
Pellets were resuspended in 4 ml of ice cold TfBII 3 and incubated 
on ice for 20 minutes. 
200 j.d of cells aliquoted into ice-cold Eppendorf tubes, snap 
frozen on solid CO2. and stored at -70°C. 
1 	p broth was made of 10 ml of salts added to 490 ml tryptone/yeast 
extract. 
10 g of tryptone and 2.5 g of yeast extract were dissolved in 
490 ml of H20, and autoclaved. 
Salts: 
1M MgSO4. 7 HO 
















NaOAc 	1.43 g 
CaC12.6H20 	1.1g 
glycerol 	75 g 
and pH to 5.9 with HOAc. 
Added solid: 
RbC1 	 6.0 g 
MnC12 4.95 g 
and autoclaved in 50 ml aliquots. 
TfBII: 
100 ml 
MOPS 	 209 mg 
RbC12 120 mg 
CaC12.6H20 	1.64g 
glycerol 	15 g 
pH to 6.8 with KOH and autoclaved 
in 10 ml aliquots. 
Transformation 
Cells were thawed on ice for 10-15 minutes. 
DNA was added in a minimum volume - less than 10 p.1. 
Cells were incubated on ice for 30 minutes. 
Cells were heat-shocked cells in a 42°C water bath for 60 seconds. 
400 p.1 of LB was added and incubated at 37°C for 60 minutes. 
250 p1 of cells were spread onto appropriate plates. 
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2 g DNA sequencing methods 
Sequencing of DNA was performed by a combination of the 
phagemid system devised by Vieira and Messing (1982) and the chain 
termination sequencing system of Sanger et al. (1977). 
i 	Deletions 
A series of unidirectional nested deletions of all four Hin dill cdc22 
subclones (Section 3b; Fig. 3A) were made, using the method of Henikoff 
(1984). The Pharmacia Deletion kit was used, according to the 
manufacturer's instructions. 
This method produces a group of unidirectional nested deletions 
using exonuclease Ill (Exo III). Exo ifi is an 3'-exonuclease which is only 
active on double stranded DNA: blunt and 5' overhanging ends are 
susceptible to digestion, while 3' overhanging ends of three or four bases 
in length are resistant to the enzyme. It is therefore possible to prepare 
linearized DNA which has only one susceptible end next to the DNA 
fragment of interest by cutting the DNA with two restriction enzymes, one 
of which produces a susceptible end and the other producing a resistant 
end. Incubation of this DNA with Exo ifi, under controlled conditions of 
salt and temperature, permits the progressive removal of nucleotides 
from one strand. By stopping the reaction at incremental times, a series of 
DNA pieces of varying length can be produced. The remaining single 
stranded DNA is removed using Si nuclease, and the molecules are re-
circularized using T4 DNA ligase. These nested deletions can then be 
sequenced using a common oligonucleotide primer, which hybridizes to a 
DNA sequence just internal to the resistant end. 






Restriction enzyme digestion 
To create a linearized molecule with resistant and sensitive ends to 
Exo ifi, the following restriction digests were completed: 
clone resistant end sensitive end 
pCDC22. 10 SstI XbaI 
pCDC22. 5 SstI BamHI 
pCDC22.7 KpnI XbaI 
pCDC22.14 KpnI BamHI 
5 p.g of DNA was cut in each digestion: the resistant end digestion 
was completed first, and monitored by gel electrophoresis to ensure 
completion; the sensitive end digestion was then performed. Both 
enzymes were then inactivated by freezing at -20°C. 
Exo III digestion 
Exo Ill digestion was performed at 30°C in 75 mM NaCl to give 
300 nucleotide spaced deletions. 
For Exo ifi digestion buffer of 75 mM NaCl added: 
Cut DNA in REact III (100 mM NaCl) 	20 j.tl 
Exo III buffer 	 8 p1 
0.3MNaC1 4tl 
1-120 	 12p1 
This mix was pre-warmed to 30°C and a 2p.l  sample removed and 
added to 3 j.tl of ice cold Si Buffer 1 . 
1 p1 of Exo III was added, mixed, and further 2 p1 samples removed 
at 3 minute intervals, and each added to 3 j.tl of SI Buff. Lu 
After all timed samples have been removed, they were incubated 
simultaneously at room temperature for 30 minutes. 
1 p1 of Si stop solution was added to each tube, mixed, and 
incubated at 65°C for 10 minutes. 
MIN 
Analysis of deletions 
1. 	3 .tl of each sample was mixed with 3 j.tl  of loading buffer and 







Figure 2 E Exonudease III deletion series of pCDC22-14. 
Exo III deletions of pCDC22-14 of 300 nucleotide 
incremental size (lanes 1-18) analysed on a 1.0% agarose gel. 
Molecular weight standards (MW) and linearized pTZI9 
(pTZ) are indicated. For method see text. 
Re-circularization and transformation 
Ligation mix prepared by adding: 
5 x ligase mix 	 85 j.il 
25% PEG 	 8591 
H20 	 195 gl 
17 p.1 of ligation mix added to 3 p.1 remaining of each sample, gently 
mixed, and incubated at room temperature for 2 hours. 
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Each ligated sample was transformed into bacterial strain JM101 
(Section 2f.iv). 
Quick prep plasmid DNA was prepared (Section 2f.iii) from 12 
transformant colonies from each time point, and the size of 
resultant inserts estimated. Initially, an EcoRI digestion was 
completed to ensure presence of the reverse sequencing primer site, 
adjacent to the polylinker. Those clones containing the primer site 
were then double digested with EcoRE and another restriction 
enzyme to release the DNA insert fragment which had been deleted 
by Exo ifi. Restriction enzymes cutting at sites progressively further 
into the clones were used, as they produced small DNA fragments, 
which could be accurately sized. 
ii 	Production of single-stranded DNA 
Single-stranded DNA (ssDNA) was produced using helper phage 
M13K07. This method yielded about 5 p.g of ssDNA template, suitable for 
dideoxy sequencing. 
Cultures and infections 
Single transformant colonies in E. coil strain JM101 were streaked 
onto M9 plates to enrich for the F9 episome. 
Single colonies were inoculated into 5m1 LB with appropriate 
antibiotic, and incubated overnight shaking at 37°C. 
400 .tl of culture was inoculated into 10 ml of 2YT 1 in a 50 ml screw 
cap tube (Falcon 7020), and incubated shaking at 37°C. 
Cultures were monitored until the Ajj was between 
0.5-1.0 (this usually took between 2 and 2.5 hours). 
2 ml of culture was transferred to another 50 ml screw cap tube, 
5 p.1 of helper phage (Bio-Rad 1703578) added, and shaken 
vigorously at 37°C for 60 minutes. 
200 p.l of culture was added to 10 ml of 2YT and 10 p.1 of kanomycin 
solution (Section 2f.ii) added, and this grown overnight at 37°C. 
Preparation 
Cultures were poured into 30 ml Corex tubes and centrifuged for 5 
minutes at 9,000 rpm; supernatants were decanted into fresh 30 ml 
Corex tubes, and the spin repeated. 
9 ml of each supernatant was removed into fresh 30 ml Corex tubes 
and 1.2 ml of PS1 added, mixed carefully, and incubated on ice for 60 
minutes. 
Helper phage was pelleted by centrifugation at 12,000 rpm for 10 
minutes. 
Supernatants were discarded and phage resuspended in 1.3 ml of 
TE; this suspension was aliquoted into two Eppendorf tubes 
each containing 650 .tl. 
40 p.1 of 40% (w/v) PEG 6000 and 80 p.1 of 5 M NaC1 were added to 
each tube, carefully mixed, and incubated at room temperature for 
30 minutes. 
Tubes were spun for 10 minutes at high speed and each pellet re-
suspended in 300 p.1 of TE. 
Each solution was phenol/ chloroform extracted 3 times, DNA 
was sodium acetate precipitated, and the pellets washed with 
70% ethanol (Section 2b.ii and iii). 
Pellets were resuspended in 20 p.1 of TE. 
0.5 p.1 was run on an agarose gel in parallel with ssDNA from the 
Pharmacia T7 sequencing kit to assay amount. 
1 	2YT: 
11 
Bactopeptone 	16 g 
yeast extract log 
NaC1 	 5 g and autoclaved. 
2 	PS: 
stock 	100 ml 
PEG 6000 	 27g 
NaCl 5M 	66 ml 




Dideoxy sequencing reactions using T7 DNA polymerase were 
performed with the Pharmacia 17 sequencing kit, according to the 
manufacturer's instructions. 
This method depends on base-specific termination, by 
dideoxynucleotides, of enzyme catalysed primer extension reactions 
(Sanger et al., 1977). Four reactions are performed, all containing primer, 
template, and four deoxyribonucleotides; each including a chain 
terminating dideoxynucleotide and 17 DNA polymerase. This results in 
stochastic mixture of extended fragments, each terminated by the 
particular dideoxyribonucleotide added to the reaction. When the 
products of the four reactions are separated by electrophoresis side by side, 
a 'ladder' of progressively larger fragments is formed. The base pair 
sequence of the DNA molecule can be deduced by reading the order of this 
ladder, which is visualised by radiolabelling. 
N.B. Buffers printed in bold were supplied with the Pharmacia T7 
sequencing kit. 
Annealing of primer 
1. 	 2 jig template DNA 	10 p.1 
annealing buffer 2 p.1 
primer 1 	 8.88 ng in 2 p.1 
were added together, and heated at 60°C for 10 minutes, and allowed 
to cool to room temperature for 15 minutes. 
1 	Primer: 
universal primer supplied with the kit was dissolved at a 
concentration of 0.8 jiM, or 4.44 jig m1 1 . Reverse sequencing 
primer (Amersham, NH512) was also used and dissolved to 
the same concentration. Other oligonucleotides were usually 
supplied at a concentration of 400 jig m1 1, and were diluted 
1 /250, to give the correct final concentration. 
Sequencing reactions 
To 'read short' (up to 500 nucleotides) or to 'read long' (50-1000 
nucleotides) mix-short or mix-long reactions were used: four 
Eppendorf tubes were labelled 'A', 'C', 'G', and 'T': into each 2.5 jtl 
of 'A' mix, 'C' mix, 'C' mix, and 'T' mix, was pipetted. 
Labelling reaction: to each tube containing annealed template and 
primer, 6 i.tl of Enzyme pre-mixl was added, and incubated at 
room temperature for five minutes. 
While this incubation was in progress, the four sequencing 
mixes just dispensed were incubated at 37 0C for at least one 
minute. 
After incubating the labelling reaction for 5 minutes, 4.5 p.1 of this 
reaction was transferred to each of the four pre-warmed sequencing 
mixes, mixed, and incubated at 37°C for 5 minutes. 
5 p.1 of stop solution was added to each sample and mixed. 
Enzyme pre-mix 
For one template mix together: 
H20 	 1 g 
Labelling mix 	 3 p.1 
Diluted T7 polymerase 2 p.1 
[a-35S]dATP (10p.Ci) 	1 p.1. 
T7 polmerase was diluted using ice cold enzyme dilution buffer, to a 
final concentration of 1.5 units p.F 1 . 
[a-35S]dAl'P: Amersham 37.0 M Bq 1.00 mCi 
iv 	Gel electrophoresis 
Electrophoresis was carried out using the BRL Model S2 sequencing 
gel electrophoresis system. 
Glass plates were cleaned with H20 and ethanol, treated with 
trimethyichiorosilane (BDH 33164), separated by spacers, and sealed 
with tape. 
To 100 ml of sequencing mix 1 , lml of freshly prepared 10% 
(w/v) ammonium persulphate (Sigma A-9164) and 25 p.1 of TEMED 
(N,N,N',N'-tetramethylethylenediamine, Bio-Rad 61-0800) were 
added, the solution mixed, and immediately poured. 
Loading wells were formed using 'shark's-tooth' combs, according 
to the manufacturer's instructions. 
Gel were pre-run at a constant 43 Watts for 30 minutes in I x TBE 
buffer, the wells flushed out out with 1 x TBE buffer, and samples 
loaded after incubation at 75°C for 3 minutes. 
Gels were run at 43 Watts for 6-12 hours. 
Glass plates were separated so that the gel remained attached to 
one plate. 
Gels were transferred to a sheet of Whatman filter paper. 
(3 MM), covered with SaranWrap, and dried on a vacuum gel 
dryer. 
Gels were processed for autoradiography (Section 2c.ix). 
1 	Sequencing mix: 
40% acrylamide (19:1 acrylamide: bisacrylamide) 	75 ml 
IOxTBE 	 50 ml 
urea 	 250g 
1-120 175 ml 
total 	SOOml. 
All reagents used were Gibco-BRL Ultra-Pure. 
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2 h Polymerase chain reaction 
The polymerase chain reaction (PCR) was used for the amplification 
of DNA fragments, for a wide number number of uses. 
Amplification was performed over 30 cycles using 0.1 p.g of either 
chromosomal (Section 2e.vi ) or plasmid DNA, with the GenAmp DNA 
reagent kit (Perkin Elmer Cetus N801-0055), in a Hybaid Thermal Reactor 
programmed as follows: 
94°C for 2 minutes (denaturation) 
55°C for 2 minutes (annealing) 
72°C for 4 minutes (elongation) 
and finishing with: 
72°C for 5 minutes 
250C for 30 minutes. 
Each reaction mixture, made up to the manufacturer's instructions, 




Reaction Buffer 1 
dNTP mix2 
H20 
Taq DNA polymerase 
0.1 p.gin 10p.1 
5 p.! of 20 p.M 





To prevent evaporation each reaction mix was overlaid with 
100 p.! of light mineral oil (PCR Grade, Sigma M-3516). 
After PCR reactions DNA product was removed from the reaction 
vessel, phenol/ chloroform extracted twice, precipitated with sodium 
acetate, and monitored by electrophoresis (Sections 2b.ii-iv). 
The oligonucleotides used as primers in PCR reactions are listed in 
Appendix A. 
For PCR, oligonucleotide primers were used at a 
concentration of 20 p.M, which is equivalent to I nJin 50 p.1. 
18mer oligonucleotides came prepared at an A260 of about 
20, where an OD unit of I = 20 p.g DNA ml -1 . 
Therefore an A260 of 20 = 400 p.g DNA ml -1 , which is 
equivalent to 0.4 p.g DNA p1 4 . 
04 p.g DNA p.1 1 is equivalent to a concentration of 80 pM pt 1 , 
which is 0.08 nme'J.Ll 1 . 
Therefore, used 2.5 p.1 per reaction. 
1 	Reaction buffer: 
10 mM Tris. Cl (pH 8.3) 
50 mM KC1 
1.5 MM  MgC12 
0.01% gelatin. 
2 	dNTP mix: 
Working solution of dNTP's was made up from 125 p1 each 
of 10 mM dATP, dCTP, dGTP, and dTTP 
(Pharmacia 27-2035-01): made up to 1 ml with H20. 
Mpt 
2i Primer extension 
A method to determine the site of transcriptional initiation was 
developed by myself, based on the methods of Jones et al. (1988) and 
Sambrook et al. (1989). 
The method works by annealing a labelled antisense 
oligonucleotide to the mRNA of the gene of interest, and extending this 3' 
to 5', using reverse transcriptase, to the 5' end of the mRNA. The size of 
this extended product is measured on a denaturing gel, and the site of 
transcriptional initiation estimated relative to the oligonucleotide's 
position. 
Labelling and purification of oligonucleotide 
Antisense oligonucleotides were end labelled using T4 
polynucleotide kinase (PNK) and ['-32P]ATP (Section 2d.ii): 
Oligonucleotide (10 pmole .tl 1 ) 	1.0 p.1 
PNK Buffer 	 2.0 p.1 
[i-32P]ATP 50000 mmole 1 	3.0 p.1 
H20 	 13.4 p.1. 
To this 10 units 0 p1) of T4 PNK (Gibco-BRL 8004SA) was added, 
mixed, and incubated at 25°C for 20 minutes. 
Reactions were stopped by heating the mixture at 70°C for 10 
minutes. 
20 p.1 of loading buffer was added to each reaction and this incubated 
at 80°C for three minutes and loaded into a 19% urea-acrylamide 
gel1 . Gels were run at 200 volts until the xylene cyanol had run 
about 5 cm: an 18mer oligonucleotide runs just behind the 
bromophenol blue at this acrylamide concentration. 
Gels were removed, wrapped in Saran-Wrap and exposed to X-ray 
film for 1 minute. This located the labelled oligonucleotide. 
Labelled oligonucleotides were cut out of the gel, placed in 
Eppendorf tubes, mashed with a tooth pick, I ml of elution buffer 2 
added, and inverted overnight at room temperature. 
Gel fragments were centrifuged at high speed for 1 minute, and 
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supernatants transferred to other Eppendorf tubes. Another 500 .tl 
of elution buffer was added to the gel fragments, mixed, and 
spun again; the supernatants were removed and placed in other 
Eppendorf tubes. 0.5 p.l of carrier glycogen (20 mg m! 1, Boehringer 
Mannheim 12463420) and two volumes of ethanol was added to 
each tube, these frozen for 20 minutes at 20 0C, and spun at high 
speed in the cold for 30 minutes. 
Supernatants were discarded and the pellets re-dissolved in 200 p.! 
of DEPC H20. 
Pellets were sodium acetate precipitated and rinsed with -20°C 90% 
ethanol (v/v), dried, and re-dissolved in 100 p.1 of DEPC F120 
(Section 2b.iii). 
Primer extension 
50p.l of labelled oligonucleotide was mixed with 20 jig of total 
S. pombe RNA (Section 2e.vi ), sodium acetate precipitated, and the 
pellet rinsed with 100 p.1 70% ethanol with DEPC H20,  and dried. 
Pellets were dissolved in 10 p.1 of hybridization buffer 3 containing 
35 units (1 Ri)  of RNAguard (Pharmacia 27-0815-01): this was 
covered with 30 Ri  of light mineral oil (Sigma M-3516), and 
incubated at 70°C for 5 minutes and 50°C for 1 hour. 
1 	10 units (lp.l) of reverse transcriptase (AMy, Promega) was added 
to 25 p.1 of reverse transcriptase buffer 4, this added to the 
hybridization mixture through the mineral oil, and incubated at 
42°C for 1 hour. 
The reaction was stopped by heating to 70°C for 10 minutes. 
5 g of RNAase5 was added and incubated at 42°C for 15 minutes. 
The bottom phase was transferred to another Eppendorf tube and 
200 p.i of TE added: this was phenol/ chloroform extracted twice, to 
give a final volume of 200 Ri  (Section 2b.ii). 
Solution was sodium acetate precipitated, the pellet washed with 
70% ethanol, and dried at room temperature (Section 2b.iii). 
Pellets were dissolved in 3 P.'  of TE and 3 i.il of loading buffer 5 added. 
DNA was denatured by heating to 75°C for 3 minutes, loaded 
onto a 6% urea acrylamide gel (Section 2g.iv), and run in parallel 
with a sequencing reaction using the same oiigonucleotide 
(Section 2g.iii). 
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10. The gel was dried on a vacuum drier, and processed for 
autoradiography (Section 2c.ix). 
19% acrylamide Gel: 








Polymerized by the addition of 1 ml of freshly prepared 10% (w/v) 
ammonium persuiphate (Sigma A-9164), 50 p.! of TEMED 
(N,N,N',N'-tetramethylethylenediamine, Bio-Rad 61-0800), and 
poured immediately. 
2 	Elution buffer: 
stock 	100 ml 
0.5 M NH4OAc 	 3.85 g 
10 mM MgOAc 214 mg 
1 mM EDTA 	0.5 M 	200 p.! 
0.1% (w/v) SDS 100 mg. 
3 	Hybridization buffer: 
stock 
0.25 MKC1 186 mg 
10 mM Tris. Cl (pH 8.0) 1 M 100 p.! 
ImMEDTA 0.5M 20 g 
DEPCH2O 9.88 ml. 
4 	Reverse transcriptase buffer: 
stock 1 ml 
20 mM Tris. Cl (pH 8.5) 1 M 20 p.1 
10MgC12 1M 10 PI 
0.25 mM dNTPs 	each 10 mM 25 p.1 
5mMDTT 1M 5 g 
DEPC H20 865 p1. 
5 	Loading buffer: 
Loading buffer from the Pharmacia T7 sequencing kit was 
used (Section 2g.iii). 
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2 j Bandshift assay 
The bandshift method permits the assay of in vitro binding 
properties of proteins to DNA fragments (Fried & Crothers, 1981; Garner & 
Revzin, 1981). 
The DNA fragment is radioactively labelled and mixed with protein 
extract. This mixture is subjected to electrophoresis under non-denaturing 
conditions. Labelled 'free' DNA runs in the gel proportional to its size 
and forms a band. Any protein that binds to the DNA sufficiently strongly 
will be carried into the gel. This DNA-protein complex will be larger than 
the 'free' DNA, and consequently runs less far: the band will be shifted to 
form a new band, and hence the name of the technique. 
Specificity of binding of the protein to the DNA can be tested by 
adding unlabelled competitor DNAs to the reaction mix, prior to 
electrophoresis. If the competitor DNA binds protein in any of the shifted 
bands, they disappear. 
End-labelling of DNA fragment 
	
1. 	DNA fragments were end labelled using polynucleotide kinase and 
[y-32P]ATP (Section 2d.ii); and purified using a G-50 column 
(Section 2d.iii), to a specific activity of 1000 cps per ng of DNA. 
Bandshift 
4% acrylamide gels (Section 2c.iv) in 0.6% TBE, using vertical 
moulds, were pre-run at 180 V for 30 minutes. 
To Eppendorf tubes on ice was added: 
binding buffer 1 	5 j.tl 
poly M. dC2 I .tl 
fission yeast protein 	5-15 j.tg (Section 2e.vii) 
H20 	 to 10 p.1. 
Samples were gently mixed, and incubated on ice for 5 minutes. 
• 4. 	1 p.1 of end-labelled DNA fragment was added to each tube, mixed 
gently and incubated at room temperature for 5 minutes. 
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Wells of the acrylamide gel were washed with running buffer, and 
5 .tl of each sample loaded. 
Gels were run for 2 hours at 180 V. 
Gel plates were split, the gel transferred to Whatman filter paper 
(3MM), covered in SaranWrap, dried on a vacuum gel-drier, and 
processed for autoradiography (Section 2c.ix). 
Binding buffer: 
stock 250 it! 
50mMKC1 1M 25 g 
50 mM Tris. HO (pH 7.5) 1 M 25 .tl 
50% (v/v) glycerol 125 p.! 
2mMDTT 1M 2 g 
2mMPMSF 100 mm 2p.1 
25 MM M902 1 M 12.5 p.! 
Protease Inhibitors (see 2e.vii) 2.5 p.1 of each 
H20 75 p.1. 
2 	Poly dl. dC (Pharmacia 27-7880): 
dissolved at a concentration of 1 p.g p.1 4, and sonicated until 
—400 nucleotides in length. 
Chapter 3: Sequence analysis of cdc22 
3a Introduction 
Why sequence a gene? The nucleotide sequence of a gene can 
provide a considerable amount of information, such as genetic structure, 
predicted amino acid sequence, and gene function. Furthermore, sequence 
data permits more molecular analysis as it creates an exhaustive 
restriction map, allowing such manipulations as deletion and over-
expression of the gene. 
The genetic structure of the gene can be inferred from the 
nucleotide sequence. An open reading frame (ORF) can be predicted, 
initiating with a start codon and terminating with a stop codon. 
Consensus nucleotide sequences are known in some organisms for the 
branch and splice sites of intervening sequences (introns), and so their 
presence interrupting the ORF can be detected. 
The ORF provides information about the precise size and amino 
acid composition of the predicted gene product. The function of some 
genes can be suggested by comparing the peptide sequence with other 
sequences of known biochemical function in a data base. Three 
dimensional structures can often be postulated from the peptide sequence: 
such structures can sometimes give information on potential functions 
for the gene product. For example, regions of hydrophobic amino acids 
within polypeptides are often associated with transmembrane domains; 
and conserved motifs in DNA binding proteins, such as zinc fingers, can 
be suggested. 
Sequencing data on flanking regions of the gene can provide 
information on control of expression of the gene. 5' to the gene, potential 
cis-acting transcriptional control regions such as TATA boxes and 
upstream activating sequences WAS) can be identified. 3' to the gene, 
DNA sequences thought to be important in mediating mRNA stability 
and processing, such as polyadenylation, may be present. 
This chapter describes the determination of the nucleotide sequence 
of the cdc22 gene, and a comparative sequence analysis of the predicted 
polypeptide product. 
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3b Experimental strategy 
The original plasmid containing cdc22, pCDC22-1, consists of two 
adjacent Hindffl genomic fragments cloned into the HindIII site of 
pDB262, which have been shown to be co-linear in the genome 
(Gordon & Fantes, 1986). 
The two Hind ifi fragments were subcloned into the polylinker 
HindIII site of pTZI8R (Section2b.v), with each fragment cloned in both 
orientations, and named pCDC22-7,pCDC22-10, pCDC22-5, and pCDC22-14 
(Fig. 3A). These subdones were made for sequencing, as the pTZ vector 
contains both the fl origin of replication which permits the generation of 
single-stranded DNA used in the chain termination sequencing method of 
Sanger et al. (1977), and the reverse sequencing primer adjacent to the 
polylinker for priming sequencing reactions. 
An extensive map of restriction enzymes that cut pCDC22-1 was 
constructed for subsequent subcloning, and is shown in Figure 3A. 
To prepare a series of subclones suitable for sequencing, nested 
deletions were made of the four Hin dill subclones using Exonuclease III, 
by the method of Henikoff (1984). The method used for the construction 
of the nested deletions is described in Section 2g.i. 
Additionally, three sub-clones of pCDC22-1 were made for 
sequencing. The first subclone was made to permit sequencing across the 
central Hind III junction. pCDC22-1 was digested with PstI and XbaI, and 
the resultant DNA ligated into similarly cut pBluescript II SK. SaiI/XbaI 
and BarnHI/XbaI subclones, for sequencing from the Sail and BamI-Tl 
restriction sites, respectivy, were made by digestion with the appropriate 
restriction enzymes, and ligated into similarly digested pBluescript II SK. 
Where no sub-clones or nested deletions were available, synthetic 
oligonucleotides were used as primers to initiate sequencing reactions. 
The position and orientation of deletions, subclones and 
oligonucleotides used in the sequencing strategy are summarised in Figure 
3B. 
Once suitable sub-clones had been generated, they were used for the 
generation of single-stranded DNA (Section 2g.ii). Single-stranded DNA 
was used in sequencing reactions, and the sequence determined by urea- 
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Figure 3 	Restriction map and sequencing strategy of pCDC22-1. 
A 	Outline map of restriction enzymes that cut pCDC22-1. 
Enzymes that do not cut pCDC22-1 include KpnI, SmaI, and XhoI. Position 
and orientation of pCDC22-1 HindIll subclones are shown (small arrows). 
The region sequenced on both strands (line) and one strand (thin line), 
predicted cdc22 open reading frame (thick arrow), and intron (dotted) are 
indicated. 
B 	Sequencing strategy for pCDC22-1. 
Arrows indicate approximate length of each subclone sequenced. 
Numbers indicate subclones referred to in the text: 1, PstI/HindllI; 
2, SalI/XbaI; 3, BamHI/XbaI. Letters indicate oligonucleotides - see 
Appendix A. Remainder indicate Exo Ill subclones. 
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acrylamide gel electrophoresis, followed by the detection of radio-labelled 
DNA by autoradiography (Sections 2g.iii and iv.). Routinely, between 300 
and 500 nucleotides were obtained from each sequencing reaction. 
Regions of sequence overlap between adjacent clones were ascertained; 
and the sequences assembled to form the whole continuous sequence, 
using the UWGCG Gelassemble program. 
3c Sequence 
DNA was sequenced on both strands for 4136 base pairs, from the 
left-hand Hin dill site to beyond the right-hand Sail site (Fig. 3A). The 
nucleotide sequence, sequenced on both strands, is shown in Figure 3C. 
Additionally, DNA was sequenced on one strand for a further 912 base 
pairs from beyond the right-hand Sail site to beyond the right-hand EcoRV 
site, and for 312 nucleotides from the right-hand Hindffi site (Fig. 3A). 
Initial confirmation that the DNA fragment sequenced was correct, 
was provided by the presence and distribution of restriction enzyme 
recognition sites that agreed with those sites that had previously been 
mapped. The only surprise was the repetition of pairs of close sites cut by 
the same restriction enzyme, such as BamFil, Sail, and EcoRI (Fig. 3C). 
These extra sites were not detected by mapping since, being so close to one 
another, they released only small DNA fragments (about 100 nucleotides) 
after digestion, that were not detected by agarose gel electrophoresis. 
i 	Open reading frame 
An open reading frame (ORF) for cdc22 of 2750 nucleotides is 
contained within the sequenced region, if the presence of a single intron is 
taken into account (Fig. 3D). 
The putative start codon (ATG) most likely to initiate translation is 
indicated in Figure 3C and 3D. 5' to the ATG is a region of 133 nucleotides 
containing no ATG's in any reading frame, or consensus sequences for 
fission yeast introns (Section 3c.ii), and stop codons in all three frames. 
Translation has been shown to start at the first ATG codon of the 
ORF of genes, in the majority of cases (Kozak, 1983). An optimum 
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Figure 3 C Nucleotide sequence of pCDC22-1. 
Nucleotide sequence of pCDC22-1 sequenced on both strands. 
Sites cut by restriction enzymes referred to in the text are 
underlined, and predicted start and stop codons are in bold typeface. 
HindIII 
-1307 AAGCTTTCTCACAGCACGTAATTGCTTATTATCGTGGAACTTTACCTGGGTCTCCAATTT -1248 
-1247 TGCACTAGAATTATTGTAGAAAATTGAAGCGACATTATCTCTGTTGATAACCTTGCTGGT -1188 
-1187 ATACAGGCGCTTGGTATTTTTATACACGTTGATAGTCGAAGTAGCAGATAGCCGTAGTTG -1128 
-1127 ATGGTTTAAACATTTTGTATTTTGCGGAAATTTGCACACTGTTTATATCTCATTCTCTTT -1068 
-1067 ACGTCAAGCATACCAATGTTTGCAATTTCATGTTTTGAAGGTGACCGTTGTTATTCTATC -1008 
-1007 TATGCATTTGTATTACCATTTCATTTTCACTCTGTCTACAGGCAAGATTATCAGATGAAG -948 
-947 ATATAACCATTGTTGACTTTACCTAAAAAAAAGGATAATTGCGAGGGAGCAAATAGTGAA -888 
-887 TTAAAGGGAAAAGAACAAAGTTTTTGTAGCTACTAAAAGCTGTTTGTCTATCTCTATGTG -828 
-827 TACCTTTTATAGTGCTTATAAGTAAAATGCAGAGTCGAAATCTTCATGCTTTAATGTAAA -768 
-767 GCATTAGTAAGGTTACATATTACAACAGAAATGGGAATCAAAATCTTAAATCTAAAAGTT -708 
-707 GAGAGGTCTTAACAAAAAAGCTAACTCAACTTAGCTTTACAATTTATAAATCAAGGAAAC -648 
-647 AATACTTTATCAATTGTATGTTATGATCTTCTCCAACAGGTAATTGACAACATCAAAAAG -588 
EcoRV XbaI 
-587 TAATATAAAGAACAAGGGGAAATTGATATCTAGATATATTAGAGAAATTAGTAGTTCAAT -528 
-527 CTCATAGAGCAGGTTGGTAGTCGGGTTGGACCGCGTGTTTAATTTATGTAAACAGTCGCG -468 
Ml uI 
-467 TCGCGTTGCAATTGAGACGGThAATAAATATTTAATTTATTACATTCAGTCGTAAACAG -408 
-407 AGTATTTATAAACACTTTTTTTATGTTTAATAAAAGATAAATGTAACAGTTGAATGTATT -348 
-347 GTATCAGGTCAGACCACTTCAACATGTTTAATCGCGTTTTTTTAAAAAAATATTTTTTTA -288 
-287 ATTTTTAAAAGTCGGACTTATTTTAGCGGAACTTTGATGTTCAGAAGTGAAAAAGATAAA -228 
-227 TCTATTTAGCAAGTCTTAATTAACGTCTTTTAGATATAGTAGAGCTACAAAAATGATCCG -168 
-167 GTTTCCACTCTTAGCTTTATTTACATTGATCAACATGACTTAAAGTTCGGATCACGCGAC -108 
Ml uI 
-107 GGGCCACATCTCAACCGGTTTAATTAATTAGCGTGACGCGTCTGAACGCTTTTTCATTTA -48 
-47 CTATAAATATTCCCGGTATTTACCACCTTACAAACTAGAACAAACACGATCTTTGTATAC 12 
13 AAAAGAGGTATGAAACAGGGAAATAAAATACAGTTAGAAGATTAGTAGAATTTTGTTACA 72 
73 CGTTGCCGTTTCGAAAAATGTCGTGATTTTACTGGGGAGTAAATGTTTAAAGAAAGTGAG 132 
133 ATTTTTCTATTTGTTTAAGCGTGTCATTCAGTATTCACTGTTTGTTGTGTGCAGAGATGT 192 
193 TTAAGCAAATGTTCTTTTAGCCGTTTGCTCTACTTCCAACTGTTCGGTTTGATTGCTGAC 252 
253 AGATTCGTTGCTGGTGGCGTTGTATTAAAATTGACTGACTGTTGACATTGAATCGAAAAG 312 
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313 CAATAATGTACTAACTGTATAGACGCACGTCAAGAGAAAGTGGCCTTTGACAAAATCACT 372 
373 GCTCGTGTTTCGAGGCTTTGTTATGGCCTTGATTCCGATCATGTTGATCCCGTCGAAATC 432 
433 ACTCAAAAAGTCATTTCTGGTGTGTATCCCGGTGTTACCACTATTGAATTGGATAATTTA 492 
493 GCTGCTGAAACTGCCGCGACTATGACTACAAAGCATCCTGATTATGCTATTTTGGCTGCT 552 
553 AGAATTGCTGTTTCCAACTTGCATAAGCAAACCGAGAAGGTGTTTTCAACTGTCGTTCAA 612 
613 CAGCTTCATGACTATGTAAATCCCAAAACAGACAAGCCTGCCCCCATGATCTCTGACAAA 672 
Ec0RV 
673 ATCTACGATATCGTAATGAAACACAAGGACGAATTAGATAGTGCTATCATATACGATCGT 732 
733 GATTTCACTTACAATTTCTTTGGCTTCAAGACTTTAGAGCGTTCTTATTTATTGCGTATC 792 
793 GACGGCAAAGTTGCTGAGCGCCCTCAGCATATGATTATGCGTGTCGCCGTTGGTATCCAC 852 
853 GGTGAGGACATTGAAGCTGCTATTGAAACATACAATTTGATGTCTCAACGCTACTTTACC 912 
913 CATGCTTCACCAACTCTTTTCAATCCCGGTACTCCTCGTCCCCAACTCTCTTCTTGTTTC 972 
973 CTCGTTACGATGAAAGACGACTCTATTGPAGCAATCTACGACACACTCAAGATGTGTGCT 1032 
1033 ATGATCTCCAAGACCGCTGGCGGTATTGGTATTTATATTCACAACATTAGAGCAACCGGT 1092 
1093 TCGTATATTGCTGGAACTAATGGTACTTCCAACGGAATTGTCCCCATGATTCGTGTTTAC 1152 
1153 AACAACACAGCTCGTTATGTTGACCAAGGAGGTAATAAGCGTCCTGGTGCCTTTGCAGCC 1212 
1213 TATTTGGAGCCTTGGCATGCCGATGTTATGGACTTTTTAGAACTTCGAAAGACTCATGGC 1272 
1273 AACGACGATTTCCGCGCACGGCAAATGTTCTATGCCTTGTGGATTCCTGACTTGTTTATG 1332 
1333 CAACGTGTTGAACGTAACGAGCAATGGACCTTCTTCTGCCCCAATGAGGCTCCAGGTTTG 1392 
1393 GCAGATGTTTGGGGTGACGAGTTTGTTGCCCTCTACGAAAAGTATGAGAAGGAGAACCGT 1452 
1453 GGTCGTCGTTCATTACCTGCTCAAAAAGTTTGGTACGCCATTCTTCAATCACAAGTTGAA 1512 
1513 ACTGGTAATCCTTTCATGTTGTATAAGGATTCATGCAACCGTAAGTCCAATCAGAAGAAT 1572 
1573 GTTGGTACTATTCGCAGCTCAAACCTGTCTACTGAGATTGTTGAATACTCTTCTCCTGAC 1632 
1633 GAAGTTGCTGTTTGTAACCTTGCTTCAGTTGCTTTGCCCACATTTATTAAAGACGGAAAG 1692 
Hindlil 
1693 TACAATTTCCAAAAGCTTCACGATGTCGTGAAGGTCGTTACTCGTAACCTCAACAAGATT 1752 
1753 ATCGACGTTAACTATTATCCTGTTCCTGAAGCTCGCCGTAGCAATATGCGCCATCGTCCC 1812 
1813 GTTGGTTTGGGTGTTCAAGGTCTTGCCGATGCTTTCTTCGCTCTTCGTTTACCATTCGAA 1872 
PstI 
1873 TCTGCAGGTGCCAAGAAGCTAAACATCCAAATCTTCGAAACAATTTACCACGCAGCCCTT 1932 
1933 GAGGCCTCTTGCGAGATTCCCCAGGTAGAGGGTACATATGAGAGTTATGAACGATCTCCC 1992 
1993 TGCATCCAGGGTATTTTACAGTATGACATGTGGAACGTTAATCCCACCGATCTTTGGGAT 2052 
EcoRI 
2053 TGGGCCGAGTTCAAGGAAAAGATTGCTAAACACGGTTCGTAATTCTTTGTTAGTAGCA 2112 
2113 CCAATGCCTACTGCTTCAACATCTCAAATCCTTGGTTTCAATGAGTGTTTTGAGCCATAT 2172 
EcoRI 
2173 ACTTCTAACATGTACCAACGCCGTGTTCTTTCTGGTGAATTCCAAATTGTCAATCCATGG 2232 
2233 CTGTTGAAGGATCTCGTTGAGCGTGATTTGTGGAATGAGGACATGAAGAACAAACTTGTT 2292 
BamHI 
2293 ATGCTTGATGGATCCATCCAAGCGATTCCTGAAATTCCTCAAGACCTTAAGGATCTTTAC 2352 
2353 AAAACCGTATGGGAGATTAGTCAAAAGACTGTTATTGACTATGCTGCCGACCGTGGCCCA 2412 
BamHI 
2413 TTCATTGATCAATCCCAAAGTTTGAACATTCACTTGAAGCATCCTTCCTACGGAAAAATT 2472 
2473 ACTAGTATGCACTTTTATGGCTGGAAGAAGGGTCTTAAGACTGGAATGTACTATCTTCGT 2532 
Sail 
2533 ACTATGGCTGCTTCTGCTGCTATCAAATTTACGGTCGACCCTGTGGCCTTGCGCGCTCGT 2592 
2593 AATGAAGAATCTAATGAAGAGAATAAGAAGCCAGTTATAAAGAATGGAAAGGCTGAAATT 2652 
2653 TCTGCAGAGCCCACTAAAGAAGAGATTGACATTTATAATGAAAAAGTGCTCGCATGCTCC 2712 
2713 ATCAAGAACCCTGAGGCTTGCGAAATGTGCTCAGCCTAATTTACTGTTGCAAAAATGGAT 2772 
2773 TTGTTAAATCCCATCCATGTTTAATATCCTACATTTTATTGTTTCTTTTAATGTTTTTAT 2832 
Sal I 
2833 TCAATATTCTTTTCATTTGTCGACATACATAATTGTGTCTTAAATTCAACCTTGGTTTTC 2892 
2893 CATTCTAGTGAGCAGGCTCAGAATGGTTCTAATACATAAATTAGATTACGAATT 2946 
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sequence for the site of initiation of translation by higher eukaryotic 
ribosomes has been determined (Kozak, 1986), with a consensus of 5'-
ACCATGG-3'. The base sequence that includes the proposed ATG of 
cdc22 is 5'-ACGATGT-3', and shows some similarity (2 nucleotides out of 
4). The ORE terminates with a stop codon (TAA) 2750 nucleotides 
downstream of the proposed start codon. 
The length of cdc22 transcript found in fission yeast is 3.3 kb 
(Fig. 4E, Gordon & Fantes, 1986), sufficient to contain the predicted 
translated region of 2433 nucleotides. 
Corroboration of the predicted cdc22 ORE is provided by the high 
similarity of the predicted peptide sequence with the large subunit of 
ribonucleotide reductase (RNR) in different organisms (Section 3d). The 
large subunit of RNR is remarkably constant in size and sequence in a 
number of organisms, and the predicted cdc22 polypeptide is consistent 
With these. 
ii 	Intron 
The cdc22 ORE is interrupted by a single putative intron of 315 
nucleotides in length (Fig. 3D). This intron starts at nucleotide 19 of the 
coding region, and finishes at nucleotide 333. Within it are sequences 
showing high similarity with intron splicing regions in fission yeast 
(Russell, 1989). The putative 5' splice site at nucleotides 19-23 is GTATG 
(consensus GTANG); the branch site at nucleotides 320-326 is TACTAAC 
(consensus NNCTPuAN); and the 3' splice site at nucleotides 331-326 is 
TAG (consensus NAG). The distance between the branch site and the 3' 
end of the intron is 14 base pairs, within the consensus range of 11-23. 
Two independent pieces of evidence support the position and size 
of the putative intron in cdc22. 
Evidence supporting the position of the intron is given by the 
similarity between the predicted peptide sequence of cdc22 with the large 
subunit of ribonucleotide reductase (Section 3d). The amino acid sequence 
across the predicted intron splice sites is highly conserved (KRDGR, Fig. 
3D), and the intron spliced out of the predicted cdc22 ORE would result in 
exactly this peptide sequence. 
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Figure 3 D Nucleotide sequence and predicted peptide sequence of 
cdc22. 
Nucleotides are numbered relative to the predicted start 
codon. Predicted start and stop codons are in bold typeface. Predicted 
intron is italisized, with consensus splice and branch sequences 
underlined. 
-44 AAATATTCCCGGTATTTACCACCTTACAAACTAGAACAAACACGATCTTTGTATACAAAA 15 
M F V Y KR 
16 GAGGTATGAAI1CAGGGAAATAAAATACAGTTAGAAGATTAGTAGAATTTTGTTACACGTT 75 
D/ 
76 GCCGTTTCGAAAAATGTCGTGATTTTACTGGGGAGTAAATGTTTAAAGAAAGTGAGATTT 135 
136 TTCTATTTGTTTAAGCGTGTCATTCAGTATTCACTGTTTGTTGTGTGCAGAGATGTTTAA 195 
196 GCAAATGTTCTTTTAGCCGTTTGCTCTACTTCCAAGTGTTCGGTTTGATTGCTGACAGAT 255 
256 TCGTTGCTGGTGGCGTTGTATTAAAATTGACTGACTGTTGACATTGAATCGAAAAGCAAT 315 
316 AATGTACTAACTGTA1QACGGACGTCAAGAGAAAGTGGCCTTTGACAAAATCACTGCTC 375 
/DG R Q E K V A F D KIT AR 
376 GTGTTTCGAGGCTTTGTTATGGCCTTGATTCCGATCATGTTGATCCCGTCGAAATCACTC 435 
VS R L C Y G L D SD H V D P V El T Q 
436 AAAAAGTCATTTCTGGTGTGTATCCCGGTGTTACCACTATTGAATTGGATAATTTAGCTG 495 
K V IS CV Y PG VT TIE L D N LA A 
496 CTGAAACTGCCGCGACTATGACTACAAAGCATCCTGATTATGCTATTTTGGCTGCTAGAA 555 
ETA ATM T T K H PD Y A IL A A RI 
556 TTGCTGTTTCCAACTTGCATAAGCAAACCGAGAAGGTGTTTTCAACTGTCGTTCAACAGC 615 
A V S N L H K Q T E K V F S TV V Q Q L 
616 TTCATGACTATGTAAATCCCAAAACAGACAAGCCTGCCCCCATGATCTCTGACAAAATCT 675 
H D 	V N P K T D K P A P MIS D K I Y 
676 ACGATATCGTAATGAAACACAAGGACGAATTAGATAGTGCTATCATATACGATCGTCATT 735 
D I V M K H K DEL D S All Y DR D F 
736 TCACTTACAATTTCTTTGGCTTCAAGATTTAGACCGTTCTTATTTATTGCGTATCGACG 795 
T Y N F F CF K T L ER S Y L L RID C 
796 GCAAAGTTGCTGAGCGCCCTCAGCATATGATTATGCGTCTCGCCGTTGGTATCCACGGTG 855 
K V A ER P Q H MI MR V A V CI H GE 
856 AGGACATTGAAGCTGCTATTGAAACATACAATTTGATGTCTCAACGCTACTTTACCCATG 915 
DIE A Al E T Y N L MS Q R Y FT H A 
916 CTTCACCAACTCTTTTCAATGCCGGTACTCCTCGTCCCCAACTCTCTTCTTGTTTCCTCG 975 
S PT L F N ACT PR P Q L S SC F L  
976 TTACGATGAAAGACGACTCTATTGAAGGAATCTACGACACACTCAAGATGTGTGCTATGA 1035 
TM K D D S 	E CI Y D T L K MC A MI 
1036 TCTCCAAGACCGCTGGCGCTATTGGTATTTATATTCACAACATTAGACCAACCGGTTCGT 1095 
S K TAG GIG I Y Ill N IRA T G S Y 
1096 ATATTGCTGGAACTAATGGTACTTCCAACGGAATTGTCCCCATGATTCGTCTTTACAACA 1155 
IA CT N CT S 	CIV PM I R V Y N N 
1156 ACACAGCTCGTTATGTTGACCAAGGAGGTAATAAGCGTCCTGGTGCCTTTGCAGCCTATT 1215 
TAR Y V D Q C G N KR PG A F A A Y L 
1216 TGCAGCCTTGCCATGCCGATGTTATGGACTTTTTAGAACTTCGAAAGACTCATGGCAACG 1275 
E P N H A DV MD FL EL R K T HG NE 
1276 ACGATTTCCGCGCACGCCAAATGTTCTATGCCTTGTCGATTCCTCACTTCTTTATGCAAC 1335 
D FR AR Q M F Y A LW I PD L FM Q R 
1336 GTGTTGAACGTAACGAGCAATCGACCTTCTTCTGCCCCAATCAGGCTCCAGGTTTGGCAG 1395 
V E RN E Q W T F F C P N E A P C L A D 
1396 ATGTTTCGGCTGACGAGTTTGTTGCCCTCTACGAAAAGTATGAGAAGGAGAACCGTGGTC 1455 
V W G 	E F V A LYE K YE KEN R G  
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1456 GTCGTTCATTACCTGCTCAAAAAGTTTGGTACGCCATTCTTCAATCACAAGTTGAAACTG 1515 
R S L PA Q K V WY A IL Q S 	VET G 
1516 GTAATCCTTTCATGTTGTATAAGGATTCATGCAACCGTAAGTCCAATCAGAAGAATGTTG 1575 
NP F ML Y K D SC N R K S 	Q K N V G 
1576 GTACTATTCGCAGCTCAAACCTGTGTACTGAGATTGTTGAATACTCTTCTCCTGACGAAG 1635 
TI R S S 	L CT El V E Y S S PD E V 
1636 TTGCTGTTTGTAACCTTGCTTCAGTTGCTTTGCCCACATTTATTAAAGACGGAAAGTACA 1695 
A V C N LAS V AL PT F 1K D G KY N 
1696 ATTTCCAAAAGCTTCACGATGTCGTGAAGGTCGTTACTCGTAACCTCAACAAGATTATCG 1755 
F Q K L H DV V K V VT RN L N K lID 
1756 ACCTTAACTATTATCCTGTTCCTGAAGCTCGCCGTAGCAATATGCGCCATCGTCCCGTTG 1815 
V N Y Y P V P E A R R S N M R H R P V C 
1816 GTTTGGGTGTTCAAGGTCTTGCCGATGCTTTCTTCGCTCTTCCTTTACCATTCGAATCTG 1875 
L G V Q GLAD A F F AL R L P F ES A 
1876 CAGGTGCCAAGAAGCTAAACATCCAAATCTTCGAAACAATTTACCACGCAGCCCTTGAGG 1935 
OAK K L NI Q IF E TI Y H A A LEA 
1936 CCTCTTGCGAGATTGCCCAGGTAGAGGGTACATATCAGAGTTATGAAGGATCTCCCTGCA 1995 
SC El A Q V E CT YES YE G S P C I 
1996 TCCAGGGTATTTTACAGTATGACATGTGGAACGTTAATCCCACCGATCTTTGGGATTGGG 2055 
Q G I L Q Y D MW N V N PT DL W D WA 
2056 CCGAGTTCAAGGAAAAGATTGCTAAACACGGAATTCGTAATTCTTTGTTAGTAGCACCAA 2115 
E F K E K I A K H G I R N S L • L V A P H 
2116 TGCCTACTGCTTCAACATCTCAAATCCTTGGTTTCAATGAGTGTTTTGAGCCATATACTT 2175 
PTA ST S 	IL G F NE C FE P Y T S 
2176 CTAACATGTACCAACGCCGTGTTCTTTCTGGTGAATTCCAAATTGTCAATCCATGGCTGT 2235 
N MY Q R R V L SC E F Q IV N P W L L 
2236 TGAAGGATCTCGTTGAGCGTGATTTGTGGAATGAGGACATGAAGAACAAACTTGTTATGC 2295 
• K D L V ER DL W N E D M K N K L 	ML 
2296 TTGATCGATCCATCCAAGCGATTCCTGAAATTCCTCAAGACCTTAAGGATCTTTACAAAA 2355 
DC S 	Q Al P El P Q DL K DL Y K T 
2356 CCGTATGGGAGATTAGTCAAAAGACTGTTATTGACTATGCTGCCGACCGTGGCCCATTCA 2415 
V WE IS Q K TV ID Y A A DR C P Fl 
2416 TTGATCAATCCCAAAGTTTGAACATTCACTTGAAGGATCCTTCCTACGGAAAAATTACTA 2475 
D Q S 	S L NI H L K D PS Y GK ITS 
2476 GTATGCACTTTTATGGCTGGAAGAAGGGTCTTAAGACTGGAATGTACTATCTTCGTACTA 2535 
M H F Y OW K K CL K T GM Y Y L R TM 
2536 TGCCTGCTTCTGCTGCTATCAAATTTACGGTCGACCCTGTGGCCTTGCCCCCTCCTAATG 2595 
A A S A A 1K F TV DP VA L R A RN E 
2596 AACAATCTAATCAAGAGAATAACAAGCCACTTATAAACAATCGAAACGCTGAAATTTCTG 2655 
ES NE EN K K P V 1K NC K A E I S A 
2656 CACACCCCACTAAACAACAGATTGACATTTATAATGAAAAAGTGCTCGCATGCTCCATCA 2715 
E PT K E El DI Y NE K V LA C S I K 
2716 AGAACCCTGAGGCTTGCGAAATGTGCTCAGCCTAATTTACTCTTGCAAAAATGGATTTGT 2775 
N PEACE MC S A * 
2776 TAAATCCCATCCATCTTTAA 2795 
am 
Evidence supporting the size of the intron is provided by 
experiments mapping the start of transcription of cdc22 by primer 
extension (Section 4b). Two oligonucleotides, one 5' and one 3' to the 
putative intron, were used to initiate separate reverse transcriptase 
reactions (Fig. 4A). Both reactions predict nearly identical start sites for 
transcription, provided the presence of the intron, 315 nucleotides in 
length, is allowed for. 
5' sequence 
A detailed analysis of the nucleotide sequence 5' to the cdc22 ORF 
will be given in the next chapter. 
iv 	3' sequence 
Most higher eukaryotic mRNAs have a polyadenylated 3' terminus 
that starts approximately 20 base pairs downstream of a transcriptional 
terminator sequence related to 5'-AAUAAA-3'. Transcription may 
proceed beyond the terminator sequence, with endonucleolytic cleavage 
and poly-A addition generating the mature 3' end (Birnstiel et al., 1985). 
Although nearly all higher eukaryotic genes contain the 5'-AATAAA-3' 
terminator sequence, many genes in budding and fission yeast lack the 
sequence altogether (Russell, 1989). In budding yeast an alternative 
terminator sequence 5'-TAG. . .TATGT. . .TI'T-3' has been proposed that can 
be positioned up to 160 base pairs downstream of the stop codon 
(Zaret & Sherman, 1982). The nucleotide sequence 3' to cdc22 does not 
contain either of these sequences, suggesting that it, and perhaps fission 
yeast genes in general, have different terminator sequences, which are at 
present unknown. 
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3 d Sequence comparisons 
Translation of the predicted ORF, allowing for the presence of the 
intron, predicts a polypeptide of 92.2 kDa containing 811 amino adds. 
The homology search algorithm FASTA (Lipman & Pearson, 1985) 
was used to search the NBRF and SwissProt protein sequence data bases 
for proteins showing similarity to the predicted cdc22 product. The 
search revealed that cdc22 encodes a predicted polypeptide with very high 
similarity to the large subunit of ribonucleotide reductase (RNR) from a 
number of organisms: alignment between the predicted gene products of 
cdc22, RNR3 from budding yeast (Yagle & McEntee, 1990, Elledge & Davis, 
1990), and Ml from mouse (Caras et al., 1985) is shown in Figure 3E. The 
degree of similarity is very high throughout the coding region: the 
predicted cdc22 product shows 69% amino acid identity with the Ml and 
RNR3 gene products. 
RNR is an enzyme essential for DNA precursor metabolism, 
providing the only means of generating deoxynucleotides from the 
corresponding ribonucleotides (Thelander & Reichard, 1979). Its structure 
is highly conserved through evolution, and consists of a heterodimer of 
two large and two small subunits. 
The predicted cdc22 polypeptide contains all the amino acid motifs 
thought essential for biological function of the large subunit of RNR, 
which include both catalytic and regulatory binding sites for 
deoxynucleotides and ribonucleotides (Eriksson & Sjoberg, 1989). These 
motifs include cysteines at positions 218, 429, and 444, involved in the 
active site; and the C-terminal cysteines at positions 806 and 809 thought to 
interact with thioredoxin and glutaredoxin (Fig. 3E). 
The proposed function of cdc22 is consistent with the arrest point 
of cdc22 mutants during the cell cycle. cdc22 is required at the G1-S phase 
boundary (Nasmyth & Nurse, 1981), and it is at this stage when its 
transcript is maximally abundant (Gordon & Fantes, 1986). RNR is likely 
to be required at the onset of, and during S-phase, when DNA precursors 
are in high demand. 
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Figure 3 E Comparison between the predicted cdc22 product and 
large subunits of ribonucleotide reductase from budding 
yeast and mouse. 
Alignment generated using the UWGCG Lineup program, between 
the cdc22 product (S.pombe), the RNR3 gene product of budding yeast (S. 
cerevisiae), and the Ml subunit of mouse (Mus). Numbering relates to the 
cdc22+ sequence. RNR represents a consensus sequence of the three: 
identity (3/3)  is indicated by upper case letters; 2/3  consensus by lower case. 
Conserved residues referred to in the text are boxed. 
1 	 50 
RNR M.VIKRDGRq E.V.FDKITs Ri.rLcYGLd .d.vDpv.IT qkvlsGvYsG 
Spombe MFVYKP.DGRQ EKVAFDKITA RVSP.LCYGLD SDHVDPVEIT QKVISGVYPG 
Scerev MYVIKP.DGRK EPVQFDKITS RITRLSYGLD PNRIDAVKVT QRIISGVYSG 
Mus MHVIKRDGRQ ERVNFDKITS RIQ}LCYGLN MDFVDPAQIT MKVIQGLYSG 
51 	 100 
RNR VTTvELDnLA AETaAtmTTk HPDYAILAAR IAvSNLHKqT .KvFS.V.ed 
Spombe VTTIELDNLA AETAATMTTK HFDYAILAAR IAVSNLHKQT EKVFSTVVQQ 
Scerev VTTVELDNLA AETCAYMTTV HPDYATLAAR IAISNLHKQT TKQFSKVIED 
Mus VTTVELDTLA AETAATLTTK HPDYAILAAR IAVSNLHKET KKVFSDVMED 
101 	 150 
RNR LhdyiNP.tg khaPMisd.i ydIVM. .kd. LnSAIIYDRD F.YnyFGFKT 
Spornbe LHDYVNPKTD KPAPMISDKI YDIVMKHKDE LDSAIIYDRD FTYNFFGFKT 
Scerev LHDWINPATG KHAPMISDEI YNIVMETRY. LNSAIVYDRD FQYTYFGFKT 
Mus LYNYINPHNG RHSPMVASST LDIVMANKDR LNSAIIYDRD FSYNYFGFKT 
151 	 200 
RNR LERSYLLrIn GkVAERPQHm .MRVavGIHg eDIeaaieTY NLmS.ryFTH 
Spombe LERSYLLRID GKVAERPQHM IMRVAVGIHG EDIEAAIETY NLNSQRYFTH 
Scerev LERSYLLRLN GEVAERPQHL VMRVALGIHG SDIESVLKTY NLMSLRYFTH 
Mus LERSYLLKIN GKVAERPQHM LMRVSVGIHK EDIDAAIETY NLLSEKWFTH 
201 	 250 
RNR AsPTLFNAGT prPQ1SSHFL . .MKDDSIEG IYDTLK.CAm ISKtAGv1.. 
Spombe ASPTLFNAGT PRPQLSSjFL VTMKDDSIEG IYDTLKMCAM ISKTAGVLVF 
Scerev ASPTLFNAGT PLPQMSS4FL IAMKDDSIEG IYDTLKECAM ISKTAGVL.S 
Mus APPTLFNAGT NRPQLSSFL LSMKDDSIEG IYDTLKQCAL ISKSAGGIGV 
251 	 300 
RNR .i.nIRaTGS YIAGTNGtSN G1vPM1RVyN NTARYVdqgg nkrpgafa.y 
Spombe NIHNIRATGS YIAGTNGTSN GIVPMIRVYN NTARYVDQGG NKRPGAFAAY 
Scerev HINNIRSTGS YIAGTNGTSN GLIPMIRVFN NTARYVTRVV TRDLVLSPFS 
Mus AVSCIRATGS YIAGTNGNSN GLVPMLRVYN NTARYVDQGG NKRPGAFAIY 
301 	 350 
RNR lepwh.d... fldlrKthGk Ee.RARd1F. ALWIPDLFMk RvE.n. .Wtl 
Spombe LEPWHADVND FLELRKTHGN EDFRARQMFY ALWIPDLFMQ RVERNEQWTF 
Scerev WSHGMQISST KFDIRKTHGK EEIBARDLFP ALWIPDLFMK RQEDGP.WTL 
Mus LEPWHLDIFE FLDLKKNTGK EEQRARDLFF ALWIPDLFMK RVETNQDWSL 
351 	 400 
RNR fcPrieaPGLd dVWGdEFe.L Ye.YEkegRg r .... AQk1W YAI1qsQtET 
Spombe FCPNEAPGLA DVWGDEFVAL YEKYEKENRG RRSLPAQKVW YAILQSQVET 
Scerev FSPSAAPGLD DVWGDEFEEL YTRYEREGRG KTIK.AQKLW YAILQAQTET 
Mus MCPNECPGLD EVWGEEFEKL YESYEKQGRV RKVVKAQQLW YAIIESQTET 
401 	 450 
RNR GtPfM1YKDs CNRKsNQqN1 GTIksSNLft EIVEYsSpDE VAVCNLAS.A 
Spoinbe GNPFMLYKDS CNRKSNQKNV GTIRSSNLCT EIVEYSSPDE VAVCNLASVA 
Scerev GTPFMVYKDA CNRKTNQQNL GTIKSSNLCC EIVEYSSPDE VAVCNLASIA 
Mus GTPYMLYKDS CNRKSNQQNL GTIKCSNLJr EIVEYTSKDE VAVCNLASLA 
45] 500 
RNR Lp.fv ..... .. ... YnFek Lhev.KVltr NLNkiID.NY YPvPEAr.SN 
Spornbe LPTFI ..... . KDGKYNFQK LHDVVKVVTR NLNKIIDVNY YPVPEARRSN 
Scerev LPAFVEVSED GKTASYNFER LHEIAKVITH NLNRVIDRNY YPVPEARNSN 
Mus LNMYV..... TPEHTYDFEK LAEVTKVIVR NLNKIIDINY YPIPEA}ILSN 
501 	 550 
RNR mrHRPIg1GV QGLADaf. .1 R1PFES.eAq .LNkQIFETI YhaaLEASCE 
Spombe MRHRPVGLGV QGLADAFFAL RLPFESAGAK KLNIQIFETI YHAALEASCE 
Scerev MKHRPIALGV QGLADTYMML RLPFESEEAQ TLNKQIFETI YHATLEASCE 
Mus KRHRPIGIGV QGLADAFILM RYPFESPEAQ LLNKQIFETI YYGALEASCE 
551 	 600 
RNR lAq.eG.Yet yEGSP.skgl LQyDMWNv.P tdlWDW. .1k ekIaKhGiRN 
Spombe IAQVEGTYES YEGSPCIQGI LQYDMWNVNP TDLWDWAEFK EKIAKHGIRN 
Scerev LAQKEGKYST FEGSPASK. I LQFDMWNAKP FGMWDWETLR KDIVKHGLRN 
Mus LAKEYGPYET YEGSPVSKGI LQYDMWNVAP TDLWDWKPLK EKIAKYGIRN 
601 	 650 
RNR SL1.APMPTA STsQILG.NE cfEPyTSNmY .RRVLSGEFQ iVNP.LLkDL 
Spombe SLLVAPMPTA STSQILGFNE CFEPYTSNMY QRRVLSGEFQ IVNPWLLKDL 
Scerev SLTMAPMPTA STSQILGYNE CFEPVTSNMY SRRVLSGEFQ VVNPYLLRDL 
Mus SLLIAPMPTA STAQILGNNE SIEPYTSNIY TRRVLSGEFQ IVNPHLLKDL 
651. 	 700 
RNR verglWne.M Kn.li. .nGS IQ.lPeipqd LK.LYKTVWE ISQKTvI.mA 
Spoznbe VERDLWNEDM KNKLVMLDGS IQAIPEIPQD LKDLYKTVWE ISQKTVIDYA 
Scerev VDLGIWDDSM KQYLITQNGS IQGLPNVPQE LKELYKTVWE ISQKTIINMA 
Mus TERGLWNEEM KNQIIACNGS IQSIPEIPDD LKQLYKTVWE ISQKTVLKMA 
701 	 750 
RNR AdRg.fIDQS qSLNihl. .P syGKiTSMHF YGWKkGLKtG MYYLRT.aAs 
Spoinbe ADRGPFIDQS QSLNIHLKDP SYGKITSMHF YGWKKGLKTG MYYLRTMAAS 
Scerev ADRAIYIDQS HSLNLFLQAP SMGKITSMHF YGWKKGLKYG MYYLRTQAAS 
MUS AERGAFIDQS QSLNIHIAEP NYGKLTSMHF YGWKQGLKTG MYYLRTRPAA 
751 	 800 
RNR aaIqFT.d ................................KEE .....N. 
Sporabe AAIKFTVDPV ALRARNEESN EENKKPVIKN GKAEISAEPT KEE.IDIYNE 
Scerev AAIQFTID 
Mus NPIQFTLNKE KLK ....... .......... .... DKEKAL KEEEEKERNT 
801 	 819 
RNR.. . . ft. .N. E..MC. * 
Spornbe KVLAIKNP E44EMCSA* 
Mus AAMVLLENR EEMCGS* 
I.E. 
3 e Conclusions 
This chapter describes the determination of the functional region of 
cdc22 by DNA and protein sequence analysis. 
The sequence of a fragment of DNA of 4136 nucleotides is presented 
which contains an ORF of 2750 nucleotides, interrupted by one intron of 
315 nucleotides in length. 
The cdc22 predicted polypeptide, of 811 amino acids, shows very 
high similarity with the large subunit of ribonucleotide reductase from a 
number of species, and contains all the peptide motifs thought to be 
required for its activity. Thus it is likely that cdc22 encodes a large 
subunit of ribonucleotide reductase in fission yeast. 
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Chapter 4: cis- and trans-acting components 
controlling cdc22 expression 
4 a Introduction 
The molecular mechanisms that control gene expression in 
eukaryotes have been well studied, and a general model proposed 
(Review: Guarente & Bermingham-McDonough, 1992; Section If). Gene 
expression is mediated by two interacting components: cis-acting 
sequences 5' of the gene, and trans-acting transcription complexes which 
bind to them. Together these components stimulate general transcription 
factors, to induce gene expression at the appropriate time. 
cdc22 transcript varies in abundance during the cell cycle with a 
maximum at the G1-S phase boundary (Gordon & Fantes, 1986). This 
chapter describes experiments which try to understand the molecular 
mechanisms that control cdc22 transcription during the cell cycle. 
Initially, the cdc22 promoter region is studied to characterize cis-
acting elements that control cdc22+ expression. Experiments are described 
that map positions of transcriptional initiation of cdc22. Next, the 
identification of putative cis-acting elements, related to budding yeast 
MCBs, in the cdc22 promoter is shown. MCBs are then demonstrated to 
be physiologically relevant in fission yeast and, significantly, shown to be 
able to confer cell cycle gene expression. 
Subsequently, experiments are described that characterize a 
trans-acting factor which specifically binds MCBs in fission yeast. We have 
have called this factor DSP1 for DNA synthesis control in S. Pombe, as it is 
related to DSCI, a MCB binding factor previously identified in budding 
yeast (Lowndes et al., 1991). DSP1 is shown to bind MCBs constitutively 
during the cell cycle. 
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4b Mapping transcriptional start 
i 	Introduction 
Transcriptional start was mapped using two methods. The first 
method, primer extension, uses a complementary oligonucleotide 
hybridized to cdc22 mRNA to initiate a reverse transcriptase reaction 
(Sambrook et al., 1989). The size of the DNA produced from such a 
reaction can be estimated, and the start of transcription calculated relative 
to the position of the oligonucleotide. The second method involves 
hybridizing cdc22 mRNA with 'probes of DNA fragments 5' and 3' to the 
predicted transcription start sites. Only those probes within the cdc22 
transcribed region would be predicted to hybridize to cdc22 mRNA. 
ii 	Results 
Primer extension 
Two complementary oligonucleotides were annealed to the cdc22+ 
mRNA to initiate separate reverse transcriptase reactions. The first 
oligonucleotide 5' to the predicted intron (L, 5'-GGTGGTAAATACCGG 
GAA-3') and the second downstream of the intron (A, 5'-GATCAACA 
TGATCGGAAT-3'), at nucleotides -38 to -21 and 403 to 420, respectively 
(see Figs. 3C, 4A, and Appendix A). The method used is described in 
Section 2i. 
The result of the primer extensions are presented in Figure 4A. 
Both primer extension reactions predicted two transcription start sites at 
very similar positions for cdc22. The reaction initiated with the 
oligonucleotide 5' to the putative intron (L) predicted two start sites at 
positions -283 and -269 relative to the start codon of cdc22 (Fig 3C). The 
reaction initiated with an oligonucleotide 3' to the putative intron (A) 
predicted two starts sites at positions +35 and +49, but when the intron of 
315 nucleotides was allowed for, this gave start sites of -280 and -266. 
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Figure 4 	Mapping transcriptional start of cdc22'. 
A 	Separate primer extension reactions primed with 
oligonucleotides 5' and 3' to the cdc22 putative intron (L and A, 
respectively - Appendix A). The method used is described in Section 21. 
The two principal extended products from each reaction, are labelled 
according to the position of their initiation relative to the start codon, 
estimated from the adjacent sequencing ladders, which were primed using 
the same oligonucleotide. 
B 	Northern blot of wild-type (972h) fission yeast RNA probed 
with DNA fragments 5' (132) and 3' (134) to the predicted transcriptional 
start sites. The 132 and 134 nucleotide fragments were made using the 
polymerase chain reaction with oligonucleotides H, I, and L, M, 
respectively (Appendix A), and end-labelled using T4 polynucleotide 
kinase and [y-32P]ATP (Section 2d.ii). Equal amounts of cdc22 mRNA in 
all lanes was shown by subsequent hybridization with a cdc22 probe, 
consisting of equimolar amounts of the Hin dIll insert fragments of 
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Northern blots 
Total RNA was prepared from exponentially-growing wild-type 
(972h-) fission yeast (Section 2e.vi ). Four 10 p.g samples were separated by 
formaldehyde agarose gel electrophoresis, and transferred to GeneScreen 
membrane (Sections 2c.vii and viii). The Northern blot was split in two: 
one half hybridized with a DNA fragment 5' (132 nucleotides) to the 
predicted transcription start sites; and the other half hybridized to a DNA 
fragment 3' (134 nucleotides) to the predicted transcription start sites 
(Fig. 4B). After this hybridization, both blots were stripped and re-
hybridized with a cdc22 probe. 
The result of the Northern blots are presented in Figure 4B. 
The Northern blots probed with DNA fragments 5' and 3' to the 
predicted transcription start sites confirmed the position of transcriptional 
starts. Only the probe 3' to the predicted start sites (134) hybridized to 
cdc22 mRNA. Subsequent hybridization of all lanes with a cdc22 probe 
confirmed the presence of equal amounts of cdc22+ mRNA. 
The predicted start sites for transcription of cdc22 agree well with 
other fission genes that have had start sites mapped (Russell, 1989). 
Transcription has been found to initiate usually within 250 nucleotides 5' 
to the ORF, and there are often two start sites within a 10 nucleotide 
region. TATA sequence motifs have been suggested for genes that are 
transcribed at moderate or high levels, located about 35 - 45 nucleotides 
upstream of the start sites (Russell, 1989). The consensus for fission yeast 
TATA motifs, is very weak and no such sequences are apparent 5' to the 




cdc22 transcript varies in abundance during the cell cycle with a 
maximum level at the G1-S phase boundary (Gordon & Fantes, 1986). A 
group of genes with similar expression patterns to cdc22+ have been 
identified in budding yeast (Johnston, 1990). This group of genes has been 
found to share a common 5' sequence, named the MluI cell-cycle box 
(MCB, Verma et al., 1992). MCBs are defined as the restriction 
endonuclease MluI recognition site ACGCGT, or a 5 /6 match with the 4 
nucleotides CGCG intact; some MCBs have adenine at position 8 
(McIntosh et al., 1991; Gordon & Campbell, 1991). A trimer of MCBs has 
been shown to confer periodic expression in Ci on a heterologous gene in 
budding yeast (Lowndes et al., 1991), implicating MCBs in the cell cycle 
control of genes. 
The Find program of the UWGCG facility in the Daresbury VAX 
was used to search for MCBs in the cdc22 promoter region. The 
distribution and types of MCBs found are shown in Figure 4C and 4D. 
Two dusters of MCBs are apparent: one cluster 5' to transcriptional start 
with one MluI site and three /6  matches; and one cluster 3' to 
transcriptional start with one MluI site and one 5 /6 match. One lone 5 /6 
match is present between these two clusters. Only the MluI site 5' to 
transcriptonal start has an adenine at position 8. 
Having identified putative MCBs in the promoter region of cdc22, 
it was necessary to test whether they were physiologically relevant in 
fission yeast. 
ii 	Results 
A 36 base pair synthetic oligonucleotide containing three MluI 
recognition sites (Appendix A) was cloned into the XhoI site of the test 
plasmid pSPi178 (Section 2b.v) to create pSPAI78.3M, and transformed 
into a wild-type fission yeast strain carrying ura4-D18, for plasmid 





-584 ------------------------------------------------------------ 	-525 
TAGAGCAGGTTGGTAGTCGGGTTGGACCGCGTGTTTAATTTATGTAAACAGTCGCGTCGC 
-524 ----+---------+---------------------------------------------- 	-465 
GTTGCAATTGAGACGCGTAAATAAATATTTAATTTATTACATTCAGTCGTAAACAGAGTA 
-464 ------------------------------------------------------------ 	-405 
TTTATAAACACTTTTTTTATGTTTAATAAAAGATAAATGTAACAGTTGAATGTATTGTAT 





-284 ------------------------------------------------------------ 	-225 
TTTAGCAAGTCTTAATTAACGTCTTTTAGATATAGTAGAGCTACAAAAATGATCCGGTTT 
-224 ------------------------------------------------------------ 	-165 
CCACTCTTAGCTTTATTTACATTGATCAACATGACTTAAAGTTCGGATGACGCGACGGGC 
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Figure 4 	Distribution of MCBs in the promoter region of cdc22. 
C 	The nucleotide sequence 5' to the cdc22+ ORF numbered 
relative to the predicted start codon (in bold typeface). MluI recognition 
sites are underlined, MluI /6  matches are wavy underlined, and 
transcriptional start sites are indicated by asterisks. 
D 	A schematic diagram of the cdc22- promoter region. 
MluI sites (filled boxes), MluI 5 /6 matches (open boxes), the cdc22 open 
reading frame (black) and intron (dots), and transcriptional start sites 
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Figure 4 E MCBs are physiologically relevant in fission yeast. 
Northern blot of RNA prepared from three clones each of 
wild-type fission yeast transformed with pSPA178.3M (+3MCB), 
and pSPA178 (-3MCB). The blot was hybridized consecutively 
with lacZ (a 2.2 kb EcoRI/XbaI fragment from pSPM78, Fig. 213), 
cdc22 (Section 4b) and adhl (a 1.1 Kb EcoRI fragment from 
the fission yeast adh1 gene) probes. 
(XhoI) immediately 5' to a budding yeast minimal cytochrome c promoter 
and the lacZ gene of E. coli (Lowndes et al., 1992). Potential cis-acting 
elements were inserted into the XhoI site and their effects on lacZ 
transcription assayed. A control plasmid, pSPA178 without the M!uI 
trimer, was also transformed into fission yeast. Three colonies from each 
transformation were grown to mid-exponential stage, and the cells 
harvested. Total RNA was prepared from the cells (Section 2e.vi ) and this 
subjected to glyoxal gel electrophoresis, and transferred to GeneScreen 
membrane (Sections 2c.vii and viii). The Northern blot was hybridized 
consecutively with lacZ, cdc22 and adh1 probes. 
The results of this experiment are shown in Figure 4E. 
A lacZ transcript was produced that is specific to those cells that 
contained pSPi178.3M. This transcript was absent in control cells which 
contained pSPM78. Thus, MCBs are physiologically relevant in fission 
yeast. 
Interestingly, cdc22 transcript was reduced in those cells that 
contained pSPM78.3M, in comparison with those cells that contained 
pSPM78. Perhaps multiple MCBs in the test plasmid titrated out the 
transcription factor common to both genes, and consequently reduced 
cdc22 transcription? Growth rate, however, was not affected in 
pSPi\178.3M carrying cells (P. Kersey, pers. comm.), suggesting that reduced 
cdc22+ transcription was not affecting cell cycle progress. 
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4 d MCBs confer cell cycle gene expression in fission yeast 
i 	Introduction 
Having shown that MCBs are physiologically relevant in fission 
yeast, the next question to address was whether they can confer cell cycle 
gene expression. Such ability has already been demonstrated for an MCB 
trimer in budding yeast (Lowndes et al., 1991). 
ii 	Results 
Wild-type fission yeast cells containing pSPAI78.3M were grown to 
mid-exponential stage of growth at 32°C, and a population of small cells 
selected using Beckman elutriator rotor (Section 2e.iv). The resulting 
culture was incubated at 32°C for 6 hours to follow two divisions, and 
samples removed every 20 minutes. Total RNA was prepared from the 
cells (Section 2e.vi ), 10 j.tg of each sample subjected to glyoxal gel 
electrophoresis, and transferred to GeneScreen membrane (Sections 2c.vii 
and viii). The Northern blot was hybridized consecutively with lacZ, 
cdc22 and adh1 probes (Fig. 4E). 
The results of this experiment are shown in Figure 4F. 
The lacZ transcript specifically produced by the MCB trimer was 
expressed in a cell cycle specific manner with a maximum when cells were 
beginning to divide, which in rapidly growing fission yeast cells 
corresponds to the Gi-S  phase boundary. In the first cycle sampled after 
synchronizatio,xpression of !acZ was slightly perturbed, as it did not 
precisely coincide with cdc22 expression. But in the second and the start 
of the third cycles lacZ expression paralleled cdc22+ expression. Thus, an 
MCB trimer can confer expression at the G1-S phase boundary on a 
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Figure 4 F 	MCBs confer cell cycle gene expression in fission yeast. 
Northern blot of RNA prepared from samples of sychronously 
dividing wild-type fission yeast cells, transformed with pSPM78.3M. 
Small cells were selected by elutriation and grown at 32°C for 61/2  hours, 
to follow two divisions. Samples were removed from the resulting 
culture every 20 minutes, and total RNA prepared. A plot of cell number 
against time is shown, and the time in minutes at which samples were 
taken is indicated above each lane. The RNA was subjected to Northern 
blot analysis, and the blot hybridized consecutively with lacZ, cdc22, and 
adh1 probes (Section 4d). Synchronization was performed with the help 
of Dr. Jim Creanor, and in this experiment Northern blotting was 
conducted by Antony Johnson. 
4 e Identification of a DSC1-like complex in fission yeast: DSP1 
i 	Introduction 
Budding yeast DSC1 (for DNA §ynthesis control) was identified 
using a synthetic oligonucleotide containing three MCBs as substrate with 
budding yeast protein extracts, in bandshift assays (Lowndes et al., 1991). 
The bandshift method characterizes in vitro binding properties of 
proteins to DNA (Fried & Crothers, 1981; Garner & Revzin, 1981). Radio-
labelled DNA fragments are mixed with protein extracts, and the reaction 
subjected to electrophoresis. Free DNA runs into the gel a distance 
proportional to its size to form a band; whereas complexes of proteins 
bound to DNA run less far, with the consequence that a new shifted band 
is formed. Specificity of binding is tested by the addition of unlabelled 
competitor DNA in excess to the reaction mixture before electrophoresis. 
If the competitor DNA binds the protein complex the shifted band 
disappears. 
To identify a protein complex in fission yeast that binds to MCBs, 
the synthetic oligonucleotide containing three MCBs was initially used as 
substrate with fission yeast protein extracts in bandshift assays (Appendix 
A). Subsequently, a fragment from the promoter region of cdc22+, 5' to 
transcriptional start, containing four MCBs (132) was used as substrate 
(Figs. 4A and 4H). Bandshifts were also attempted with a fragment of the 
promoter region of cdc22, 3' to transcriptional start, containing two MCBs 
(134). 
ii 	Results 
The method used for bandshift assays is described in Section 2j. 
Bandshifts were conducted with budding and fission yeast protein 
extracts using three radiolabelled DNA fragments as substrates: a synthetic 
oligonucleotide containing three MCBs, of 73 nucleotides; a DNA 
fragment 5' to transcriptional start of cdc22 containing four MCBs, of 132 
nucleotides; and a DNA fragment 3' to transcriptional start of cdc22 
containing two MCBs, of 134 nucleotides (Figs. 4A and 4H) 
All three DNA fragments were made using the polymerase chain 
IIOU 
reaction (Section 2h). The synthetic MluI trimer cloned into p178 
(pSPA178.3M, Section 40 was amplified using two flanking 
oligonudeotides 0 and P (Appendix A). The 134 and 132 nudeotide 
fragments were amplified from pCDC22-1 (Section 3b) with 
oligonucleotides H, I, and L, M, respectively (Appendix A). 
All DNA fragments were end-labelled to a specific activity of 
approximately 1000 counts per second per ng of DNA, and purified using a 
G-50 molecular size exclusion column (Section 2d.ii and iii). 0.5 ng of 
DNA was used per reaction. 
Protein extracts were made from exponentially-growing wild-type 
budding (CB001 S100) and fission (972h1 yeast cells (Section 2e.vii). For 
bandshifts using the synthetic MluI trimer as substrate, 20 p.g of budding 
or 5 j.tg of fission yeast protein extract was used per reaction, to normalize 
exposure times for radiography. For bandshifts using the upstream cdc22 
fragments of DNA as substrate, 15 .tg of fission yeast protein was used per 
reaction. 
In competition experiments 10 x and 100 x molar excesses of 
unlabelled DNA fragments were added to reaction mixtures prior to 
electrophoresis. 
All DNA fragments for competition experiments were produced 
using the polymerase chain reaction. The synthetic MluI trimer, 132 and 
134 nucleotide fragments were made as described above. A DNA fragment 
from the promoter region of cdc22 containing one MCB, of 166 
nucleotides, was amplified using the oligonucleotides K and J from 
pCDC22-1 (Appendix A). 
Two other DNA fragments were used in control competition 
experiments: 
a synthetic oligonucleotide identical to the MluI trimer, 
except that the central GC of all three MCBs was replaced by AT (3Mut); 
a DNA fragment from the budding yeast CDC9 promoter 
(55) containing two MCBs, of 55 nucleotides. CDC9 encodes DNA ligase in 
budding yeast and is periodically expressed at the G1-S phase boundary 
(White et al., 1986). 
Both of these DNAs were previously cloned into pLGA178 
(Lowndes et al., 1991) and amplified using the same flanking 




Figure 4 	Identification of a DSC14ike complex in fission yeast: DSP1. 
C 	Bandshift analysis showing binding of specific proteins 
from fission and budding yeast to multiples of the ACGCGT sequence 
element. Wild-type yeast protein extracts were mixed with a labelled 
synthetic oligonucleotide containing three MCBs, generated from 
psE178.3M by the the polymerase chain reaction. Control lanes (C) show 
reactions where no competitor DNA was added. Competitor DNA (in 10 
and 100 molar excesses) added to reactions was as follows: fragments from 
the cdc22 promoter containing four and one MCBs (132 and 166, 
respectively); three mutated MCBs (3Mut); and a fragment from the CDC9 
promoter containing two MCBs (55). Large and medium arrows indicate 
specific DSC1 and DSP1 shifted complexes, smaller arrow indicates 
unbound DNA. 
H 	Promoter regions of cdc22 from fission yeast and of CDC9 
from budding yeast, showing distribution of MCBs, and DNA fragments 
used in competition experiments. Filled boxes represent MluI recognition 
sites, and open boxes MluI /6  matches. Transcriptional start sites are 
indicated by arrowed lines. Numbers refer to nucleotide positions relative 
to the start codons. 
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Synthetic MluI trimer 
The results of bandshift assays using the synthetic MluI trimer as 
substrate, with fission and budding yeast protein extracts, are shown 
Figure 4G. 
In the control lanes (C), where no competitor DNA has been added, 
a number of shifted complexes are observed for protein extracts from both 
yeasts. In budding yeast extracts it is the lowest mobility complex that is 
DSC1 (Lowndes et al., 1991). A complex of similarly low mobility is also 
present in fission yeast extracts. We suggest calling this complex DS Fl, for 
DNA .ynthesis control in S. pombe. 
In competition experiments it is the lowest mobility complex from 
both budding and fission yeast extracts (indicated in Fig. 4G by a large 
arrow) that disappears in the presence of molar excess of cdc22 (132) and 
CDC9 (55) promoter regions. Both of these promoters contain multiple 
MCBs, and thus the two complexes recognize MCBs in their normal DNA 
context. Furthermore, the binding specificities of the two complexes are 
interspecific: DSC1 and DSP1 can both bind budding and fission yeast 
prompter fragments containing MCBs, suggesting structural conservation. 
Additionally, shifted bands of fastest mobility, from both fission and 
budding yeast proteii}s"extracts are competed by MCBs (medium arrows in 
Fig. 4G). Potentially, these are partial DSP1 /DSC1 complexes. 
No effect is observed on the bandshift profile in the presence of 
molar excess of a 5' region of cdc22 containing only a single MCB (166), 
and the mutated synthetic MluI trimer (3Mut), suggesting that these 
fragments do not bind any of the protein complexes in the bands. Thus 
DSC1 and DSP1 recognize only multiples of the CGCG core, and not other 
sequences in the oligonucleotide used as substrate. 
cdc22 promoter fragment containing four MCBs 
The results of bandshift assays using a cdc22 promoter fragment 
containing four MCBs (132, Fig. 4J) as substrate with wild-type fission yeast 
protein extracts, are shown in Figure 41. This bandshift was deliberately 
over-exposed to X-ray film to show lower abundance shifted bands. 
A similar bandshift profile is observed in control lanes (Cl and C2 
with 15 and 8 .tg of protein, respectively) where no competitor DNA has 
been added, to that observed with the MluI trimer as substrate, although 
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Figure 4 	A cdc22 promoter fragment containing four MCBs 
binds DSP1 in bandshift assays. 
I 	Bandshift analysis showing specific binding of proteins 
from fission yeast to a promoter fragment of cdc22+ containing four MCBs. 
Wild-type fission yeast (972fr) protein extracts were mixed with a 132 
nucleotide labelled fragment generated from pCDC22-1 by the polymerase 
chain reaction. Control lanes (Cl and C2: 15 and 8 pg of protein, 
respectively) show reactions where no competitor DNA was added. 
Competitor DNA added to reactions (in 10 and 100 molar excesses) was as 
follows: fragments from the cdc22+ promoter containing four, one, and 
two MCBs (132, 166, and 134 respectively); synthetic MluI trimer (3Mlu); 
mutated MluI trimer (3Mut); and a fragment from the CDC9 promoter 
containing two MCBs (55). Large and medium arrows indicates specific 
DSP1 shifted complexes, smaller arrow indicates unbound DNA. 
J 	Promoter regions of cdc22 from fission yeast and of CDC9 
from budding yeast, showing distribution of MCBs and DNA fragments 
used in bandshifts. Filled boxes represent MluI recognition sites and open 
boxes MluI I6 matches. Transcriptional start sites are indicated by 
arrowed lines. Numbers refer to nucleotide positions relative to the start 
codons. 
I 
Cl 132 Mu 3Mut 134 166 55 C2 
10 100 	10 100 	10 	100 	10 100 	10 100 	10 100 
40 
ww 
• • - - 







-539 	 -407 	 -155 	 -21 	 cdc22# 
I I 






L 	 COC9 J 
55 bp 
fewer faster mobility bands are apparent. 
As in bandshifts using the synthetic MluI trimer, it is the lowest 
mobility band (indicated in Fig. 41 by a large arrow) that disappears only in 
reactions containing molar excess of unlabelled DNA containing 
multiples of MCBs. This band disappears in the presence of the cdc22 
promoter fragment containing four MCBs (132), the synthetic trimer 
(3MIu), and the CDC9 promoter fragment (55). Interestingly, the lowest 
mobility band (medium arrow) also disappears in the presence of an 
unlabelled cdc22 promoter fragment containing a pair of MCBs from a 
region 3' to transcriptional start (134), suggesting that this DNA also binds 
to the complex. This conlex is perhaps a degradation product of DSP1. 
As expected, the presence of DNA fragments, such as the mutated 
MluI trimer (3Mut) and the promoter region of cdc22 containing only 
one MCB (166), have no effect on the band shift profile. 
Thus, the cdc22 promoter fragment containing four MCBs from a 
region 5' to transcriptional start (132), recognizes DSPI when used as 
substrate in the bandshift assay. 
cdc22 promoter fragment containing two MCBs 
The results of bandshift assays using a cdc22 promoter fragment 
containing two MCBs (134, Fig. 4J) as substrate with wild-type fission yeast 
protein extracts, are shown in Figure 4K. 
Two control lanes (Cl and C2, with 8 and 15 pg of fission yeast 
protein, respectively) show bandshift reactions using the cdc22 promoter 
fragment containing four MCBs (132) as substrate. Both show the specific 
low mobility band, demonstrating that DSP1 is present in these protein 
extracts. 
In the absence of competitor DNAs (lane C), a different bandshift 
profile is observed using the cdc22 promoter fragment containing two 
MCBs (134) as substrate. The low mobility band is not observed. None of 
the observed bands disappear in the presence of competitor DNAs, 
suggesting that these complexes do not specifically bind MCBs in the 
substrate. 
Thus a cdc22 promoter fragment containing only two MCBs, from 
a region 3' to transcriptional start (134), does not recognize DSPI, when 
used as substrate in the bandshift assay. 
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Figure 4 	A cdc22 promoter fragment containing two MCBs 
does not bind the DSP1 in bandshift assays. 
K 	Bandshift analysis showing absence of specific binding of 
proteins from fission yeast to a promoter fragment of cdc22 from within 
the transcribed region, containing two MCBs. Wild-type fission yeast 
(972h) protein extracts were mixed with a 134 nucleotide labelled 
fragment, generated from pCDC22-1 by the polymerase chain reaction. 
Control lane (C) show reactions where no competitor DNA was added. 
The competitor DNA added to reactions was as follows, where 10 and 100 
molar excesses were used: fragments from the cdc22+ promoter containing 
four, one, and two MCBs (132, 166, and 134 respectively); synthetic MluI 
trimer QM/u); mutated MluI trimer (3Mut); and a fragment from the 
CDC9 promoter containg two MCBs (55). The two last lanes show controls 
using the cdc22 promoter fragment containing four MCBs as substrate 
with 15 and 8 tg of protein (Cl and C2, respectively). Large arrow indicates 
specific DSP1 shifted complex, smaller arrow indicates unbound DNA 
L 	Promoter regions of cdc22 from fission yeast and of CDC9 
from budding yeast, showing the distribution of MCBSs, and DNA 
fragments used in the bandshifts. Filled boxes represent MluI recognition 
sites and open boxes MluI /6  matches. Transcriptional start sites are 
indicated by arrowed lines. Numbers refer to nucleotide positions relative 
to the start codons. 
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Bandshift assays are a stringent in vitro assay for proteins' ability to 
bind DNA. DNA and protein have to bind very tightly for bandshift to 
work, as the complex must remain intact under conditions of 
electrophoresis. Many weaker DNA-protein interactions will not be 
detected using this technique. The cdc22 promoter fragment containing 
two MCBs does bind to DSP1, as it can compete in bandshifts using other 
substrates. Presumably it does not bind DSP1 tightly enough for itself to be 
a substrate. This observation is consistent with the lack of success in 
attempting to use promoter fragments from budding yeast genes 
containing two or less MCBs, as bandshift substrates (N. Lowndes, pers. 
comm.). 
4 f Cell cycle behaviour of DSP1 
i 	Introduction 
Budding yeast DSCI has been shown to bind MCBs in a cell cycle 
specific manner coincident with transcription of genes that are expressed 
at the G1-S phase boundary (Lowndes et al., 1991). Recently, however, 
DSC1 has been found to bind invariantly in sychronized cells after a factor 
block and release (Dirick et al., 1992). 
This experiment analyses the cell cycle binding activity of DSP1. 
ii 	Results 
Wild-type fission yeast cells (972h - ) were grown to mid-exponential 
stage of growth at 32°C, and a population of small cells selected, using a 
Beckman Elutriator rotor (Section 2e.iv). The resulting culture was 
incubated at 32°C to follow one division, and duplicate samples removed 
every 20 minutes for 3 1 /2 hours: protein extracts were prepared from one 
sample (Section 2e.vii), and total RNA from the other (Section 2e.vi ). 
Bandshift assays were performed with 15 jig of protein from each 
sample, using the 132 nucleotide cdc22 promoter fragment as substrate 
(Sections 2j and 4e). In separate bandshift reactions, 10 molar excess of 
unlabelled cdc22 promoter fragment containing two MCBs (134) was 
added to each reaction mixture, prior to electrophoresis. 
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Figure 4 M 	DSP1 binds MCBs constitutively during the cell cycle. 
Bandshift analysis of DSP1 binding activity from samples of 
synchronously dividing wild-type (972h- ) fission yeast cells. A population 
of small cells were selected by elutriation, and grown at 32°C. Duplicate 
samples were removed from the culture every 20 minutes for 3 hours, to 
follow one division cycle. A plot of cell number against time is shown, 
and the time in minutes at which samples were taken is indicated above 
each lane. From one set of cell samples protein extract was prepared, and 
from the other total RNA. 15 .tg of each protein was used per bandshift 
reaction, with the cdc22 promoter fragment containing four MCBs (132) 
as substrate. The RNA was subjected to Northern blot analysis, and the 
blot hybridized consecutively with cdc22 and adhi + probes (Fig. 4E). 
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10 jtg of each RNA sample was separated by electrophoresis in a 
formaldehyde gel, and transferred to GeneScreen membrane (Sections 
2c.vii and viii). This Nothern blot was probed with cdc22 and adh1 
probes (Fig. 4E). 
The results of this experiment are shown in Figure 4M. 
DSP1 binds to the cdc22 promoter fragment at a constant level in 
protein extracts from synchronously dividing fission yeast cells. Similar 
results have been obtained using the synthetic MluI trimer as substrate (N. 
Lowndes, pers. comm.). The nucleotide fragment containing two MCBs 
from 3' to transcriptional start (134) competed DSP1 equally in all samples 
(data not shown), suggesting that DSP1 also binds this DNA fragment 
invariantly during the cell cycle. Thus, DSP1 binds MCBs from the 
promoter region of cdc22 constitutively during the cell cycle. As a 
control, cdc22+ transcript levels are periodic, demonstrating that the cells 
are dividing synchronously. 
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4 g Conclusions 
In this chapter both cis-acting elements and a trans-acting factor that 
are involved in the control of cdc22+ expression have been described. 
Sequences resembling budding yeast MIO cell cycle boxes (MCBs), 
have been found 5' to the cdc22 ORF. A synthetic oligonucleotide 
containing three MCBs has been shown to confer periodic expression of a 
heterologous gene in fission yeast, suggesting that MCBs are cis-acting 
elements that have a role the control of cdc22+ periodic expression. 
An activity that specifically binds MCBs in the promoter region of 
cdc22 has been identified in fission yeast, by bandshift assays. This 
complex has very similar bandshift properties to DSCI, a budding yeast 
MCB binding activity, and so we have named it DSP1, for DNA synthesis 
control in S. pombe. Both DSP1 and DSC1 have low mobilities under 
electrophoresis and so are large proteins. DSPI and DSC1 are likely to 
contain a number of components, as faster mobility complexes, probably 
representing partial complexes, are also observed. 
DSC1 and DSP1 recognize only multiples of MCBs in bandshift 
assays. Both complexes only recognize at least three MCBs in substrate 
DNA, but can be competed by DNA fragments containing two MCBs. 
DNA containing single MCBs cannot even act as competitor DNA. 
Structural conservation of DSC1 and DSP1 is suggested by their ability to 
recognize promoter fragments containing MCBs from the promoters of 
genes from both yeast species. DSP1 binds MCBs constitutively during the 
cell cycle. Both DSCI and DSPI are probably trans-acting transcription 
complexes which are involved in the control of MCB genes at the G1-S 
phase boundary. 
In the next chapter experiments will be described which identify a 
component of DSP1. 
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Chapter 5: cdc1O 
5 a Introduction 
In Chapter 4 experiments were described showing the discovery of a 
binding activity from fission yeast which specifically recognizes MCBs. 
This activity has been called DSP1, as it is closely related to DSC1, an MCB 
binding activity previously characterized in budding yeast (Lowndes et al., 
1991). It is likely that DSP1 is a trans-acting transcription complex which 
controls cdc22 expression by binding cis-acting MCBs in its promoter 
region. 
A transcription complex which is involved in the control of 
expression of .a gene required for cell cycle progress may itself be required 
for cell cycle progress. One could predict, therefore, that cells defective in 
such a complex would show the cdc mutant phenotype (Section lc.i). Two 
fission yeast cdc genes are required before cdc22+ in the cell cycle: cdc2 and 
cdc1O (Nurse et al., 1976). Both of these genes are needed for transition 
through the 'START' event (Nurse & Bissett, 1981), a point during G1 at 
which cells decide to enter either the vegetative or sexual life cycles 
(Section lb.ii). cdc2 functions have been well characterized at the onset of 
mitosis, although less is known about its role in G1 (Nurse, 1990). cdclO 
is more enigmatic, although its gene product contains regions that are 
homologous to parts of the budding yeast SWI4 and SWI6 gene products, 
which are believed to be transcriptional activators of cell cycle regulated 
genes (Breeden & Nasmyth, 1987b; Andrews & Herskowitz, 1989b). 
In the first part of this chapter experiments are described which 
demonstrate that the cdc1O gene product, p87CdC10 (Simanis & Nurse, 
1989), is part of DSP1. Then a mutant form of p87CdClO,  p87CdCIOC4, is 
characterized: p87CdC10 C4 appears to be constitutively hyperactive, 
resulting in cdc22+ over-expression throughout the cell cycle. This mutant 
phenotype is genetically recessive to wild-type, but dominant to cdclO-129. 
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5b In vivo temperature shift of cdclO mutants 
I 	Introduction 
The three cdclO mutants used in this work are temperature-
sensitive conditional-lethals. Such mutants, at the permissive 
temperature of 24°C behave apparently normally, whereas at the 
restrictive temperature of 36°C display the cdc phenotype, where they are 
no longer able to divide, but continue to grow, and so elongate. This 
experiment analyses the effect of an in vivo temperature shift on DSP1 
binding activity, from both cdclO mutant and wild-type cells. 
ii 	Results 
972h (wild-type) and cdclO-129 fission yeast cells were grown to 
mid-exponential stage of growth at the permissive temperature of 24°C, 
and subjected to a temperature shift to the restrictive temperature of 36°C 
(Section 2e.iv). Samples of cells were removed from the culture during 
the shift at time intervals of 0, 5, 30, 60, 120 and 210 minutes, and protein 
extracts prepared from each sample (Section 2e.vii). Bandshift assays were 
conducted with these extracts using either the synthetic MluI trimer or the 
cdc22 promoter fragment containing four MCBs as substrates (Sections 2j 
and 4e). 
The result of an in vivo temperature shift on DSP1 binding activity, 
from wild-type and cdclO-129 cells, is shown in Figures 5A and 5B. 
DSP1 binding activity was rapidly lost in cdclO-129 cells when 
shifted to the restrictive temperature, using either the synthetic MluI 
trimer or the cdc22 promoter fragment as substrates. This loss in activity 
was not observed in similarly treated wild-type cells. Slight variation in 
the time taken to lose activity was apparent using the two substrates. 
With the MluI trimer, loss was evident after only 5 minutes at 36°C, and 
there was no detectable activity after 30 minutes. Using the cdc22 
promoter fragment, loss of activity was not apparent till after 30 minutes 
at the restrictive temperature. This may reflect differences in the binding 
properties of DSP1 to the two substrates. 
The temperature-sensitive effect observed on DSP1 binding activity 
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Figure 5 	Bandshift analysis of DSP1 binding activity in cdcl0-129: 
in vivo temperature shift. 
Wild-type (9721:-) and cdclO-129 cells were grown to mid-
exponential stage of growth at 24°C, shifted to 36°C, and samples taken at 0, 
5, 30, 60, 120, and 210 minutes. Protein extracts were prepared and assayed 
for DSPI activity. In separate experiments the Miul trimer (A) and cdc22 
promoter fragment (B) were used as substrates. Arrows indicate the 
specific DSP1 shifted band. In experiment 5A probe preparation and 
electrophoresis were performed by Noel Lowndes. 
suggests that p87CdC 10 is either part of the DSPI itself, or, is at least required 
for activation or regulation of the complex. In both cases, loss of activity 
was well within the period for one cell cycle for fission yeast at 36 0C, so the 
loss cannot be a secondary consequence of a cell cycle block. 
5 c In vitro temperature shift of cdclO mutants 
i 	Introduction 
This experiment was designed to confirm and extend the result of 
the in vivo temperature shifts. Extracts were taken from wild-type and 
cdclO mutant strains grown at the permissive temperature. These extracts 
were then subjected to an brief in vitro temperature shift, and DSP1 
binding activity tested. 
ii 	Results 
The fission yeast strains cdclO-129, cdclO-C4, cdclO-K28 and972h 
(wild-type) were grown at the permissive temperature of 24°C to mid-
exponential stage of growth, and protein extracts prepared (Section 2e.vii). 
These extracts were subsequently subjected to an in vitro temperature 
shift, and samples removed at time intervals of 0, 5, 10, 15, and 30 
minutes. Each sample was processed for bandshift assay, using either the 
MluI trimer or the cdc22 promoter fragment as substrates (Sections 2j and 
4e). The temperature shift was varied depending on the substrate used: 
28°C for the synthetic MluI trimer, and 31°C for the cdc22 promoter 
fragment. 
The results of in vitro temperature shifts on protein extracts from 
wild-type and cdclO mutant strains is shown in Figures 5C and 5D. 
Two alleles, cdclO-129 and cdclO-K28, produced reduced DSPI 
binding activity, which was rapidly lost in vitro. Thus the temperature 
sensitive loss of DSP1 activity in cdclO mutants is due a temperature 
sensitive gene product, and strongly suggests that p87CdC10 is a component 
of DCPI, and not an ancillary regulatory protein. 
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Figure 5 	Bandshift analysis of DSPI binding activity in cdclO mutants: 
in vitro temperature shift. 
Wild-type (972h-), cdclO-129, cdclO-K28, and cdclO-C4 cells 
were grown to mid-exponential stage of growth at 24 0C, samples taken, 
and protein extracts prepared. In separate experiments the M!uI trimer (C) 
and cdc22 promoter fragment (D) were used as substrates. The protein 
extracts were incubated at 28°C and 31°C (for the Mlul trimer and cdc22 
promoter fragment, respectively), for 0. 5, 19 and 15 minutes, and assayed 
for DSPI activity. Arrows indicate the specific DSPI shifted band. In 
experiment 5C probe preparation and electrophoresis were performed by 
Noel Lowndes. 
permissive temperature using both substrates, which strongly implies that 
the protein complex is extremely unstable in this mutant form. 
No temperature effect is observed on DSP1 activity with extracts 
from wild-type cells using either substrate, in agreement with the in vivo 
temperature shift. 
5 d Supershift of DSP1 
i 	Introduction 
The two previous experiments demonstrate that p87CdClO is likely to 
be a component of DSP1. To confirm this result, antip87Cdc10  polyclonal 
serum was used in supershift experiments. 
If antibody is added to a bandshift reaction prior to electrophoresis, 
and it binds a protein that is part of one of the shifted bands, the band may 
be further shifted - 'supershifted' - to form a new band. This new band has 
even lower mobility band than the original, as the complex contains 
bound antibody, which may even crosslink complexes to form oligomers. 
Thus, components of shifted bands can be identified if suitable antiserum 
is available. 
ii 	Results 
Wild-type fission yeast cells (972h-) were grown to mid-exponential 
stage of growth, and protein extracts prepared (Section 2e.vii). These 
extracts were used in bandshifts, with the cdc22 promoter fragment as 
substrate (Sections 2j and 4e). Prior to electrophoresis, I j.tl of antip87CdC10 
polyclonal antibody was added to reaction mixtures at a series of 
concentrations from 1 /125 to 1 /200, with controls of 191  of 1 /125 of pre-
immune serum, and no antibody. 
The result of the supershift experiment using p87CdClO antibody on 
DSP1 activity is shown in Figure 5E. 
When anti-polyclonal serum was added to the binding reaction it 
caused a supershift of the DSPI shifted complex, an effect not seen with 
pre-immune serum. Thus, p87CdC 10 is indeed part of DSPI. When high 
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Figure 5 E DSP1 contains the cdc1O gene product, p87ClC 1 
Bandshifts were conducted using fission yeast wild-type 
(972h - ) protein extracts and the cdc22 promoter fragment as substrate. 
Prior to electrophoresis, to separate binding reactions, were added the 
following: C, binding buffer; Pr., /2.5 dilution of preimmune serum; 
p87CdC 10 Ab., a dilution series of antip87CdClO polyclonal antibody, as 
indicated. Both the preimmune and immune sera were from the same 
rabbit, and were a kind gift from Uli Deuschle and David Beach. 
concentrations of antip87C!clO serum were used, the supershifted complex 
did not even enter the gel, suggesting that oligomers of DSP1 were formed 
by crosslinking. When the antibody was diluted the electrophoretic 
mobility of the supershifted complex increased, presumably because fewer 
of the available epitopes were bound, and so monomers of DSP1 bound to 
antibody were present, which would have lower mobility than free DSP1. 
5 e Effects of cdcTIO mutants on cdc22+ and reporter gene 
expression 
i 	Introduction 
The previous experiments have demonstrated that p87CdClO is part 
of DSP1, and that the binding properties of this activity, at least in 
bandshift assays, are affected in cdclO mutants. 
As DSP1 specifically binds MCBs, and it is MCBs 5' to the cdc22 ORF 
which are implicated in the control of cdc22+ expression, one could predict 
that DSP1 is involved in the control of cdc22 expression. The next 
experiment tests this prediction by observing the effect of cdclO mutants on 
cdc22 expression. Furthermore, the effect of cdclO mutants on a reporter 
gene under the control of the MluI trimer is also tested (Section 40. 
ii 	Results 
Four fission yeast strains, each carrying ura4-D18 for plasmid 
selection, were transformed with pSPA178.3M (Sections 4c and 2e.v): 
cdclO-C4, cdclO-129, cdc2-33, and wild-type (cdc). 
Three clones of cdclO-129 and cdclO-C4, two clones of cdc2-33, and 
one clone of wild-type, all containing pSP178.3M, were grown to mid-
exponential stage of growth at the permissive temperature of 24 0C. 
Samples of cells were removed from each culture at 0 and 3 1 /2 hours after 
a temperature shift to 36°C. Total RNA was extracted from all samples 
(Section 2e.vi ), and this subjected to glyoxal gel electrophoresis, and 
transferred to GeneScreen membrane (Section 2c.vii and viii). This 
Northern blot was hybridized consecutively with cdc22, lacZ and adh1 
probes (Fig. 4E). 
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Figure 5 F Effect of cdclO mutants on cdc22 and reporter gene 
expression. 
Strains of fission yeast wild-type (972h1, cdc2-33, cdcl0-129, 
and cdclO-C4, ura4 for plasmid selection, were transformed with 
pSPM78.3M, and checked for unstable plasmids. One clone of cdc, two 
clones of cdc2.33, and three clones of cdclO-129 and cdclO-C4, were grown 
to mid-exponential stage of growth at 24 0C, and subjected to a temperature 
shift to 36°C. Samples of cells were removed at 0 and 3 1 /2 hours, total 
RNA extracted, which was separated on a glyoxal gel, and transferred to 
GeneScreen membrane. The Northern blot was hybridized consecutively 
with cdc22, 1acZ, and adh1 probes (Section 4d). 
The results of this experiment are shown in Figure 5F. 
No changes were observed in cdc22+ and reporter gene transcript 
levels in cdclO-129 at the permissive and restrictive temperatures (lanes 4-
6 and 13-15, respectively). lacZ does appear to be expressed at slightly 
higher levels at the restrictive temperature, but this can accounted for in 
slight overloading in these lanes. 
Although no reduction in cdc22+ transcript levels was observed in 
cdclO-129 after 3 1 /2 hours, cells did cdc arrest. This suggests that absolute 
cdc22 transcript levels are not limiting for cell cycle progress. cdc1O may 
have other functions required for cell cycle progress which, at the 
restrictive temperature in cdcl 0 mutants, result in cell cycle arrest. If 
cdclO-129 cells are synchronized for division by elutriation, and then 
subjected to a temperature arrest, cdc22 transcript levels are reduced 
(M-J. Fernandez-Sarabia, pers. comm.) 
If p87CdC10 is part of DSP1 which controls cdc22 expression, why is 
there no reduction in cdc22 transcript levels when DSP1 binding activity 
is lost (Fig 5A and 5B)? The lack of correlation between the two 
observations may be a reflection on the two techniques used. DSP1 is 
rapidly thermplabile in cdcl0-129 at the the restrictive temperature in 
L,' 
vitroj In cells, how4 1rer, DSP1 could take longer to lose binding activity, 
and this loss may have a delayed effect on cdc22 expression. The rapid 
thermolability observed in bandshifts may, therefore, be an in vitro 
artifact. 
cdcl0-C4 shows a surprising and interesting result. At the 
permissive temperature both cdc22 and lacZ transcripts are highly over-
expressed, relative to wild-type and other cdc strains carrying the test 
plasmid (lanes 7-9). This over-expression is reduced to wild-type levels at 
the restrictive temperature (lanes 16-18). -galactosidase levels parallel 
lacZ transcript levels in these mutant cells (P. Kersey, pers. comm.) One 
explanation for this observation is that the cdclO-C4 form of p87CdC10 is 
hyperactive as part of DSP1 at this temperature, with the consequence that 
both cdc22 and lacZ are over-expressed. The two genes have different 
promoters both containing MCBs, so perhaps any genes under MCB 
control are over-expressed in this mutant. 
• 	This explanation is difficult to reconcile with the absence of DSP1 
activity in bandshift assays in this mutant (Figs. 5C and 5D). One would 
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expect there to be a positive correlation between binding activity of DSPI 
and expression levels of genes under MCB control: DSP1 might be 
expected to bind tighter to MCBs, to induce higher expression of genes 
under its control. This paradox will be further discussed in the next 
experiment. 
The observed over-expression of cdc22+ and lacZ in cdclO-C4 does 
fulfil the prediction that was to be tested by this experiment. MCB gene 
transcripts are specifically over-expressed in cdclO-C4, consistent with the 
hypothesis that p87CdClO is part of a transcription complex that controls 
MCB gene expression. 
5 f Effect of cdclO-C4 on cdc22 transcript levels 
i 	Introduction 
In the previous experiment it was shown that cdc22 transcript was 
over-expressed in cdclO-C4 cells at the permissive temperature of 24 0C. 
Mutant cells were transformed with the test plasmid pSPM78.3M carrying 
the lacZ gene, whose transcript was also over-expressed. 
It was proposed that p87CdC 10 C4, as part of DSP1, forms a 
hyperactive transcription complex resulting in over-expression of MCB 
controlled genes. An alternative explanation is that the combination of 
the cdclO-C4 mutant allele with artificially high numbers of MCBs in the 
test plasmid created a deregulated system, resulting in over-expression of 
cdc22 and lacZ. 
This experiment was designed to exclude the second of the two 
possible explanations, by examining cdc22+ expression in cdclO-C4 cells in 
the absence of pSPA178.3M. 
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Figure 5 C Over-expression of cdc22 transcript in cdclO-C4. 
Wild - type (972h), cdc10 - 129, and cdclO -C4 cells were 
grown to mid-exponential stage of growth at 24°C, and 
subjected to a temperature shift to 36°C. Samples of cells 
were removed at 0 and 3 1 /2 hours, total RNA extracted, 
separated on a formaihehyde gel, and transferred to 
GeneScreen membrane. The Northern blot was hybridized 
consecutively with cdc22, 1acZ, adh1 probes (Section 4d), 
and cdc1O (a PCR fragment generated using oligonucleotides 
S and T - Appendix A). 
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ii 	Results 
Fission yeast strains 972h - (wild-type), cdclO-129, and cdclO-C4 were 
grown to mid-exponential stage of growth at 24°C, and subjected to a 
temperature shift to 36°C (Section 2e.iv). Cells were harvested at 0 and 
3 1 /2 hours, and total RNA prepared (Section 2e.vi ). The RNA was 
separated by formaldehyde gel electrophoresis, and transferred to 
GeneScreen membrane (Sections 2c.vii and 2c.viii). The Nothern blot was 
hybridized consecutively with cdc22, adh1, suc1, and cdc1O probes. 
The results of this experiment are shown in Figure 5G. 
cdc22 transcript levels were much higher in cdclO-C4 at the 
permissive temperature, than at the restrictive temperature, or in 
cdclO-129 and wild-type. This excludes artifactual deregulation as an 
explanation for cdc22+ over-expression in this mutant. 
The smaller transcript which hybridizes to suc22 probes is not 
over-expressed in cdclO-C4, suggesting this gene is not under MCB control. 
The smaller transcript is present constitutively during the cell cycle 
(Gordon & Fantes, 1986), consistent with the proposed role of DSPI and 
MCBs in the control of expression of periodically transcribed genes. 
Interestingly, the larger transcript which hybridizes to suc22 probes, is 
present in cdcl O-C4 cells at the permissive temperature, albeit at lower 
levels that at the restrictive temperature. The larger transcript is usually 
only observed after treatment with hydroxyurea, or after certain cell cycle 
arrests (P. Harris, pers. comm; see lanes 5 and 6). An even lower 
abundance transcript, larger than the large suc22 transcript, is also present 
in cdclO-C4 cells at 24°C. 
Neither of the two observed cdclO transcripts (Ayes et al., 1985) are 
affected in cdclO-C4, arguing that over-expression of MCB genes in this 
mutant is due to post-transcriptional deregulation of cdc1O. 
5 g Cell cycle behaviour of cdc22 transcript in cdclO-C4 
i 	Introduction 
cdc22 transcript is periodically expressed during the normal fission 
yeast cell cycle, with a maximum at the G1-S phase boundary (Gordon & 
Fantes, 1986). Although cdc22 is over-expressed in cdclO-C4, is the 
regulation of its cell cycle expression maintained? This experiment 
addresses this question by examining cdc22 transcript levels in a 
population of synchronously dividing cdclO-C4 cells. 
ii 	Results 
cdcl O-C4 cells were grown to mid-exponential stage of growth at 
24°C, and a population of small cells selected by elutriation (Section 2e.iv). 
The resulting culture was incubated at 24°C, samples removed every 20 
minutes, and total RNA prepared (Section 2e.vi ). 10 p.g of RNA from each 
sample was separated on a formaldehyde gel, and transferred to 
GeneScreen membrane (Sections 2c.vii and viii). The Northern blot was 
hybridized consecutively with cdc22, adh1 and histone 2A1 probes. 
The results of this experiment are shown in Figure 5H. 
cdc22 transcript is present at higher than wild-type levels 
throughout the cell cycle in cdclO-C4. Not only is cdc22 over-expressed in 
this mutant, but cell cycle regulation is lost. 
Histone 2A1 is periodically expressed in cdclO-C4. This confirms the 
synchrony of the dividing cells, and also suggests that histone periodic 
expression during the cell cycle is independent of DSCI /MCB controls. 
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Figure 5 H 	cdc22 transcript is constitutively over-expressed in cdclO-C4. 
cdcrl O-C4 cells were grown to mid-exponential stage of growth, a 
population of small cells selected by elutriation, and grown at 24°C. 
Samples were removed from the culture every 20 minutes for 4 hours, to 
follow one division cycle. A plot of cell number against time is shown, and 
the time in minutes at which samples were taken is indicated above each 
lane. Total RNA was prepared from each sample. The RNA was subjected 
to Northern blot analysis, and the blot hybridized consecutively with 
cdc22, adh (Fig. 4E) and histone 2A1 (a PCR fragment using 
oligonucleotides S and T - Appendix A) probes. Two control lanes of RNA 
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5i Dominance relation cdclO alleles 
i 	Introduction 
cdclO-C4, as are most cdc mutants, is a recessive loss of function 
mutant. Thus in the presence of wild-type copy of cdc1O the cdc 
phenotype is not observed. In the previous two experiments it has been 
demonstrated that a phenotype of cdclO-C4 cells is that cdc22 transcript is 
over-expressed at 24°C. The next experiment analyses the dominance of 
the over-expression of cdc22 transcript in a variety of cdclO-C4 diploid 
strains. 
ii 	Results 
Diploids of cdclO-C4, cdclO-129, and wild-type were made in the 
following combinations, all carrying the mat2-102 mutation for diploid 
stability: 
cdclO-C4 mat2-102 ade6-M216 /cdclO-C4 leul-32; 
cdclO-C4 mat2-102 ade6-M216 /cdclO-129 leul-32; 
cdclO-C4 leul-32 / mat2-102 ade6-M216; 
cdclO-129 leul-32 /cdclO-129 lysl-131 mat2-102; 
cdclO-129 leul -32 /mat2-102 ade6-M21 6; 
leu3-155 /mat2-102 ade6-M216. 
Each strain was grown to mid-exponential stage of growth at 24°C, 
and subjected to a temperature shift to 36°C (Section 2e.iv). Cells were 
harvested at 0 and 3 1 /2 hours, and total RNA prepared (Section 2e.vi ). 
The RNA was separated by formaldehyde gel electrophoresis, and 
transferred to GeneScreen membrane (Sections 2c.vii and 2c.viii). The 
Nothern blot was hybridized with cdc22 and adh1 probes (Fig. 4E). 
The results of this experiment are shown in Figure 51. 
In the diploid containing one copy of cdc1O and one copy of 
cdclO-C4, cdc22 transcript is present at wild-type levels at 24°C (lane 4). 
Thus the cdclO-C4 phenotype of over-expression of cdc22 is genetically 
recessive. cdc22 transcript appears to be present at higher levels than 
wild-type in the cdclO-C4 /cdclO-129 diploid at 24°C (lane 7); thus this 
cdclO-C4 phenotype is possibly dominant to cdclO-129. 
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Figure 51 	Over-expression of cdc22 transcript in cdc10-C4 cells is 
recessive to wild-type, but dominant to cdclO-129. 
A variety of diploids of cdclO-C4, cdclO-129 and wild-type (9721r), 
were made, grown to mid-exponential stage of growth at 24°C, and 
subjected to a temperature shift to 35 0C. Samples of cells were taken at 0 
and 3 1 /2 hours, and total RNA extracted. The RNA was separated on a 
formaldehyde gel and transferred to GeneScreen membrane. The 
Northern blot was hybridized with cdc22 and adh1 probes. (Section 4d). 
Lane numbers represent the following: 1, wild-type; 2 and 9, cdclO-C4; 
3 and 10, wild-type/wild-type; 4 and 11, wild-type/cdclO-C4; 5 and 12, wild-
type/cdclO-129; 6 and 13, cdcl0-1291cdc10-C4; 7 and 14, cdclO-1291cdclO-129; 
8 and 15, cdc10-C41cdcl0-C4. 
5j Conclusions 
The cdc1O gene product, p87CdC10, is a component of DSP1. The 
binding properties of DSP1 are specifically affected in cdclOts mutants after 
both in vivo and in vitro temperature shifts. DSP1 is supershifted in the 
presence of p87cdclO antibody. 
A mutant form of p87CdC 10, p87CdC10-C4, appears to be constitutively 
hyperactive, resulting in cdc22 over-expression throughout the cell cycle. 
A reporter gene under MCB control is also over-expressed in cdclO-C4. 
This mutant phenotype is genetically recessive to wild-type, but may be 
dominant to cdclO-129. 
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Chapter 6: Discussion 
6 a Conclusions 
The main conclusions from the work presented in this thesis can be 
summarised as follows: 
1 	cdc22 encodes the large subunit of ribonucleotide reductase in 
fission yeast. 
2 	cdc22 contains MCBs (MluI cell cycle boxes) in its promoter 
region. 
3 	MCBs can confer periodic expression on a reporter gene in fission 
yeast, strongly implicating them in the control of cdc22 expression 
during the cell cycle. 
4 	A binding activity, DSP1 (QNA gynthesis control in S. porn be), has 
been identified in fission yeast which specifically binds MCBs, and is 
probably a transcription complex. 
5 	Both MCBs and DSP1 are conserved through evolution, as related 
components are present in budding yeast. 
6 	DSP1 binds to MCBs constitutively during the cell cycle. 
7 	The product of the cdc1O gene, p87CdC10, is a component of DSP1. 
8 	cdc1O and cdc22 are required for START and S-phase, respectively. 
Thus, this work has found a molecular link between these two cell 
cycle stages. 
9 	A mutant form of p87CdClO, p87CdClO-C4, appears to be constitutively 
hyper-active, resulting in cdc22+ and reporter gene over-expression 




A model to incorporate the observations on cdc22 and cdclO+ made 
in this thesis is represented in Figure 6A. 
A transcription complex, DSPI, probably containing a number of 
components, including the gene product of cdc1O, p87CdC10, binds MCBs in 
the promoter region of cdc22. DSP1 binds to the MCBs constitutively 
during the cell cycle. At the G1-S phase boundary DSP1 is activated by 
unknown processes, which cause it to stimulate transcription of cdc22. 
For the remainder of the cell cycle DSP1 is in an inactive form, resulting in 









Figure 6 A 	DSP1 control of cdc22 expression at the Gi-S  phase boundary 
in fission yeast 
6 c Problems with the model 
i 	Introduction 
Although the model presented for the observations on cdc22 and 
cdclO+ does explain the results, there are a number of unanswered 
questions and loose ends. In this part of the discussion I will highlight 
these problems, speculate a little, and suggest experiments that could 
resolve them. 
ii 	What is the constitution of DSP1? 
Bandshift assays using DNA substrates containing MCBs with 
fission yeast protein extracts have identified a specific binding activity, 
which we have called DSP1. A component of DSP1 is the product of the 
cdc1O gene. How representative of the 'real' DSPI complex present in 
vivo, is this in vitro binding activity? 
In temperature shifts with cdcl Ots mutants DSP1 is thermolabile, 
disappearing at the restrictive temperature, and so behaves in vitro as we 
would expect it to in vivo. However conditions, such as protein 
concentrations, are almost certainly different between the cell and the test 
tube. Consequently DSP1 could contain more components in vivo, which 
are not present in the complex detected by bandshift assays. Futhermore, 
DSP1 normally binds chromatin and not small fragments of DNA, which 
is likely to modify itbinding properties. Interpretations of bandshift assays 
have to be made, therefore, with caution. 
DSP1 has a very low mobility in bandshift assays and so is likely to 
be a large proteir Faster mobility complexes are also detected which are 
competed by MCBs (Figs. 4G and 41), and so are likely to be partial forms of 
DSPI. Thus DSP1 is probably a protein complex containing a number of 
components. The faster mobility complexes are not supershifted by 
p87CdC10 antisera (Fig. 5E and Lowndes et al., 1992a), arguing that there are 
other polypeptides beside p87CdC10 in DSP1. 
There are other reasons for suspecting the presence of additional 
components in DSP1 to p87CdC10 . A novel type of transcription complex 
has been recently characterised from rat liver nuclei, called GABP 





Figure 6 B 	Potential similarities between GABP and DSF1. 
The GABP transcription complex is a heterodimer consisting of two a and 
two 3-subunits. The a-subunits contact DNA and confer binding specificity. The 
subunits contain t i  the ankyrin motif, which binds them to the a subunits and hold the 
the complex together. 7cdC1O in DSP1 contains ankyrin motifs and so is possibly a 
3-type subunit. DSPI requires two MCBs to bind DNA, which suggests that it may be 
dimeric in form. After Thompson etal., 1991. 
related to DSP1. GABP was originally identified as a factor that is required 
for VP16-mediated activation of herpes simplex virus immediate early 
genes (Trienzenberg et al., 1989). GABP consists of a heterodimer of two 
a and two 13-subunits (Fig. 6B). The a-subunits contact DNA and confer 
DNA sequence binding specificity, whereas the 13-subunits bind the 
a subunits, and hold the two dimers together. DSP1 may be related to this 
type of transcription complex as p87CdC10 shares a motif, the 'cdclOISWI6 
'or 'ankyrin motif', with the 13-subunit of GABP. This motif is thought to 
important in mediating protein-protein interactions in a variety of 
multiprotein complexes, but specifically in GABP by binding the 13-subunit 
to the a-subunit, as deletion of cdcl0/SWI6 motifs abolishes this binding 
(Thompson et al., 1991). Furthermore, the predicted cdclO polypeptide 
does not contain any obvious DNA binding motifs (Ayes et al., 1985). If 
DSP1 is related to this type of transcription complex, DSPI may contain 
two molecules of p87CdClO and two molecules of an a-type subunit (Fig. 
6B). 
Two genes which when mutated can suppress cdclO mutants have 
been independently characterised, and called sctl + and sdcl + (Marks et al., 
1992; Caligiuri & Beach, 1992). Mutant forms of both genes are able to 
suppress cdcl QtS  mutants as well as a cdcl 0+ deletion (cdcl Oil). sdcl + has 
been cloned and sequenced, and is essential for viability (Caligiuri & 
Beach, 1992). Its predicted amino acid sequence shows similarity to the 
predicted cdclO polypeptide. sdc1 and sct1 are almost certainly the same 
gene as they map to same position on chromosome II (V. Simanis, pers. 
comm.). 
What is the role of sdcl+?  Does it encode another component of 
DSP1? To prove this formally would require ts mutants or specific 
antibody to the gene product of sdc1, sdcl, to do similar experiments to 
those completed on cdc10 (Chapter 5). Perhaps wild-type DSP1 contains 
molecules of p87CdClO and sdcl. One could then explain sdc1 mutants' 
ability to suppress cdclOil and cdclOts mutants, by the mutant forms of sdcl 
being able to functionally replace p87CdC 10 in DSPI. DSP1 is not, however, 
detected by bandshift analysis in sctl-1 cdc10E, cells W. Simanis, pers. 
comm.). 
The genetic screens that obtained both sdcl + and sctl + used 
cdclO-129 as starting strain, which would have determined the type of 
suppressor mutations isolated. Different suppressors, as well as sdcl + and 
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sct1, might be obtained if cdclO-C4 was used instead as the starting strain 
in a similiar screen, as this mutant has strikingly different regulatory 
properties to cdclO-129. 
If DSPI is related to GABP, and p87Cdc10 a 3-type subunit, are there 
a-type subunits? One possibility is that sdcl is an a-type subunit. 
However, considering the similarity between the predicted gene products 
of sdc1 and cdc1O this seems unlikely, a-type subunits contact DNA, and 
confer binding specificity (Thompson et al., 1991): thus there are two 
possible experimental routes to isolate such DNA binding proteins. 
DNA binding proteins have been isolated by using UV crosslinking 
techniques (Chodosh, 1988). This approach has already proved successful 
in isolating one partner to Swi6 in DSCI (Dirick et al., 1992). The cdc22 
promoter fragment containing four MCBs (Section 4e) would be mixed 
with yeast cell extracts and separated by electrophoresis, as in bandshift 
assays. The DSP1 /DNA complex would then be irradiated with UV light 
which covalently binds proteins bound to the DNA, the band excised after 
autoradiography, digested with DNAse I, and analysed by SDS-PAGE 
electrophoresis. Any p87CdC 10  binding to the MCBs would be identified by 
specific antisera, while other components could be identified by silver 
staining. 
Other components of DSPI could be detected by Southwestern blot 
analysis (Miskimmins et al., 1985) using the cdc22 promoter fragment as 
probe with total fission yeast protein extracts. If polypeptides were 
• 	detected, this would suggest that the DNA binding component of DSP1 can 
bind DNA by itself. As a precedent for this, the a-subunit of GABP can 
bind DNA in the absence of the 3-subunit (Thompson et al., 1991). If the 
DNA binding part of DSPI can bind DNA by itself this could permit its 
cloning, by probing a fission yeast A.gtll expression library with the cdc22 
promoter fragment (Young & Davis, 1983). 
If DSP1 is normally composed of sdcl and p87CdClO, what are their 
functional roles in the complex? One could be a positive regulator and the 
other a negative regulator of cdc22 transcription. Clues to the roles of 
these two polypeptides may be given by the following two experiments. 
Is cdc22 transcript periodically expressed in sdcl cdclOA cells? If 
cdc22 is periodically expressed in such cells, this would argue that mutant 
sdcl can act as an inducer of transcription. 
Can sdcl suppress the over-expression of cdc22+ transcript in 
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cdclO-C4? If cdc22 transcript is not over-expressed in sdcl cdclO-C4, this 
argues that mutant sdcl can act as a repressor of transcription. 
The interpretations about the role of sdcl + that can be made from 
these experiments are limited, as the effect of mutant sdcl would be 
analysed. Mutant sdcl may well behave differently to wild-type sdcl . 
iii 	What does DSP1 bind in the cdc22 promoter? 
Bandshift experiments have conclusively shown that DSPI 
specifically binds multiple MCBs in DNA fragments from the promoter 
region of cdc22 (Chapter 4). DSPI recognizes two fragments of DNA both 
containing clusters of MCBs, one 5' and one 3' to transcriptional start (Figs. 
4C and D). The cluster of MCBs 5' to transcriptional start is most likely to 
be relevant for cdc22+ expression, as it is in the conventional position for 
yeast cis-acting elements. However, both clusters may be required for 
complete and periodic expression of cdc22 transcript. Key questions are: 
which cluster of MCBs does DSP1 bind in vivo; and, is one or are both 
clusters relevant to the control of cdc22 expression? 
These questions could be tested by cloning the whole cdc22 
promoter region into pSPM78, mutating single MCBs by site-directed 
mutagenesis, and assaying their effect on lacZ transcript expression. The 
core GC of each MCB could be changed to AT, as we know these base 
changes abolish binding of DSP1 to DNA, from bandshift experiments 
(Fig. Q. 
Promoters of yeast genes expressed by RNA polymerase II contain 
two types of 5' cis-acting elements that stimulate general transcription 
complexes to induce expression of genes, depending on their position 
relative to transcriptional start (Section lf.i). The first type are proximally-
placed and are position-dependent. The second type are distally-placed 
and are orientation and position-independent; these cis-acting elements 
are related to metazoan enhancers have been named UASs, for upstream 
activating sequences. What type of cis-acting element are MCBs? 
The cdc22 promoter region contains two clusters of MCBs, one 5' 
and one 3' to transcriptional start. The 5' cluster is -160 nucleotides 
upstream of transcriptional start, and so could be either a proximal type 
cis-acting element or a UAS. The 3' MCB duster, if it is relevant to 
transcription, cannot be defined as it is unprecedented in yeast for cis- 
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acting elements to be in such a position. 
MCBs, when they are MluI restriction sites are palindromes, and so 
have no intrinsic orientation. The MCB trimer in pSPM78.3M, being 
palindromic, presumably stimulates lacZ transcription when present in 
either orientation. To show that MCBs are also position independent, and 
so are UASs, would require demonstrating that lacZ expression is not 
affected by insertion of extra DNA between the MluI trimer and the 
cytochrome c promoter. 
The cdc22+ promoter contains seven MCBs, six of which are in two 
dusters. Two of the MCBs are perfect MluI restriction recognition sites 
and the other four are /6  matches, and so the MCB clusters are not 
palindromic. To show that these MCBs can act as UASs would require 
cloning each into pSPA178 in both orientations and demonstrating that all 
DNAs conferred periodic expression on lacZ. 
Although it has been established that DSPI binds MCBs, we do not 
know exactly what region of DNA around the MCBs it binds. This 
question can be answered by DNAse I protection studies ('footprint 
analysis'; Galas & Schmidtz, 1978), which are currently being undertaken. 
Such studies determine the region of DNA protected from DNAse I by 
protein complexes, and so delimit the precise area of protein/DNA 
contact. Preliminary results have identified groups of nucleotides 
protected from DNase I activity by DSP1: they include all four of the MCB 
elements 5' to transcriptional start (Figs. 4C and 4D). 
What is the relationship between DSP1/DSC1 binding and the 
expression levels of MCB genes, in fission and budding yeast? 
DSPI and DSC1 have remarkably similar binding specificities, 
binding MCBs from the promoters of both fission and budding yeast genes 
(Figs. 4G and I). The MCB cluster 5' of cdc22 transcription start contains 
four MCBs, whereas the duster 3' contains two. In budding yeast, DNA 
synthesis genes have been found to have only one or two MCBs 
(Review: Johnston & Lowndes, 1992). 
Two MCBs are required for competition of DSPI and DSC1 in 
bandshift assays (Fig. 4G and I), arguing that both complexes need two 
MCBs for binding. This observation is consistent with the proposal that 
DSPI and DSC1 are related to the GABP type transcription complex which 
has two regions of contact (Fig. 8B). However, reporter gene experiments 
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in both budding and fission yeast have demonstrated that three tandem 
MCBs are required in for significant expression of lacZ transcript to occur 
(Lowndes et al., 1991; Section 4c). These contradictory observations may be 
reconciled if spacing of MCBs is important for expression. Two MCBs, 
which are a certain distance a part, might only be required to stimulate 
gene expression. This hypothesis could be tested by replacing the middle 
MCB by random DNA of the same size in pSPM78.3M, and assaying its 
effect on lacZ expression. 
iv 	cdclO-C4 
The cdclO-C4 mutant presents an apparent paradox. In these cells at 
the permissive temperature cdc22 transcript is constitutively over-
expressed, but DSP1 is not detectable in vitro by bandshift assay (Sections 
5b, 5c and 50. How can DSPI induce over-expression of cdc22 if it cannot 
bind its promoter? Bearing in mind that DSP1 in vitro may not be 
representative of DSPI in vivo (Sections 6c.ii and 6c.vi), there are two 
possible explanations. 
First, that DSPI, containing mutant p87CdC10 C4, has altered binding 
affinity for MCBs in vivo. Such altered binding coincidentally results in 
over-expression of cdc22, but is not detectable by bandshift assay. 
Second, that p87CdClO-C4 binds MCBs by itself. In the absence of other 
components of DSPI p87CdClOC4 causes over-expression of cdc22. This 
hypothesis would argue that p87CdC10 C4 is an inducer of cdc22 
transcription. Against this explanation no complexes of faster mobility, 
containing p87CdC10 C4, are observed by bandshift in cdclO-C4 cells. The 
hypothesis can however be tested. If the sdcl+ gene product is another 
component of DSP1 (Section 6c.ii) one possibility is that p87CdC10 C4 does 
not interact with this molecule at the permissive temperature. Can, 
therefore, mutant sdcl suppress cdc22 over-expression in cdclO-C4? 
The phenotype of over-expression of cdc22 in cdclO-C4 is recessive 
to wild-type, but may be dominant to cdclO-129 (Section 50. This 
difference may reflect alterations in the binding affinity to MCBs of the 
three forms of DSP1 present in these strains. If this interpretation is 
correct wild-type DSPI would have the highest affinity and bind 
preferentially to the cdclO mutant forms, resulting in the wild-type levels 
of cdc22 transcript; and the cdclO-C4 form of DSPlwould have higher 
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affinity than the cdclO-129 form, consistent with the observed over-
expression of cdc22. If this is true, and the cdclO-C4 form of DSP1 has 
higher affinity than the cdclO-129 from, the inability to detect DSP1 in 
cdclO-C4 by bandshift assays becomes even more inexplicable. 
v 	Are there other genes under DSP1/MCB control? 
In budding yeast a large group of genes required for DNA synthesis 
has been identified which are coordinately expressed at the G1-S phase 
boundary, and are under DSC1/MCB control (Johnston & Lowndes, 1992). 
In fission yeast cdc22 is the only gene known that is periodically 
expressed, and under DSP1 /MCB control. Are there likely to be others? 
The genes encoding DNA ligase and DNA polymerase I are 
expressed at the G1-S phase boundary in budding yeast, but the equivalent 
genes in fission yeast are not (White et al., 1986; Johnston et al., 1987; 
Bouvier et al., 1992)). Thus, there is precedent for alternative forms of 
gene expression in the two organisms, and so one cannot predict whether 
other fission yeast DNA synthesis genes will be periodically expressed. 
If cdc22 is the only gene whose transcription requires p87Cdc10 , 
then expression of cdc22 independently of the DSP1/MCB system should 
bypass the requirement for cdcl 0+ function. This hypothesis can be tested 
by introducing cdc22+, constitutively expressed from the nmtl promoter, 
into cdcl0ts strains, and seeing if the cdcl0 cell cycle arrest is alleviated. 
Both cdc22 and the reporter gene lacZ, which contain different 
MCB promoters, are over-expressed in cdclO-C4. Thus, if there are other 
genes under MCB control, they would be predicted to be also over-
expressed in this mutant, which may permit their isolation. A differential 
screen (Leonard et al., 1987; Lee et al., 1990) could be conducted to isolate 
mRNA species that are selectively over-expressed in cdcl0-C4. A cDNA 
library would be made from mRNA extracted from cdcl 0-C4 cells grown at 
the permissive temperature, to enrich for over-expressed mRNAs. 
Replica filter lifts would be hybridized to cDNA probes made from 
cdclO-C4 and wild-type cells, or cdcl0-129 cells grown at the restrictive 
temperature. mRNA species over-expressed in cdclO-C4 would be 
identified by stronger hybridization signals when hybridized to the 
cdclO-C4 probe. Isolated cDNAs would be initially characterised by 
restriction mapping, cdc22 clones discarded, and the DNA sequence 
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determined of the remaining clones. 
Histone 2A1 transcript levels are not affected in cdc10-C4 (Section 
5g) arguing that cell cycle histone expression is controlled by other 
mechanisms than the DSP1 /MCB system. This observation is consistent 
with the presence of alternative cis-acting repeat motifs to MCBs in the 
histone promoters, and the different expression pattern of histones to 
cdc22 during the cell cycle (Matsumoto et al., 1987). Budding yeast 
histones are also expressed independently of the DSC1/MCB system, as the 
transcript levels are unaffected in a SWI6 deletion (Lowndes et al., 1992b). 
Vi 	How does DSP1 induce transcription of cdc22? 
The DSP1 complex, as detected in vitro by bandshift, is invariant in 
amount and mobility during the cell cycle. This excludes the simple 
hypotheses that binding of DSP1, or large conformational changes in DSPI 
bound to MCBs, correlates with transcriptional activation. DSP1 might 
induce cdc22 expression at the G1-S phase boundary by subtle changes in 
binding to the DNA, or by changes in binding by other proteins not 
detected by bandshift, at this cell cycle stage. Such changes may be 
detectable by DNAse I protection ('footprinting') studies. 
Formally we cannot exclude the possibility that DSP1 binds MCBs 
periodically in vivo. Other components of DSP1 required for periodic 
binding may not be present in vitro (Section 6c.ii). Alternatively, DSP1 
may only available for binding MCBs at the appropriate cell cycle stage. As 
an example of the latter, the transcription factor Swi6 has been shown to 
be present in the nucleus only at the cell cycle stage when it induces 
expression of the HO endonuclease (Taba et al., 1991). 
How and what activates DSPI at the Gi-S  phase boundary? 
p87CdC10 is known to be a phosphoprotein (Simanis & Nurse, 1989), 
and so phosphorylation is a potential form of regulation of DSP1 activity. 
This is quite likely, as phosphorylation is a common form of control of 
transcriptional regulators (Review: Jackson, 1992). 
Gross phosphorylation levels of p87CdC10 have been shown to be 
invariant during the cell cycle (Simanis & Nurse, 1989). The principal 
phosphorylation site of p87CdC10  has been mapped to serine 196 (Deuschle 
& Beach, 1992). Permanent dephosphorylation of this site, by mutating the 
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serine to an alanine, reduces the ability of cdc1O-A196 to complement 
cdclO-129, and is accompanied by reduced DSP1 binding activity in vitro 
(Deuschle & Beach, 1992). Neither the phosphorylation state of serine 196 
during the cell cycle, or the effect of permanent dephosphorylation of 
serine 196 on cdc22 expression patterns during the cell cycle, have been 
reported. Phosphorylation of serine 196 is inessential for cell cycle 
progress, so perhaps there are different changes than phosphorylation of 
p87cdC10, or it is phosphorylation of other components of the complex, that 
cause activation of DSP1. 
If phosphorylation of p87CdC10 is important for DSPI transcriptional 
activity, what is the protein kinase responsible? The p34CdC2  protein 
kinase is required for START transition in fission yeast (Nurse & Bissett, 
1981), and is an obvious candidate. However, cdc2 mutants have been 
shown to have no effect on the phosphorylation state of p87CdClO, so 
p34CdC2 is unlikely to be the protein kinase (Deuschle & Beach, 1992). 
vii Are there alternate modes of induction of cdc22? 
As well as being cell cycle regulated, the transcript that hybridizes to 
cdc22 probes has been shown to be induced in cells after treatment with 
the DNA synthesis inhibitor hydroxyurea (P Harris & P. Fantes, pers. 
comm.). There are two possible explanations for this observation. First, 
that cdc22 expression, as well as being cell cycle controlled, can be induced 
by hydroxyurea; second, that cdc22 expression is only cell cycle regulated, 
and there is another gene that is induced by hydroxyurea whose transcript 
hybridizes to the cdc22 probe. 
In budding yeast there are two genes which encode the large subunit 
of ribonucleotide reductase, RNR1 and RNR3, which are differentially 
regulated (Elledge & Davis, 1990). RNRI expression is specifically 
regulated during the cell cycle by the DSC1 /MCB system (Elledge & Davis, 
1990). RNR3 is coordinately induced with RNR2, which encodes the small 
subunit of ribonucleotide reductase, after treatment with drugs that 
damage DNA or block DNA replication by alternative cis and trans 
components (Elledge & Davis, 1989; 1990). 
A cdc22 related gene could be detected by low stringency Southern 
blot analysis, and cloned by probing a genomic library under similar low 
stringency conditions. 
If cdc22 is the only gene encoding ribonucleotide reductase in 
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fission yeast, is the hydroxyurea induction mediated through the 
DSPI/MCB system, or by different transcription factors binding MCBs or 
other parts of the cdc22 promoter? The former hypothesis could be tested 
by assaying the effect of hydroxyurea on lacZ transcript in pSPM78.3M 
carrying cells. The promoter of lacZ in this test plasmid only contains 
MCBs, so if induction was observed it would have to occur via MCBs. 
Such induction could occur through DSP1 or another transcription 
complex binding to MCBs. Induction of cdc22 transcript independent of 
the DSP1/MCB system could be tested by cloning the whole cdc22 
promoter region 5' to lacZ in pSPM78, and then assaying lacZ expression 
after hydroxyurea treatment. The promoter region required for 
hydroxyurea induction outwith the MCBs could be delimitated by 
mutation studies. 
viii What other roles might cdclO4 have in G1? 
The cdc1O gene is essential for cell cycle progress, and when 
mutated results in cdc arrest at START. The cdc1O gene product, p87CdC1 O, 
is a component of DSP1 which, as a transcription factor, controls the 
periodic expression of cdc22 at the G1-S phase boundary. At the 
restrictive temperature cdclOts mutant cells cdc arrest, while there is no 
correlative reduction in cdc22 transcript (Fig. 5F). p87CdC10 may, therefore, 
have other roles to cdc22+ induction which are required for cell cycle 
progress. What might these be? 
The gene product with the analogous role to p87CdC10 as part of DSC1 
in budding yeast is Swi6 (Lowndes et al., 1992b; Dirick et al., 1992). Swi6 is 
also part of the distinct transcription complex which controls expression of 
Gi cydins, CLNs (Fig. iF). Expression of CLNs is required for cell cycle 
progress in budding yeast. If cdc1O has further analogous roles to SWI6, 
one could explain its cell cycle requirement because it controls Gi cydin 
expression in fission yeast. 
One putative fission yeast G1 cyclin, puci +, has been isolated 
(Forsburg & Nurse, 1991). One could test if cdc1O controls puc1 
expression, by analysing the effect of cdclO mutants on pucl+ transcript 
levels. 
Both the predicted cdcl 0 and S W16 polypeptides have ankyrin 
motifs, and so are likely to be f'-type subunits in DSP1 and DSC1, 
respectively (Fig. 6C). Swi6 is part of three complexes which stimulate 
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transcription of three groups of genes: DSC1 binds MCBs to induce DNA 
synthesis genes; Swi6 with Swi4 bind CCBs to induce CLNs (Fig. iF), and 
Swi4 and Swi6 have recently been shown to control expression of a 
chitinase gene (CTS1). This alternate gene induction could be conferred by 
different cc-type subunits in the three complexes, with binding specificity 
to either MCBs, CCBs or the CTSI cis-acting element. Potentially, p87CdClO 
could control cdc22+ and G1 cyclin expression by a similar mechanism. 
S W16 or S W14 singly are inessential for division, whereas deletion 
of both genes is lethal. cdc1O by itself is essential. The predicted cdclO 
polypeptide has modest similarities with both SW14 and SWI6 (Breeden & 
Nasmyth, 1987a; Andrews & Herskowitz, 1989b). These observations can 
perhaps be explained if cdcl 0+ carries out the functions of both S W16 and 
5W14 in fission yeast. 
6d General considerations 
i 	Why is cdc22 cell cycle regulated? 
Expression of a number of genes has been found to be cell cycle 
regulated. Examples include the G1 cydins, CLNs, of budding yeast 
(Wittenberg et al., 1990), cdc25 of fission yeast (Moreno et al., 1991), and 
the mitotic cyclins of clam (Evan et al., 1983). There are three potential 
reasons why gene expression is cell cycle regulated. 
1 	Activity of the gene product is rate limiting for cell cycle 
progress. Thus, expression of the gene at a particular cell cycle stage allows 
passage through that stage. An example of this is cdc25. At the end of the 
G2 phase a critical amount of p80cdC25 is required to dephosphorylate 
p34CdC2 and and activate it, to permit mitotic onset (Section le.i). 
2 	A gene product is periodically expressed, because its gene 
product would have a deleterious effect if present at the 'wrong' time 
during the cell cycle. Cyclins provide an example. It has been proposed 
that there are Gi and G2 specific cyclins, in budding yeast - CLNs and CLBs, 
respectively - which bind and activate p34CdC2  at different time during the 
cell cycle (Reed, 1991). CLNs are expressed only during G1, bind to p34CdC2 
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and activate it perform G1 roles; CLBs are expressed only during G2 and 
activate p34cdc2  to do C2 roles. If this hypothesis is true, inappropriate 
expression of cyclins would obviously have serious consequences to the 
cell, as p34CdC2  would complete cell cycle functions when it shouldn't. 
Consistent with this hypothesis is the observation that puci , a putative 
fission yeast C1 cyclin, when over-expressed causes a delay in mitosis 
(Forsburg & Nurse, 1991). 
3 	Periodic expression of some genes has evolved as a form of 
cell economy, with expression being merely coincident with peak 
requirement. This explanation suggests that such periodic expression has 
a subsidiary role in controlling cell cycle progress. 
cdc22 transcript is constitutively over-expressed in cdclO-C4 at the 
permissive temperature, when the cells are able to complete apparently 
normal cell cycles. This argues that absolute levels of cdc22 transcript are 
not rate limiting for cell cycle progress, as S-phase onset occurs normally. 
Fission yeast has a very short G1 period, so constitutive over-expression of 
cdc22+ may induce a premature onset of S-phase that is undetectable. Gi is 
extended in weel mutants (Nurse, 1975), so an effect of abnormal cdc22+ 
expression on S-phase onset may be detectable in these cells. One could do 
this by comparing the timing of S-phase onset in a weel cdclO-C4 double 
mutant with the weel single mutant. 
As cdclO-C4 cells complete normal cell cycles, the presence of cdc22 
gene product at cell cycle stages other than the Gi-S  phase boundary is 
presumably not deleterious. Thus, cdc22 transcript may be periodically 
expressed for cell economy. 
ii 	Is the DSPIJMCB system likely to be found in higher eukaryotes? 
Molecular mechanisms found to common to both budding and 
fission yeast have often subsequently been shown to present throughout 
the animal kingdom. How conserved is the DSP1 /MCB system between 
the two yeasts, and is it present in higher eukaryotes? 
The DSP1/MCB systems are, to an extent, closely related in the two 
yeast species. MCBs are related in DNA structure in the two yeasts. 
Furthermore, DSC1 and DSP1 are similar in mobility, and the binding 
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specificities of the complexes are extremely similar under bandshift 
conditions (Fig. 4G). Indeed DSC1 can bind fission yeast MCBs and DSP1 
can bind budding yeast MCBs, so in terms of DNA binding specificity, as 
determined by bandshift, the two complexes are indistinguishable. 
There are differences between DSP1 /MCB systems of the two yeast 
species. DSP1 binds MCBs constitutively during the cell cycle (Fig. 4M) 
whereas DSCI was originally reported to bind MCBs periodically (Lowndes 
et al., 1991). Recently, however, DSCI has been found to bind invariantly 
in synchronized cells after a-factor block and release (Dirick et al., 1992). 
So the mechanism by which the two complexes induce periodic expression 
of their target genes may or may not be different. 
p87cdC10 and Swi6, components of DSPI and DSC1, respectively, are 
related (Breeden & Nasmyth; 1987a; Andrews & Herskowitz, 1989b). 
However, neither can genetically complement the other, and antibodies to 
p87CdC10 do not supershift DSC1, and vice versa (L. Johnston, pers. comm). 
As the DSPI/MCB systems in the two yeast species are quite similar, 
so related components would be expected to present in higher eukaryotes. 
In mouse the genes encoding both subunits of ribonucleotide reductase are 
periodically expressed in parallel, with strong maxima in early S-phase 
(Engstrom et al., 1985; Bjorklund et al., 1990). No MCBs have been 
observed in the promoter region of either gene, so these two genes are 
likely be regulated by/different common cis-acting elements (L. 
Thelander, pers. comm.). The nearest known analogous metazoan 
transcription factor to DSP1 /DSC1 is E2F, which has the target sequence 
TTTCGCGC (Mudryj et al., 1990). E2F is active in late Gi and has binding 
sites in the dihydrofolate reductase gene, which is expressed under cell 
cycle control (Farnham & Schimke, 1985). A polypeptide of similar size to 
p87CdC10  is recognized in human cells with antisera to p87CdC 10 (Simanis & 
Nurse, 1989), although the significance of this observation is not yet 
understood. So it would seem at present that homologues of the 
DSPI/MCB system have not been characterised. It will be interesting to 
see in the future if related components are found. 
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Appendix A: Oligonucleotides 
This list contains all the oligonucleotides referred to in the text of 
the thesis. 
The nucleotide sequence and annotation of each oligonucleotide is 
shown. The position and orientation of those oligonucleotides relative to 
pCDC22-1 (A-N) are shown in Figure A. Oligonucleotides 0 and P were 
used for the amplification of DNA fragments cloned into pSPA178. Two 
pairs of oligonucleotides were used for amplifying probes: Q and R, for 
cdc1O; and S and T, for histone 2A1. 
Each oligonucleotide is shown 5'- 3'; ,-dotted underline indicates 
extra DNA, and underline indicates restriction sites for cloning. 
All oligonucleotides were made by the Oswell DNA Service, 
University of Edinburgh.  
c'J 	c.1 
> 	 > c'J 	> 
F Ca 	•o 	E 	• 0 0 
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Figure A Schematic diagram of pCDC22-1, and an enlargment of the 
promoter region of cdc22, showing the position and 
orientation of oligonucleotides used in experiments. The 






A GATCAACATGATCGGAAT 721J 
B ACACGCGGTCCAACCGA 723J 
C AGCGGAACITIGATGTFC 722J 
D AGATCATAGCACACACAT 720J 
E GACGACCACGGTFCTCCT 719J 
F GCGATTCCTGAAATFCCT 131H 
G CACAATTATGTATGTCGA 322L 
XhoI 
H X.GCCTCGAGGTAGTFCAATCTCATAGA 716K 
I cc.CTCGAGCTCTGTTFACGACTGAATG 832L 
CATTCAGTCGTAAACAGAG 831L 
CGCCTCGAGCA1TCAGTCGTAAACAGAG 321M 
K X...XCTCGAGCCGCTAAAATAAGTCCGA 715K 
L GGTGGTAAATACCGGGAA 041M 
CGCCTCGAGGGTGGTAAATACCGGGAA 323M 
M CATTGATCAACATGACTTAAAG 040M 
cc.GCCTCGAGCATFGATCAACATGACTTAAAG 322M 
N UCCCGGTATFTACCACCTF 407T 
pSPA178 oligonucleotides 
o CACGCCTGGCGGATCTG 	 839M 
P CTAAACTCACAAATTAGAGC 	 661N 
cdc1O oligonucleotides 
BamHI 
Q ççç. GGGATCCTTATGCTTGATGTFCTTT 	 404L 
XbaI 
R ccGCTCTAGACATATGGCTTCAGCCAATFTT 	405L 
Fission yeast histone 2A1 oligonucleotides 
S . GTCTGGAGGTAAATCTGGTG 	 231T 
T CAGCTCCTGACTAGGC1TFC 232T 
MluI trimer 
This 36 nucleotide double stranded synthetic oligonucleotide 
contains three MluI restriction sites separated by XhoI restriction sites, and 
XhoI sites at each end. It was inserted into the XhoI site of pSPM 78 
(Lowndes et al., 1992a). One strand is shown. 
XhoI 	Miul 	XhoI 	MIuI 	XhoI 	MluI 	XIwI 
5' - CTCGAGACGCGTCTCGAGACGCGTCTCGAGACGCGTCTCGAG -3' 
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Control of DNA synthesis genes 
in fission yeast by the cell-cycle 
gene cdclO' 
Noel F. Lownd es *, Christopher J. McInerny'', 
Anthony L. J ohnson *, Peter A. Fantes1 
& Leland H. Johnston * 
Laboratory of Yeast Genetics. National Institute for Medical Research. 
The Ridgeway. Mill I-till, London NW7 1AA, UK 
Institute of Cell and Molecular Biology. University of Edinburgh. 
West Mains Road, Edinburgh EH9, UK 
IN the budding yeast Saceharomyces cerevisiae, cell-cycle control 
over DNA synthesis occurs partly through the coordinate 
expression in late Cl phase of many, if not all, of the genes 
required for DNA snthesis' 3 . A cis-acting hexamer element 
ACGCGT (an .%'Ilul restiction site) is responsible for coordinating 
transcriptional regulation of these genes at the Cl/S phase boun-
dars"4 and we have identified a binding activity, 1)SCI, that 
recognizes these sequences in a cell-cycle-dependent manner'. In 
the distantly related fission yeast 5 Schizosaccharomyce.s pombe. 
only one of the known DNA synthesis genes.,cd22 which encodes 
a subunit of ribonucleotide reductase, is periodically expressed in 
late G  (ref. 6). The promoter region of cdc22 has two .'.iiul sites 
and five related sequences, suggesting that similar controls over 
DA synthesis genes could occur in fission yeast. We report here 
a binding activity in fission yeast that is very similar to DSCI in 
budding yeast. We also show that the fission yeast cdclO gene 
product, which is required for Start and entry into S phase 7 ' 8, is 
a component of this binding activity. 
We initially established that Miul motifs (Figs ]a and 2a) 
are physiologically significant in fission yeast. A plasmid con-
taining three synthetic Miul sequences linked to the Escherichia 
coil iacZ gene was transformed into a wild-type strain and the 
cell-cycle expression of the iacZ transcript was examined in a 
synchronous culture (Fig. 16). LacZ is expressed periodically. 
In the first cycle, expression of !acZ is slightly perturbed as it 
does not coincide precisely with cdc22 expression, which is 
similar to our results with budding yeast'. But in the second 
cycle and even at the beginnings of a third cycle, !acZ and 
cdc22 are expressed in the same intervals of the cell cycle. 
Thus MIul sequences can confer expression in late Cl to a 
heterologous gene in S. pombe, as they do in budding yeast. 
To detect a binding activity in S. pombe that recognizes Mlul 
motifs, we used a probe containing three tandem Miul site 
repeats in gel retardation assays. With this probe we detect a 
binding activity in fission yeast which, like the budding yeast 
DSCI activity, produces a retarded complex of very low mobility 
(Fig. 2h, lane I I. Furthermore, the specificity of the fission yeast 
activity is essentially identical to that of DSCI (Fig. 26), hence 
it will he referred to as 'DSCI-like. In both cases the uppermost 
retarded complex is specifically competed away by multimeric 
copies of the Mlul sequence, ACGCGT (Fig. 26. lanes 2,3 and 
17, 18(, but not by multimeric copies of a mutated version of 
this sequene, ACtaGT (Fig. 2h, lanes 4,5 and 19, 20), nor by 
multimeric copies of a similar oligonucleotide containing an 
unrelated hexamer, ATGATT (Fig. 26, lanes 14, 15 and 29, 30). 
Therefore, both binding activities recognize the AC'GCGT core 
itself and not other sequences found on the oligonucleotide used 
as a probe (see legend to Fig. 2(. 
The 132-base pair (bp) and 134-hp fragments from the cdc22 
promoter containing four and two Mlu I elements (Figs 1 a and 
2a), respectively, each compete successfully for binding of both 
the budding yeast DSCI activity and of the fission yeast DSCI-
like activity (Fig. 26; compare lanes 8-11 and 23-26). Thus both 
activities recognize .ttIu I motifs in their normal sequence context 
= To wtOo cOrresporwerce sTo..i he 3ad,essea 
NATURE VOL 355 . 30 JANUARY 1992  
'I 
\AATFAcIIAC;ii(AA\ I (i(Ai \i..A(.( \(( iiI..(. IA(iRGCC., iiOGA(,j,ICl 
Ii ,\ATiTATGTAAACAUTCG((IU_'[i((AA ii (,AC.4CGCGTAAA1 A/SAl ATTI 
A ..S1-E-rATFACAT7CAGTCGTAAACAGAC]AIIIAIAAACACIIII ii IATGrnAA1 







TCCCGGTA1717ACCACCTFACAAACT ACAACAAACAC OATG 
(mm) 
LacZ 
— 	— '--ø cdc22 










FIG. 1 a. The DNA sequence of the S. pombe cdc22' promoter region. The 
likely ATG at the start of translation is shown in bold and the asterisk marks 
the start of transcription (C.J.Mcl. and P.A.F., manuscript in preparation(. The 
two M/ul sequences, ACGCGT, are italicized and underlined and the near-
match sequences that are likely to be significant 2 are also underlined. b. 
M/ul motifs confer periodic expression on a reporter gene in S. pombe. 
Northern blot analysis of RNA was carried out on cells synchronized by 
elutriation and containing a test plasmid with three ACGCGT sequences 
linked to IacZ The transcript levels of (acZ and cdc22 are shown together 
with alcohol dehydrogenase (ADR), which acted as a control to show that 
the gel loading was even. The times in minutes at which samples were 
taken are shown above each lane. Note that the RNA in lane 1 was degraded 
during preparation. The lower panel shows the increase in cell numbers 
during the experiment. 
METHODS. The budding yeast test plasm(d pLGM78.3M 1 containing three 
repeats of the M/ul sequence makes use of the S. cerevisiae cytochrome 
c minimal promoter which would be expected to function in S. pombe9 . As 
it also carries the S. cerevisiae URA3 gene which can be selected in a S. 
pombe ura4 mutant, the plasmid was adapted for use in fission yeast. The 
S. cerevisiae 2 I.Lm origin of replication was removed by digestion with EcoRl 
and replaced by ARS6. a S. pombe chromosomal origin of replication. The 
resulting vector, pSP.178.3M. was transformed into S. pornbe h ura4 and 
synchronized by elutriation ° . Cell numbers were monitored using a Coulter 
counter and samples were removed at intervals (circled points in the lower 
panel). RNA extraction, northern blotting and probing have been described'0. 
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as they occur in the cdc22 promoter. Similarly, the fission yeast 
binding activity recognized the MluI sites in the promoter region 
of the periodically expressed DNA synthesis gene CDC9 (DNA 
ligase( from budding yeast"'. A 55-hp fragment from this pro-
moter', which Contains a single MIul site and a near-match (Fig. 
2a, competes successfully for binding of both DSCI and the 
DSC I-like activity from fission yeast. (Fig. 2b, lanes 12, 13 and 
27, 28). In contrast, a 166-bp fragment from the cdc22 upstream 
containing only a single M!ul near-match (Fig. 2a( did not 
compete for binding of either the fission or the budding yeast 
activities (Fig. 2h, lanes 6,7 and 21, 22). These experiments have 
been repeated using the 132-hp fragment from the cdc22 
upstream as a labelled substrate, which gives essentially identical 
results (data not shown). In conclusion, the identical competi-
tion profiles for both binding activities, particularly when using 
promoter fragments from periodically expressed DNA synthesis 
genes from these two highly divergent organisms, strongly 
argues that the two binding activities are functionally conserved. 
Mutants defective in the I)SC1 and DSCI-like binding 
activities would greatly facilitate their further characterization. 
As these activities control genes essential for DNA synthesis, 
such mutants might themselves he cell-cycle mutants with execu-
tion points in late GI. In the fission yeast, only cdc2 and cdc10 
are known to act in late GI and prevent DNA synthesis' - "". 
Significantly, the cdc10 gene product is homologous with the 
budding yeast SWI4 and SWI6 gene productsI2L, which are 
believed to he transcriptional activators' Furthermore, they 
actually regulate the cell-cycle specific expression of the HO 
endonuclease (involved in mating type switching) which is peri-
odically transcribed in late GI (refs. ' ). Thus the cdclO gene 
may have a similar function. Consistant with this, cdcIO 
mutants blocked al the restrictive temperature have substantially 
lower cdc22' transcript levels than in wild-type cells (M.J.F-S. 
and P.A.F., unpublished results). We have now found that 
cdclO mutants are also defective in their DSCI-like activity 
(Fig. 3). When cdciO-129 mutant cells are shifted to the restric-
tive temperature there is a rapid loss of DSCI-like binding 
activity which is not observed in similarly treated wild-type cells 
(Fig. 3a, compare lai]es 1-6 with 7-12(. This loss was evident 
after only 5 min at 37 °C and there was no binding activity after 
30 mm, which is well within one cell cycle, so the loss cannot 
be a secondary consequence of a cell-cycle block. 
To confirm this result, we prepared crude extracts from cells 
containing one of three edelO mutant alleles grown at the 
permissive temperature. Extracts were incubated at 28 'C for 0, 
5, 10 and is min before assaying their binding activities (Fig. 
3h(. In one allele, edc104-4, no DSC I-like binding activity was 
detectable even before the incubation at 28 ' C' (Fig. 3b, lanes 
13-16). which presumably indicates that the protein product is 
extremely unstable. The other two alleles, cdclO-129 and cdc10-
K281 produced much reduced DSC1-like activity, which was 
rapidly inactivated at 28 °c in vitro (Fig. 3h. lanes 5-8 and 9-12). 
This loss of activity is not simply due to inhibition of binding 
in the mutant cells, because mixing extracts from mutant and 
wild-type cells has no effect on wild-type activity (Fig. 30. 
Furthermore, three revertants of cdclO- 129 that are able to grow 
at 37 'C contained binding activity that was insensitive to the 
temperature shift (Fig. 3d, lanes 1-6). Finally, introduction of 
a plasmid carrying the cdclO gene into the cdelO-129 mutant 
strain fully restores the binding activity at the restrictive tem-
perature (Fig. 3d. lanes 7 and 8). Thus the temperature-depen-
dent loss of DSC I-like activity in cdcIO cells seems to be due 
to a temperature-sensitive gene product and suggests strongly 
that the cdcIO protein is directly involved with the binding 
activity. 
To determine whether the cdc10 gene product itself is a 
component of the fission yeast DSCI-like activity, we used 
anti-cdcIO polyclonal serum, which when added to a binding 
reaction caused a super-shift of the DSC I-like retarded complex 
(Fig. 4a, lanes 3-7, an effect not seen with preimmune serum 
(Fig. 4a, lane 2(. When high concentrations of the anti-cdc10' 
serum were used, the super-shifted complex did not even enter 
a polyacrylamide gel (Fig. 4a, lanes 3,4), but in agarose its 
electrophoretic mobility increased when the serum was diluted 
(Fig. 4b, lanes 3-7), presumably because fewer of the available 
epitopes are bound. This shows that the cdclO' gene product 
is itself part of the fission yeast DSCI-like activity. 
Given the homology of cdc1O with SWI4 and SWI6, the 
cdc10 protein is very likely to he a transcription factor. Also, 
the occurrence of the 'SWIó-cdclO" motif (also known as the 
'ankyrin' repeat) in these three proteins' 2 ' 3 ' suggests that they 
may be analogous to the [3-subunit of the recently characterized 
heteromeric GABP transcription factor"'. The cdc10 protein is 
probably not the only component of the fission yeast MIul 
binding activity as several of the retarded species shown in 
Fig. 2h are competed out by t,1c22 and CDC9 upstream 
fragments. Whereas the faster migrating species are partly due to 
proteolysis of the uppermost complex (see legend to Fig. 2), 
it could be significant that only this uppermost species is 
absent in cdclO mutants and it alone is affected by the 
cdc/O antiserum. 
The striking similarity between the mobility and specificity of 
the budding and fission yeast DSCI activities argues that these 
binding activities have been functionally conserved in both 
organisms. But much of the molecular detail has to be estab-
lished, for instance the similarity between the proteins in the 
retarded complexes (the cdclO' antiserum we used did not bind 
to the huddng yeast complex) and the regulation of the binding 
activities. As the cdclO' gene product is a phosphoprotein'', 
the cdc2' protein kinase might he involved in its phosphorvla-
tion. When edclO is present on a high-copy-number plasmid, 
the level of the DSC1-like activity is not increased significantly , 
above the wild-type level (Fig. 3(1, lanes 7, 8(, which is consistent 
with some form of post-translational control. Alternatively, 
assembly of the complex could be limited by a component other 
than the cdclO' protein. 
It is nevertheless clear that the mechanisms for regulating 
DNA synthesis genes are similar in both organisms and, there-
fore, that this particular aspect of DNA synthesis control is 
conserved. The system is more limited in fission yeast, for 
example its DNA ligase gene cdcI7 is not cell-cycle regulated, 
unlike (DC9 in budding yeast''. Indeed, of the DNA synthesis 
genes known in the fission yeast only ribonucleotide reductase 
(cde22') seems to he cell-cycle regulated'. Interestingly, this 
enzyme is cell-cycle regulated in many organisms (for a review, 
see ref. 20), which suggests that it could he rate-limiting and 
therefore have a widespread role in controlling DNA synthesis. 
Whether it is regulated in these other organisms by a system of 
MIut sites, or related sequences, together with a DSCI-like 
binding activity is not yet clear. However, budding and fission 
yeasts are widely divergent evolutionarily' so that systems 
conserved in both organisms are frequently widespread in 
nature. 
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FIG. 2 Gel retardation analysis showing binding of 	U 	 -5 
specific proteins from S. pombe and S. cerevisiae 
to the ACGCGT sequence element, a, The promoter 
regions of the periodically expressed cdc22 gene 
from S. pombe and CDC9 gene from S. cerev,siae 
and the relative positions of the DNA fragments 	cdc 22+ 
used in competition experiments. The scale is in 
base pairs and numbered relative to the ATG 
codon. Filled boxes represent perfect matches to  
the ACGCGT sequence element, whereas open 
boxes represent near-matches where either the 
A or the I are altered from the MIul consensus2 . 
The wavy arrows represent the position of the 
transcripts for both genes. The 132 bp. 166 bp 
and 134 bp DNA fragments were generated by the 	
CDC 
pot.'merase chain reaction, whereas the 55-bp 
fragment was generated by digestion with Mn/I 
*nd A/ui restriction endonucleases. b, Clarified 
prude extracts were prepared from the S 
cerevisiae strain CG378 and from S. pombe wild-
/ type cells and 20 p.g or 5 p.g aliquots. respectively 
( were used with a 73-bp A/ul/Sau3A fragment 
from pLG.1178.3M as previously described'. The 
competitor DNAs used were as follows (in each 	b 
case a 10-fold and a 100-fold molar excess was I 
used) lanes 1 and 16. no specific competitor; lanes 	 ____ ____ _________ _____ 	
____ r____1 r____ 
2.3 and 17.18 a tetrameric form of the M/ul site 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 	16 1718 19 20 21 22 23 24 25 26 27 28 29 30 
oligonucleotide. 5'-TCGAGACGCGTC-3': lanes 4. 5 
and 19, 20 a tetrameric form of the mutated MIul 
site oligonucleotide, 5'-TCGAGACtaGTC-3'; lanes 
6.7 and 21, 22, the 166-bp fragment from the 
cdc22 upstream: lanes 8. 9 and 23. 24. the 132- 	 W 
bp fragment; lanes 10. 11 and 25, 26, the 134-bp 
fragment; lanes 12. 13 and 27, 28, the 55-bp frag-
ment from the CDC9 upstream: lanes 14,15 and 
taining an unrelated hexamer, 5'-TCGAGATGA'fl'C-
3'. The multimeric forms of the competitor oligonucleotides were generatea 
by ligation and either total ligation products were used or the tetrameric 
form was purified by gel electrophoresis. The small arrowhead indicates the 
specific DSC1 and DSC1-like retarded products, the larger arrowhead indi-
cates the unbound probe. Brackets indicate specific retarded species, which 
may correspond to proteolytic products of the uppermost retarded com-
plexes as gradual loss of these due to proteolysis is accompanied by a 
concomitant increase in the faster-migrating species (unpublished observa-
tions). The fission yeast activity is more readily detectable in crude extracts 
FIG. 4. The DSC1-like activity of S. pombe contains the cdclO' gene product. 
Binding reactions were allowed to equilibrate as before' (see also legend 
to Fig. 2) and then further additions were as follows: lane 1. binding buffer; 
lane 2. 1/12.5 dilution of pre-immune serum; lanes 3-7. a dilution series 
of anti-cdc10 serum, 1/12.5, 1/25, 1/50, 1/100. 1/200. Equal volumes of 
each reaction were then loaded onto either a. 4% (40:1) non-denaturing 
polyacrylamide or b. 2% Nusieve: 1% agarose gels. 
ETH0DS. All binding reactions were performed as described previously' 
in Fig. 2 legend, except that once equilibrated on ice a further 1 p.l of 
- .her binding buffer or the appropriate dilution of serum was added and 
,tuated for a further 5 min on ice before loading onto gels. Gels were run 
B 	hpr:''"1.,r 	"O .'Y:nTu'e Selh yOre C:m 
, 
00 	 -400 	 -300 	-200 	 -100 
29. 30, multimeric form of an oligonucleotide con -  
then the cuading yeast activity, so to give comparadle autoradiographic 
times and reveal all the retarded species. only 5 p.g S. pombe crude extract 
was used in this experiment, 
METHODS. All binding reactions were performed with 0.5 ng Y_12  P-5' end-
labelled 73-bp A/ul/Sau3A fragments at -'-1 x 10 8  c.p.m. p.g 1. The prepar-
ation of clarified crude extracts, protein estimations, binding buffer and gel 
running conditions were as before', except that electrophoresis was through 
nondenaturing 4% (401) polyacrylamide gels. 
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FIG 3 Gel retardation analysis of the 'DSCl-like activity in S. pombe cdclO 
mutants, a. In vivo temperature shift. Mid-log cultures of S. pombe wild 
type (lanes 1-6) and cdc10-129 cells (lanes 7-12), grown at 25 'C, were 
shifted to 37 CC  and samples taken at 0, 5, 30.60. 120 and 210 mm. Clarified 
crude extracts were prepared and 10 IJg wild type or 20 ig cdc10-129 
aliquots were assayed for DSC1-like activity. The small arrowhead indicates 
the specific DSC1-like retarded product and the larger arrowhead indicates 
the unbound probe. b. In vitro temperature shifts. Clarified crude extracts 
were prepared from wild type (lanes 1-4). cdclO-129 (lanes 5-8). cdc10-
K28 (lanes 9-12) and cdc10-C4 (lanes 13-16) cells grown at 25 °C to 
mid-log phase. These clarified crude extracts were then incubated at 28 CC 
for 0, 5. 10 and 15 min respectively, as indicated, immediately before use 
in binding assays. Note that 10 IJg wild-type extract and 20 ig cdclO 
mutant extract was used for each time point. c. Mixing experiment. Clarified 
crude extracts from wild-type cells (10 p.g: lane 1) or cdc10-129 mutar';t 
cells held at the restrictive temperature for 1 h (20lug; lane 2) were assayed 
either individually or mixed together (10 lu.g wild type 4-20 g cdclO-129: 
lane 3). d, Analysis of revertants and plasmid rescue of the mutant 
phenotype. Three spontaneously occurring intragenic revertants (confirmed 
by genetic analysis) of the cdclO-129 allele were isolated, grown to mid-log 
phase at 25 "C sampled (lanes 1. 3 and 5). shifted to 37 "C for 1 h and then 
sampled once more (lanes 2.4 and 6). Lanes 1, 2. revertant 1; lanes 3,4 
revertant 2: lanes 5.6 revertant 3. The cdc10-129 mutant strain was also 
Received 2 August accepted 7 November 1991 
LowndeS. N F,, Johnson. A. L & Johnston, L H Nature 350, 247-250 (19911 
Johnston. L H. Lowndes, N. F., Johnson, A L & Sug;no. A. Cold Spring Har'b Symp quarrt Broi 
(in the press) 
1 Andrews, B J. & Herskowitz. I. i. bral. Chem, 265. 14057-14060 (1990). 
4 Maclrrtosh, E. Atjr,r,son. 1.. Storms. R. K, & smith. M Mdcc. cell. B,Ql. 11. 329-337 (1991). 
Sipiczkir M in Molecular Biology of the Fission Yeast reds Nasim. A., Young, P & Johnson. Or 
431-452 Academic. New Vary. 19891. 
Gordon, C. B & Farrtes, P A. EPrVO iS. 2981-2986 119861 
7 Nurse, P Thunaux. P & Nasmyth, K. Molec gen. Genet 146. 167-178 (1976). 
S. Nurse, P & Brssett. V Nature 292, 558-560 119811. 
9. Russell. P R Nature 301. 167-169 1983) 
10 White. J. H. M. Burlier. D G. Nurse. P. & Johnston, L H. El'r€O i 5. 1705-17091986) 
123 
to to 12345678 
T. 
trans'o'n "1 with a plusmid carring the wild 'i),! 0(7, 70 gene grown at 
25 C to mid-log phase, sampled (lane 7m, then shifted to 37 C for 1 h and 
sampled again (lane 8( 
METHODS All binding reactions were performed as described before' and 
in the legend to Fig 2 using 10 lug clarified crude extract unless otherwise 
stated. 
Nasmytir. K. A & Nurse. P Molec gee. Gerret 182. 119-124 (1981) 
Breeden. L. & Nusmyth. K Nature 329, 651-654 (1987) 
13 Andrews, B. J. & Herskowitz. I Nature 342. 830-833 '1989). 
Andrews. B. J. & Herskowitz, I. Cell 57,21-29119891. 
Nasmyth. K Nature 302. 670.67319831 
16 Breeden. L & Nasmyth. it Cell 48. 389-397 119871. 
17 Ayes. S. I. Dijrlracz. B W., Cart. A & Nurse. P. E%VO i 4.457-463(1985). 
18 Thompson. C. c. Brown. T. A. & McKnight, S. L. Science 253. 762-768 (1991). 
19 Siman,s. V. & Nurse, P 1 Cell, Sc,. 92. 51-56 (1989) 
20 Fernandez-Sarabia. M, J. & Fantes. P A Trends Genet. 6, 275-276 (1990). 
ACKN0WLEDG[IvNTS, We thank U. Deusctde, D. Beach and V Simanis for cdolO antiserum; 
Crezarror for cc1c10-C4 and for eiutrratron, and M J. Fernandez-Sardo,a for unpublished information. 
NATURE - VOL 355 ' 30 JANUARY 1992 
